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Minimally invasive surgery
Surgery is a cornerstone of medical management, also in gynecology. Minimally invasive 
surgery (MIS) is a medical technology that intends to minimize surgical trauma. It 
encompasses surgical techniques that limit the size of incisions needed, resulting in lower 
postoperative patient morbidity compared with conventional open approaches. MIS is called 
a technology because it applies on scientific principles and keeps on advancing to make 
its appliances smarter and more efficient. The rapid evolution of this technology has led to 
the development of new surgical applications within the field of minimally invasive surgery.
As a result of technological developments, MIS evolved rapidly. Less visible scarring, less 
postoperative pain and rapid recovery after MIS have fuelled patient advocacy and enabled 
an increasing use of laparoscopy. For healthcare providers, laparoscopy has the benefit of 
shorter hospital stays and thus reduced inpatient costs. The benefits for the surgeon include 
the magnified optics and no-touch operative technique (1,2). There is indeed evidence that 
laparoscopy has advantages compared to the open abdominal technique (i.e. laparotomy), 
which include fewer surgical injuries, fewer postoperative complications, less postoperative 
pain and shorter hospital stays (3,4,5). At present, with advanced laparoscopic operations 
for pelvic organ prolapse, urinary incontinence and gynaecological cancers, laparoscopy 
has become completely integrated into the field of gynaecologic surgery.
Another minimally invasive technique that became popular in the late 1970s is hysteroscopy. 
Hysteroscopy is the inspection of the uterine cavity by endoscopy with a transcervical 
approach. With the evolvement of hysteroscopic procedures, female sterilization became one 
of the possibilities within the palette of hysteroscopic procedures. Hysteroscopic sterilization 
aims at the objective of minimally invasive surgery: less morbidity and a quicker return to 
normal activities, attempted through avoiding the transabdominal route.  
The evolution of minimally invasive surgery has led to the development of many new 
technologies and techniques such as robot (-assisted) surgery, natural orifice transluminal 
endoscopic surgery (NOTES), and laparo-endoscopic single-site surgery (LESS). Robot 
surgery is a technological development where robotic systems are used to aid in surgical 
procedures (6). NOTES refers to surgery via natural orifices, where procedures are performed 
with transluminally placed instruments to gain access to the intra-abdominal cavity (7). LESS 
surgery is an advanced minimally invasive approach that allows laparoscopic operations to 
be undertaken through a single small incision, typically placed at the patient’s umbilicus (8). 
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Evidence-based guidelines in MIS
Scientific evidence from clinical research supports us to acquire knowledge whether 
minimally invasive procedures serve their intended aims. Evidence-based medicine (EBM) 
aims to use scientific methods to guide interventions in healthcare. An evidence-based 
guideline is an instrument to integrate the best evidence from clinical research into clinical 
practice. Evidence-based guidelines also aim to reduce variations, to stimulate evidence-
based clinical practice and to fulfil the internal and external (e.g. from health agencies and 
patient associations) need for transparency and controllability of healthcare.
In the Netherlands, the direct reason leading to development of an evidence-based guideline 
was the report of the Dutch Health Care Inspectorate ‘Risico’s minimaal invasieve chirurgie 
onderschat’ (9). The inspectorate had conducted a study of the risks presented by MIS 
procedures and observed many unsubstantiated pragmatic differences between general 
surgery, gynecology and urology. Though these specialisms practice relatively similar 
basic techniques, there was little cooperation to assure and improve the quality of MIS. 
Transcending the boundaries of monodisciplinary knowledge and skills and criticizing the 
differences between disciplines should result in multidisciplinary agreements to optimize 
patient safety. The involved professional bodies, mandated experts were to contribute to 
the development of the guideline.
Important topics that were identified from problem analysis for the MIS guideline were: 
laparoscopic entry techniques, intra-abdominal pressure, laparoscopic port instruments (i.e. 
trocars), port site closure, electrosurgical techniques, patient positioning, anesthesiology, 
perioperative care, patient information, multidisciplinary user consultation and complication 
registration. These problem topics were translated into clinical key questions. The scientific 
literature was systematically searched in collaboration with an information specialist. The 
scientific literature was summarised followed by a conclusion including the level of evidence. 
Then considerations, including patient preferences, availability of services, organization 
of care, impact of costs and legal consequences were discussed and recommendations 
were formulated. The recommendations in the guideline are the practical answer to the 
key question. They are based on ‘evidence’ (the summary of literature) and balanced with 
‘experience’ (the considerations). 
Evaluating the evidence of new techniques in MIS 
One of the identified important topics concerned laparoscopic port instruments (i.e. trocars). 
In laparoscopic procedures, intraperitoneal access for laparoscopic instruments is provided 
via ‘ports’. Specific cannulas, called trocars, are introduced through the abdominal wall to 
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create these ports. Trocars are commonly named in malpractice injury claims associated 
with laparoscopic procedures (10). The complications include intra-abdominal vascular and 
visceral injury, trocar site bleeding, herniation and infection. The incidence of trocar-related 
complications is estimated to be 3 to 4 per 1000 procedures (11,12). Of all trocar-related 
complications, vascular and visceral injuries are associated with the highest morbidity and 
mortality (11,13). Other trocar-related complications are trocar site herniation (TSH), trocar 
site bleeding and infection. It is important to determine how trocar-related complications 
may be prevented. It is hypothesized that trocar-related complications and pain may be 
attributable to certain types of trocars. Then, it would be possible to minimize trocar-related 
complications and pain. This question will receive further attention in this thesis.
The trocar designs illustrate the innovative character of MIS. To innovate, new designs and 
technologies are developed, introduced into surgical practice and evaluated for their clinical 
value. LESS was developed to extend the benefits of MIS: a single incision technique might 
offer advantages over the standard multiport laparoscopy as abdominal wall trauma is 
decreased, potentially leading to less postoperative pain and improved cosmesis (14,15,16). 
The potential drawbacks of the single port approach are a larger umbilical incision and 
the proximity of the instruments resulting in a technical challenge, especially for advanced 
surgery such as laparoscopic hysterectomy (17,18). Reports have currently shown the 
feasibility of LESS surgery in many benign gynecologic procedures (19,20). However, it remains 
debatable whether this new technology has added value over the existing conventional 
laparoscopic technique and whether it should be broadly implemented for hysterectomy. 
Hysteroscopic sterilization is another MIS innovation aiming at the objectives of MIS: incision-
free and withal reduced need for anesthesia which facilitates sterilization in an ambulatory 
setting. The initial techniques were difficult and inefficient. Failure rates were high, and 
serious complications by perforation and thermal bowel lesions were reported in clinical 
trials (21,22). Nevertheless there was continuing belief that hysteroscopic sterilization would 
be a suitable method for permanent contraception. In the past decades new systems became 
available, all with different mechanisms inducing fibrosis of the fallopian tubes leading to 
occlusion (23,24,25). These differing mechanisms may result in differences in feasibility, 
safety and effectiveness. Data from phase II and III clinical trials showed high feasibility and 
effectiveness, though their follow-up periods were relatively short (23,25,26). Hysteroscopic 
sterilization has limitations as well. Firstly, the likelihood of successful bilateral placement of 
the devices on first attempt varies from 76 – 96% (27). Secondly, hysteroscopic sterilization 
is not immediately effective; a period of 3 months is required for tubal fibrosis leading to 
tubal occlusion and contraceptive effectiveness. During these 3 months, women need to 
use alternative contraception until they can undergo a post procedure hysterosalpingogram 
(HSG). And thirdly, blockage does not occur in 5 – 16% of post procedural confirmation 
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tests (27). More than ten years after the introduction followed by broad clinical application, 
we question the feasibility, safety and effectiveness of current practice in hysteroscopic 
sterilization. Additionally, identifying risk factors for placement failure is important for patient 
selection and to identify cases at risk for failure of hysteroscopic sterilization. A review of the 
evidence of hysteroscopic sterilization techniques including an assessment of risk factors 
for failure is covered in this thesis.                                  
Finally, a recently introduced innovation in MIS practice and to be evaluated is robotic-
assisted surgery. In the late 1990s, MIS was introduced into urological surgical practice. 
Initially, surgeons adapting the laparoscopic radical prostatectomy (LRP) needed to overcome 
significant challenges and a significant learning curve (28). In 2000, the US company Intuitive 
Surgical Inc. launched the da Vinci® surgical system, leading to the development of robotic-
assisted radical prostatectomy (RARP) in the early 2000s (29). This surgical system offered 
technological innovations such as 3D visualisation, articulated instruments and tremor 
filtration, which addressed some of the technical limitations of LRP. In 2016, the total world-
wide procedure volume was approximately 653,000, therewith the da Vinci® dominates the 
market. However, the clinical implementation of robotic surgery in the Netherlands will be 
explored and discussed in the light of the available scientific evidence of RARP.  
Randomised controlled trials in MIS
Clinical research generates knowledge that allows assessment whether the aims of MIS are 
targeted. Randomised controlled trials (RCTs) represent the best method to evaluate healthcare 
interventions (30). They are the most rigorous way of assessing the effectiveness of a treatment. 
RCTs aim to evaluate the (clinical) advances of new and existing medical technologies. The 
bundled outcomes of different RCTs should ultimately lead to a clear answer whether the 
new method should be used over the existing method. The Cochrane collaboration is globally 
known as an independent network where the best evidence from research is gathered and 
summarised for the use of high quality information to make health decisions (31). In the case 
of MIS, the question remains whether randomized controlled trials serve the clinical needs of 
MIS? Is the design of a RCT feasible to produce enough real data to inform clearly about the 
important clinical outcomes effectiveness and safety? It is suggested that RCTs might be less 
feasible in surgery than in other medical domains (32). Furthermore, concerns exist about the 
objectivity of the conclusions of published RCTs. The scientific literature on lung cancer and 
rheumatology showed substantial discordant conclusions in the abstract versus article (33) 
and misleading conclusions (34). In order to investigate the usefulness of RCTs on MIS, we 
explore the clinical importance of study outcomes in RCTs in MIS, whether these RCTs are set 
up sufficiently to answer the study question and if their conclusions correspond to their results. 
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Thus, the current thesis explores the evidence base of new techniques in minimally invasive 
surgery. For this purpose the main objectives of this thesis are:
•	 To present a multidisciplinary evidence-based guideline for MIS including the 
main topics in laparoscopic surgery; 
•	 To identify the evidence of three new minimally invasive techniques: trocar types 
for laparoscopy, LESS-hysterectomy and hysteroscopic sterilization; 
•	 To evaluate the course of introduction of a new minimally invasive technique 
(robot-assisted surgery) and the status of the evidence;
•	 To assess whether recent RCTs serve the clinical needs of the MIS approach.
Outline of this thesis
Chapter 2 describes the development of a multidisciplinary evidence-based guideline for 
minimally invasive surgery. Recommendations for clinical practice are formulated based on 
the evidence and a consensus of expert opinion aiming towards better patient care and safety.
Chapter 3 describes a systematic review of randomized controlled trials that aims to 
determine whether specific trocar designs can be recommended for use in people undergoing 
laparoscopy, with a goal to minimize trocar-related complications and postoperative pain. 
Chapter 4 compares the safety and effectiveness of laparoendoscopic single-site surgery 
(LESS) and conventional laparoscopic hysterectomy using a systematic review and meta-
analysis.    
Chapter 5 contains a systematic review that assesses whether hysteroscopic sterilization 
is feasible and effective in preventing pregnancy. Secondarily risk factors for failure of 
hysteroscopic sterilization are identified.
Chapter 6 evaluates the clinical implementation of robot-assisted surgery in the Netherlands. 
Furthermore the results of a systematic review on the effectiveness and safety of most 
frequently performed robot-assisted surgical procedure: radical prostatectomy is discussed.
In Chapter 7 we inquire if randomised controlled trials serve the clinical needs of minimally 
invasive surgery. We critically appraise the clinical relevance, clearness and objectivity in 
randomised controlled trials on gynaecological minimally invasive surgery. 
Finally, in the general discussion a summary of the most important findings of this thesis 
will be outlined and perspectives for future research will be given. Eventually, based on the 
evaluated evidence-base of new techniques in minimally invasive surgery guidance towards 
more useful research in minimally invasive surgery will be provided.
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Part 1: Entry techniques and the pneumoperitoneum 
Claire F. La Chapelle, Willem A. Bemelman, Bart M.P. Rademaker, Teus A. van 
Barneveld, Frank Willem Jansen, on behalf of the Dutch multidisciplinary 
guideline development group Minimally Invasive Surgery
Gynecol Surg (2012) 9:271-82
Chapter 2
A multidisciplinary evidence-based guideline 
for minimally invasive surgery
Part 2: Laparoscopic port instruments, trocar site closure 
and electrosurgical techniques 
Claire F. La Chapelle, Willem A. Bemelman, Marlies Y. Bongers, Teus A. van 
Barneveld, Frank Willem Jansen, on behalf of the Dutch multidisciplinary 
guideline development group Minimally Invasive Surgery
Gynecol Surg (2012) 10:11-23
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Abstract
Background: The Dutch Society for Endoscopic Surgery together with the Dutch Society of 
Obstetrics and Gynecology initiated a multidisciplinary working group to develop a guideline 
on minimally invasive surgery to formulate multidisciplinary agreements for minimally 
invasive surgery, aiming towards better patient care and safety. 
Methods: The guideline development group consisted of general surgeons, gynecologists, 
an anesthesiologist and urologist authorized by their scientific professional association. 
Two advisors in evidence-based guideline development supported the group. The guideline 
was developed using the ‘Appraisal of Guidelines for Research and Evaluation” instrument. 
Clinically important aspects were identified and discussed. The best available evidence on 
these aspects was gathered by systematic review. Recommendations for clinical practice 
were formulated based on the evidence and a consensus of expert opinion. The guideline 
was externally reviewed by members of the participating scientific associations and their 
feedback was integrated. 
Results: Identified important topics were: laparoscopic entry techniques, intra-abdominal 
pressure, trocar use, electrosurgical techniques, prevention of trocar site herniation, patient 
positioning, anesthesiology, perioperative care, patient information, multidisciplinary user 
consultation and complication registration. The text of each topic contains an introduction 
with an explanation of the problem and a summary of the current literature. Each topic 
was discussed, considerations were evaluated and recommen dations were formulated. 
The development of a guideline on a multidisciplinary level facilitated a broad and rich 
discussion, which resulted in a very complete and implementable guideline.
PArt 1 Entry tEChniquEs And thE PnEumoPEritonEum
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introduction
Since the early 1990s, ‘minimally invasive surgery’ (MIS) or laparoscopic surgery has been 
rapidly implemented into a variety of surgical disciplines. Accordingly, new risks have emerged 
and complications of laparoscopic surgery are constantly being evaluated. The Dutch 
Healthcare Inspectorate (IGZ) conducted a study of the risks presented by MIS procedures 
and observed many unsubstantiated differences between general surgery, gynecology and 
urology. Although the basic knowledge and skills are identical regardless of specialism, 
multidisciplinary agreements were lacking. The Dutch Healthcare Inspectorate encouraged 
different specialties performing laparoscopy to work together and develop a multidisciplinary 
guideline for MIS.
This guideline represents a review of the evidence and consensus clinical opinion. The 
objective of this guideline is to provide guidance for MIS in daily practice. By formulating 
multidisciplinary agreements, the aim is to increase patient safety in MIS. It is intended 
primarily for all specialists performing laparoscopic surgery or those directly involved. 
This guideline can also be used as a standard by patients, patients’ organizations, hospital 
organizations, health insurances and government agencies. The scope of this guideline is 
laparoscopy in general, specific laparoscopic procedures are not addressed. Different aspects 
in MIS are described, including: laparoscopic entry techniques, pneumoperitoneum, trocar 
use, electrosurgical techniques, prevention of trocar site herniation, patient positioning, 
anesthesiology, perioperative care, patient information, multidisciplinary user consultation 
and the registration of complications.
In this first of two papers on the multidisciplinary guideline we present our literature 
reviews, conclusions and practical recommendations for entry techniques, and the 
pneumoperitoneum.   
methods
The Dutch Society for Endoscopic Surgery (NVEC) together with the Dutch Society for 
Obstetrics and Gynecology (NVOG) initiated a multidisciplinary working group to develop a 
guideline on MIS. Two general surgeons, two gynecologists, a urologist and an anesthesiologist 
participated in the guideline working group. All were authorized by their scientific professional 
association (the Dutch Society of Surgery, the Dutch Urological Association and the Dutch 
Association of Anesthesiologists respectively). Because of the surgical technical contents, 
patients were not involved in the guideline development.
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The guideline was developed consistent with the ‘Appraisal of Guidelines for Research and 
Evaluation’ (AGREE) instrument (1). Initially, the working group performed a problem analysis 
to define the scope and topics of the guideline. These problem-topics were translated 
into clinical key questions and the scientific literature was searched for answering the key 
questions. Separate search strategies were developed for each problem-topic. Searches were 
conducted in collaboration with information specialists. Studies were limited to English and 
Dutch language in view of the limitations on time and resources. The search strategies are 
appended (see appendix). The developers selected relevant literature. The bibliographies of 
relevant articles were hand searched for other valuable references. The characteristics and 
methodological quality of the studies were assessed using the checklists from the Dutch 
Cochrane Center (2). The evidence was summarized in evidence tables and in the guideline 
text. The grading system of the Dutch Institute for Healthcare improvement CBO, was used 
to level the evidence (table 1). The guideline text is structured according to a prescribed 
Evidence Based Guideline Development (EBGD) format. Each defined key question has its own 
text-section that comprises the clinical key question followed by a summary of the literature 
and a conclusion including the level of evidence. Then, considerations (including: patient 
preferences, availability of services, organization of care, impact on costs, legal consequences) 
are discussed and each section ends with recommendations. The recommendations are the 
practical answer to the key question. They are based on ‘evidence’ (the summary of literature) 
and balanced with ‘experience’ (the paragraph considerations). An illustrative overview of 
the EBGD process is shown in figure 1.
Background
The incidence of laparoscopic complications described in the literature varies considerably. 
Reported complication rates vary from 1.0 to 12.5 per 1,000, depending on the retrospective 
or prospective nature of the study, the definition of ‘complication’, the experience of the 
surgeons, the characteristics of the study-participants and the complexity of the procedure. 
The largest reported studies on complication rates in laparoscopy are based on gynecologic 
procedures. The Finish National Insurance Association registered a total of 256 complications 
in 70,607 gynecologic laparoscopic procedures (3.6 / 1,000). The incidence of gastrointestinal 
injuries was 0.6 / 1,000, of urological injuries 0.3 / 1,000 and of vascular injury 0.1/1,000 
(3). A Dutch prospective multicenter study reported 145 complications in a total of 25,764 
gynecologic laparoscopies (5.7 / 1,000). Two fatal cases were described and in 84 procedures 
a complication resulted in conversion to laparotomy. The incidence of gastrointestinal injuries 
was 1.13 / 1,000, and of intra-abdominal vessels 1.05 / 1,000. 57% of the complications were 
entry-related (closed and open-entry techniques were included). Women who had undergone 
a prior history of laparotomy, had an increased risk of complications (4).
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Other complications in laparoscopy are a pneumothorax or subcutaneous emphysema, 
with reported incidences of 1.9% and 2.3% respectively (5). Pneumothorax is frequently seen 
together with subcutaneous emphysema and associated with inadequate insufflation of 
CO2 through an improperly placed trocar or Veress needle (6,7). Subcutaneous emphysema 
may also occur when pressurized CO2 moves into pre-existing or iatrogenic defects in the 
diaphragm or retroperitoneum. Due to its good solubility, CO2 is rapidly absorbed in the 
blood circulation and may lead to an increase in hypercapnia and acidosis. Subcutaneous 
emphysema located in the head and neck area can lead to airway obstruction. The airways 
should therefore be secured until all emphysema has been dissolved (8).
Table 1 Grading system for level of evidence
Level Studies on therapy/ 
prevention
Studies on diagnostic 
accuracy
Studies on harm, etiology 
or prognosis 
A1 Systematic review/meta-analysis of at least two independent studies of A2 level with 
consistent results.
A2 Double-blind randomized 
controlled trial of good 
quality and sufficient power 
Study with respect to 
a reference test (gold 
standard) with pre-defined 
cut-off values, among large 
series consecutive persons 
that received both the 
index and the reference test 
and adequate blinding of 
interpretation of test results.
Prospective cohort study of 
sufficient power and follow-
up, adequate control for 
confounding and selective 
follow up.
B Randomized controlled 
trial of modest quality or 
insufficient power, or other 
analytic study (e.g. case-
control study, cohort study) 
A comparison with a 
reference standard that 
does not meet the criteria 
required for level A2 
evidence.
Prospective cohort study 
that does not meet the 
criteria required for level A2 
evidence. Or retrospective 
cohort study or case-control 
study. 
C Non-analytic study
D Expert opinion
Level Conclusion based on 
1 One systematic review (A1) or at least two independent randomized controlled trials of level 
A2. 
2 One study of level A2 or at least 2 independent studies of level B. 
3 One study of level B or C.
4 Expert opinion 
Grading system used at the Dutch Institute for Healthcare Improvement CBO.
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The incidence of complications related to laparoscopy is low; however they can be 
very severe. More than 50% of laparoscopic complications are entry–related and these 
occasionally require emergency surgery. Basically two different entry techniques can be 
distinguished: the open and closed-entry technique. Surgeons and urologists often use the 
open technique with Hasson trocar (also called the Hasson technique) (9) while gynecologists 
often use the closed technique with blind introduction of the Veress needle and primary 
trocar. The risks associated with the two different techniques are investigated and can be 
variously interpreted. The text below describes the strategies for a safe application of entry 
techniques in laparoscopy.
Key question
Which entry technique, open or closed, is associated with the lowest risks for complications?
summary of the literature
Injuries of the intra-abdominal vessels and bowel are known entry-related complications. 
Since the incidences of these complications are low, a randomized controlled trial (RCT) 
would not be the appropriate design to detect risk differences. To detect a risk difference 
for bowel injury from 0.3 to 0.2%, over 800,000 patients would be needed for inclusion in 
a RCT (10).
In a Cochrane review different entry techniques were compared in terms or their influence on 
intraoperative and postoperative complications (11). The outcomes were divided into major 
complications (mortality, vascular injury, bladder injury, bowel injury, gas embolism, solid 
organ injury) and minor complications (e.g., extraperitoneal insufflation, trocar site bleeding). 
Two RCTs were included (a total of 210 patients enrolled) wherein open and closed-entry 
techniques were compared. No significant risk differences were found for major and minor 
complications, neither in more specified analyses. In 2001, the Australian College of Surgeons 
systematically reviewed the effectiveness and safety of entry techniques for establishing 
a pneumoperitoneum in laparoscopic surgery. Besides RCTs, other relevant studies with 
different study designs were included. The outcome data for bowel injury and vascular injury 
in five nonrandomized prospective and retrospective comparative studies were pooled. A 
higher risk of bowel injury showed for the open compared to the closed-entry technique (RR 
2.17, 95% CI: 1.14 to 4.10). No statistical significant risk difference was found comparing the 
open versus closed-entry technique for vascular injury (RR 0.68, 95% CI: 0.16 to 2.84) (12).
Interpreting these results, the potential for selection bias should be taken into account. For 
example, the open-entry technique would often be the preferred technique in patients with 
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previous abdominal surgery. This selection bias may result in an increased relative risk of 
bowel injury for the open-entry technique compared to the closed-entry technique.
Conclusion
Level 1
No significant risk differences have been found for bowel and vascular 
injuries, when comparing the open-entry to the closed-entry technique.
Evidence level A1 (11) 
Considerations
Theoretically, it could be claimed that retroperitoneal vascular injury can be prevented 
by using the open-entry technique and thereby eliminating the potential for abrupt and 
uncontrolled introduction of the primary trocar that may result in a deeper penetration than 
needed. This risk is inherent in the closed-entry technique and thus vigilance is needed. In 
practice, it shows that the risk of uncontrolled introduction reduces by gaining experience. 
No robust conclusions can be drawn from the results of nonrandomized studies because of 
insufficient power and a high risk of bias.  
recommendations
•	 In general, no completely safe entry technique can be recommended. Specialists should 
preferably practice the technique they have learned and with which they are familiar. 
According to expert opinion, experience with a particular entry technique will reduce the 
risks of complications. Exceptions to this rule are: patients with prior abdominal surgery, 
obese patients, very thin patients and pregnant patients.
Key question
How should the closed- and open-entry techniques be performed?
summary of the literature 
There are no comparative studies of good methodological quality about differing aspects in 
specifically closed- and open-entry techniques. The majority of the studies are descriptive 
and based on expert opinions.
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Closed-entry technique: placement of the Veress needle
The Veress needle will be checked for its potency and spring action before inserting it into 
the abdomen. This is to ensure a free flow of CO2 and the protective function of the blunt tip. 
The blunt tip emerges out of the sharp end to protect the bowel and other intra-abdominal 
organs from inadvertent puncture.
 The abdominal wall is lifted until a 45° angle to the horizontal. This can be done by lifting the 
skin at the umbilicus by hand or with a towel clip. In the Cochrane review on laparoscopic 
entry techniques, one RCT was included comparing abdominal wall lifting versus not lifting for 
placement of the Veress needle. Not lifting the abdominal wall showed less failed entries, with 
no difference in complication rate. According to the experts however, abdominal wall lifting 
is aimed to prevent compression and thereby reduction of distance between instruments 
and retroperitoneal structures. The Veress needle is inserted perpendicular to the fascia and 
then directed towards the surgical field, avoiding the major vessels.
There are several tests to verify the correct position of the Veress needle tip. Different tests 
were evaluated in an observational study and it was concluded that a low initial gas pressure 
(< 10 mm Hg) followed by a free influx of CO2 is the only valuable measure to reflect correct 
intraperitoneal Veress needle placement (13).
Conclusions
Level 3
A low initial gas pressures (< 10 mm Hg), followed by a free influx of CO2, 
is a reliable indicator of correct intraperitoneal Veress needle placement. 
Evidence level B (13)
Level 4
There are insufficient high-quality comparative studies on safety and 
effectiveness of the different aspects in the specific open- and closed-
entry techniques. 
Evidence level D (opinion of the guideline development group)
Considerations
In practice, for selected patients only specific entry techniques are applied. An adequate 
selection is required.
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During every laparoscopic procedure, instruments to perform a laparotomy should be 
available. These could be necessary in case injury occurs for which a conversion is required. 
Prior to the closed-entry technique, the patient is catheterized or an indwelling catheter 
is inserted. A naso-gastric tube can be used. A filled stomach or bladder may hinder the 
placement of laparoscopic instruments or these structures can be damaged. Positioning 
the patient in Trendelenburg prior to the insertion of laparoscopic instruments could 
theoretically increase the risk of inadvertent aortic puncture. In most cases, the primary 
incision is preferred in the umbilicus because it overlies the location where the skin, fascia, 
and parietal peritoneum converge and fuse. Consequently, the distance between skin and 
abdominal cavity is short and an umbilical incision generally has a good cosmetic result. 
The skin incision should be large enough to prevent overshoot injury. In lean patients it must 
be avoided that the skin incision already involves the fascia. One should avoid stab incision. 
These precautions are not sufficiently investigated, but are considered common sense.
Closed-entry technique: insertion of the primary trocar
After the pneumoperitoneum is achieved and the Veress needle is removed, the primary trocar 
is inserted through the umbilical incision in the same directions as the Veress needle. When 
using a normal intra-abdominal pressure (IAP; 12 – 16 mm Hg), the umbilicus should be lifted 
and fixed as with the insertion of the Veress needle. Every move associated with introduction 
of the instrument should be well controlled. It is recommended to open the valve of the 
trocar to hear if the tip is located in the abdominal cavity. After inserting the laparoscope, 
visual inspection is intended to check for iatrogenic injuries and intraperitoneal aberrations.
open-entry technique: insertion of the primary trocar
In the open-entry technique the introduction of sharp instruments is avoided. A small incision 
is created and the layers of the abdominal wall are incised. The peritoneum is opened bluntly 
or sharply. When reaching the peritoneal cavity this is often visible and can be verified by 
palpation with a finger. The primary trocar is then inserted and CO2 is inflated to create the 
pneumoperitoneum. Today, balloon blunt-tip trocars are commonly used. The distal end of 
the sleeve has an inflatable balloon to create an air-tight fixation of the trocar.
trocar removal
At the end of each laparoscopic procedure, the removal of all trocars should be under direct 
vision. As yet, unnoticed injuries, e.g. tamponaded hemorrhage or bowel perforation, can 
be detected. Thereby, trocar site herniation can possibly be prevented by avoiding bowel 
or omental tissue is pulled into the trocar site.  
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recommendations for the closed-entry technique
•	 Prior to continuing the insufflation, the initial IAP should be <10 mm Hg (measured via 
Veress needle).
•	 Prior to the closed-entry technique, it is preferable to insert a nasogastric tube and to 
empty the urinary bladder.
General recommendations for primary entry
•	 Instruments to perform an emergency laparotomy should be available at close hand. 
These could be necessary in case a complication occurs for which conversion is required.
•	 During primary entry, the patient must be positioned horizontally until the primary 
trocar is safely inserted. The umbilicus can be stabilized by lifting it, this can prevent 
compression and consequent reduction of distance between instruments and 
retroperitoneal structures.
•	 After opening the peritoneum and prior to the introduction of the (blunt) primary trocar, 
it is important to ensure that the peritoneal cavity has been reached.
•	 The primary trocar must be introduced in a controlled manner, at an angle of 90 ° to 
the fascia. Once the peritoneal cavity has been reached, the insertion must be stopped 
immediately.
•	 After introduction of the laparoscope, the abdomen must be inspected for adjacent bowel 
by rotating the laparoscope 360°. If adjacent bowel is observed, it must be inspected for 
(signs of) hemorrhage, lesion and retroperitoneal hematoma.
•	 The removal of all trocars should occur under direct vision, to recognize a tamponaded 
hemorrhage or a bowel perforation that has not been noticed, and to prevent bowel or 
omental tissue to be pulled into the trocar site. 
Key questions
Closed-entry technique and IAP: 
1. What IAP should be achieved prior to insertion of the primary trocar?
2. What IAP should be applied once the insertion of trocars is complete?
summary of the literature
When applying ‘peritoneal hyperdistention’, the abdomen is insufflated to 25 – 30 mm Hg 
before inserting the primary trocar. After introduction of the trocars, the IAP is reduced to a 
normal pressure (12 – 16 mm Hg). 
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Prospective observational studies have shown that the increased size of the ‘gas bubble’ has 
a splinting effect and allows the trocar to be more easily inserted through the layers of the 
abdominal wall. Furthermore, when force is applied to a hyper-distended abdomen (25 mm 
Hg), the depth under the umbilicus is larger, compared to a normally distended abdomen 
(10 mm Hg) (14). An increased IAP induces a hemodynamic stress response. The venous 
return from the lower extremities alters, cardiac output decreases and there is an increase 
in mean arterial pressure (MAP) systemic, pulmonary and vascular resistances (15-17). In a 
prospective observational study, significant hemodynamic changes were observed when 
the IAP was elevated above 12 mmHg. There was a decrease in stroke volume and cardiac 
output and an increase in MAP and systemic vascular resistance (18). 
No studies were found that analyzed for the upper limit of IAP. Neither systematic reviews 
nor RCTs evaluating the clinically relevant consequences of ‘peritoneal hyperdistention’ 
were found. In a prospective cohort study including 100 women undergoing gynecological 
laparoscopy, hemodynamic changes were analyzed. High pressures (25 – 30 mm Hg) resulted 
in minimal changes in heart rate and blood pressure and a statistical significant decrease 
of pulmonary compliance, all without clinically relevant consequences (19). This study 
was conducted in healthy women with classified American Society of Anesthesiologists 
scores (ASA) I and II. The hemodynamic and pulmonary consequences of ‘peritoneal 
hyperdistention’ has not been studied in men and patients with higher ASA-scores. A larger 
prospective cohort study (1,150 consecutive ASA I patients undergoing gynecological 
laparoscopy) investigated the safety of the pressure technique for insertion of the primary 
trocar. No insertion complications or adverse clinical effects were noted during hospital 
stay (20).
In a Cochrane review, the harms and benefits of the low pressure pneumoperitoneum (< 12 
mmHg) compared with standard pressure pneumoperitoneum (12 – 16 mmHg) were assessed 
in patients undergoing laparoscopic cholecystectomy (21). A total of 15 RCTs were included 
(690 patients), all with high risk of bias. There was no difference in mortality, postoperative 
complications, or conversion to open cholecystectomy between the groups. None of the 
trials reported any cardiopulmonary complications. Only patients with ASA I scores were 
included in the trials, together with a low overall incidence of cardiopulmonary complications 
(0.5% in a case series of 400 patients, 70% of the patients were scored ASA I) (22) the meta-
analysis was under powered. In seven trials, the outcome data were incomplete: reasons 
for conversion were not reported. This caused a high risk of bias and thus the safety of the 
low-pressure pneumoperitoneum could not be ascertained (21). 
Chapter_2_Claire.indd   32 13-11-2017   17:15:40
33
MULTIDISCIPLINARY GUIDELINE FOR MINIMALLY INVASIVE SURGERY
2
Conclusions
Level 1
The safety of low pressure pneumoperitoneum (< 12 mm Hg) has only been 
studied in patients undergoing cholecystectomy. It is uncertain whether 
low pressures in comparison with conventional pressures, result in equal 
risks of morbidity and conversion to open surgery.
 Evidence level A1 (21)
Level 2
Elevated IAP above 12 mm Hg is associated with significant hemodynamic 
effects. These effects did not demonstrate any clinically relevant 
consequences. 
Evidence level A2 (18)
Level 3
‘Peritoneal hyperdistention’ has only been studied and found to be safe 
in healthy female patients with ASA scores I or II.
 Evidence level C (19,20)
Level 3
‘Peritoneal hyperdistention’ (insufflation to IAP 25 – 30 mm Hg), results in 
an increased size or ‘gas bubble’ and a splinting effect of the abdominal 
wall, compared to the traditional, limited-volume pneumoperitoneum.
Evidence level C (14)
Considerations
The abdominal wall cannot be lifted when the abdomen is hyper distended. Thus when using 
the ‘peritoneal hyperdistention’ technique, the primary trocar is inserted perpendicular to 
the abdominal wall.
‘Peritoneal hyperdistention’ can result in hemodynamic changes and compromise the 
respiratory ventilation of the patient. The anesthesiologist should therefore be informed 
when changing the IAP. ‘Peritoneal hyperdistention’ should last no longer than necessary: 
after introduction of the trocars, the IAP should be reduced to a normal pressure (12 – 16 mm 
Hg). High pressures did not result in any clinical relevant compromises in healthy patients but 
could possibly have more clinically significant effects in patients with ASA III and IV scores.  
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RCTs have shown that the use of a low pressure pneumoperitoneum results in less 
hemodynamic changes (22), less shoulder pain (23,24), less postoperative pain (25) and less 
use of analgesics (24,25). However, main criticism of low pressure pneumoperitoneum is its 
ability to provide adequate surgical exposure and its safety.
recommendations for iAP
•	 Before blind introduction of the primary trocar, the IAP must be at least 12 – 16 mm Hg. 
The ‘pressure technique’ to 25 – 30 mm Hg may be applied briefly in selected patients. 
•	 After introduction of the trocars, the IAP must be reduced to a normal pressure (12 – 16 
mm Hg, depending on patient characteristics) creating sufficient distension to perform 
laparoscopy and where the anesthesiologist can provide safe and effective pulmonary 
ventilation.
Key question
What alternative entry techniques are available?
summary of the literature
direct trocar entry
The direct trocar entry has been described as an alternative to the Veress needle technique. 
The primary entry is initiated with one blind step instead of two (Veress needle and trocar). 
The direct trocar entry is faster than any other method of entry (26). In the Cochrane review 
on laparoscopic entry techniques, a meta-analysis was performed comparing direct trocar 
entry to Veress needle entry. A total of 1,909 participants in six RCTs were included and no 
major complications occurred with both techniques (27-32). There were however, statistically 
significant reductions in the risk of extraperitoneal insufflation and failed entry in the direct-
entry group (OR 0.06; 95% CI 0.02 – 0.023) and 0.22; 95% CI 0.08 – 0.56 respectively) (11).
other entry systems
Different entry-systems have been developed to reduce the risk of entry-related complica-
tions: direct-vision entry systems (33,34), radially expanding trocars (35), tapered blunt 
tipped trocars (TrocDoc, second generation Endotip®) (36). For the Cochrane review, no 
RCTs comparing direct-vision versus Veress needle entry were identified. There were no 
other observational studies with sufficient power to demonstrate a risk reduction for major 
complications when direct-vision entry was used. The Cochrane review on laparoscopic 
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entry techniques concludes that radially expanding access trocars offer advantages in 
terms of reduced trocar site bleedings, less extraperitoneal insufflations and failed entries 
(11,34,37,38). RCTs and other observational studies comparing tapered blunt tip-systems 
with the conventional Veress needle or open-entry technique did have insufficient power 
to demonstrate risk reductions for any complication. 
Needlescopes are optical Veress needles with 1 – 2 mm diameter (39). There is as yet no 
evidence for their superiority compared to the conventional Veress needle entry.
Conclusions
Level 1
Direct-trocar entry leads to fewer extraperitoneal insufflations and failed 
entries when compared with Veress needle entry.  
Evidence level A1 (11,27-32)
Level 1
For primary entry, radially expanding access trocars reduce the risks 
for trocar site bleedings, extraperitoneal insufflations and failed entries 
compared to conventional trocars.
Evidence level A2 (11,34,37,38)
Level 3
There is no evidence that use of direct vision systems, a tapered blunt 
tipped trocar or a needlescope for primary entry with is safer than the 
conventional open- or closed-entry techniques.
Evidence level C (26,40)
Considerations
Some RCTs excluded specific patient groups, e.g. patients with previous abdominal surgery, 
obese patients or patients at risk for subumbilical adhesions. Therefore, the results of these 
RCTs do not apply for the complete laparoscopic patient population. For a select patient 
group, the direct-trocar entry seems a safe and fast method with a lower risk of extraperitoneal 
insufflation and failed entry compared to Veress needle entry. This technique is not widely 
used in laparoscopic practice, probably because extensive experience is required for its use.
Chapter_2_Claire.indd   35 13-11-2017   17:15:40
Chapter 2
36
Moreover, high costs of newly developed systems could be a limiting factor for their use. 
Studies on cost effectiveness should be conducted to make informed choices for the use of 
specific instruments in laparoscopic practice. 
recommendations for alternative entry techniques
•	 The guideline development group does not recommend the use of direct trocar entry, 
since much experience is needed for safe application of this technique.  
•	 The use of visual entry systems is only recommended when an adequate pneumoperi-
toneum (with the Veress needle) has been created.
•	 Radially expanding trocars are an expensive alternative to standard trocars. The use of 
these trocars may reduce tocar site bleedings and extraperitoneal insufflations.
Key question
What alternative sites can be safely used for insertion of the Veress needle and primary trocar?
summary of the literature
The rate of adhesion formation at the umbilicus may occur up to 50% in patients following 
midline laparotomy and 23% following low transverse incision (41). A Veress needle or 
trocar should never be blindly inserted at a site where adhesions may be expected. In those 
cases, the umbilicus is not the appropriate site for closed-entry. The most usual alternative 
site following laparotomy, is in the left upper quadrant via Palmer’s point. Palmer’s point is 
located 3 cm below the costal margin in the midclavicular line. Adhesions are rarely formed 
in this area, though, in cases of previous surgery in this area or splenomegaly, Palmer’s point 
may as well be inappropriate.  
It remains unclear what rates of adhesion formation are found in patients following 
laparoscopy and thus which entry location is most suitable following a prior laparoscopy.
Conclusion 
Level 3
When periumbilical adhesions may be expected, Palmer’s point is the 
appropriate site for insertion of the Veress needle and primary trocar.
Evidence level C (41)
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Considerations
When periumbilical adhesions are suspected, either an open-entry technique or a closed-
entry at a different location (preferably Palmers’ point) must be performed. It could be an 
option to insert the primary trocar subumbilical, after first having excluded periumbilical 
adhesions with a needlescoop (42).
Other sites for insertion of the Veress needle and trocar have been described (suprapubic, 
through the uterine fundus or posterior fornix) but, given the greater risks of complications, 
are to be avoided.
recommendation for alternative entry site
•	 In the event of doubt or suspected periumbilical adhesions, the Veress needle and 
primary trocar should not be introduced at the umbilicus. An alternative technique 
(e.g., the open-entry technique or insufflation at the point of Palmer) should be chosen.
Key question
How should secondary ports be created?
summary of the literature
The safety of different methods to create secondary ports has not systematically been 
studied. A prospective observational study showed that 64% of the superficial epigastric 
vessels could be identified with transillumination. Laparoscopic visualization successfully 
identified 82% of the inferior epigastric vessels. Both methods were less effective as patient’s 
weight increased (43).
The insertion of secondary ports should be visualized laparoscopically, taking care to avoid 
injury to the vessels and viscera. Suprapubic insertion of a trocar puts the bladder at risk of 
damage; therefore the bladder should be visualized. If the margins of the bladder are unclear, 
the bladder can be filled retrograde.       
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Conclusion 
Level 3
Superficial epicastric vessels can be visualized with transillumination. 
Deeper epigastric vessels can be visualized laparoscopically.
Evidence level B (43) 
Considerations
Secondary ports are inserted perpendicular to the skin to minimize the iatrogenic defect in 
the fascia. Once the tip has passed the peritoneum it is directed towards the surgical site. 
The inferior epigastric vessels should be visualized laparoscopically to ensure that the entry 
site is away from the vessels. The deep epigastric arteries and venae comitantes are located 
lateral to the lateral umbilical ligaments. The visualization can be difficult in obese patients. 
Then, the incision should be placed lateral to the rectus sheath, taking care to avoid injury 
of the pelvic side wall. 
recommendations for secondary ports
•	 The superficial epigastric vessels should be visualized by translumination prior to 
the insertion of secondary trocars. Deeper epigastric vessels should be visualized 
laparoscopically.
•	 When inserting the secondary trocars, this must be under direct vision and with presence 
of an adequate pneumoperitoneum. The trocars should be inserted perpendicular to 
the fascia and then directed towards the surgical site.
•	 When a suprapubic port is inserted, attention must be paid to the localization of the 
bladder. Retrograde filling of the bladder is possible. 
Key question
What entry techniques should be applied for laparoscopy in a pregnant patient, a patient 
who is very thin or a patient with morbid obesity?
summary of the literature
No trials that compare different entry techniques in pregnant patients or very thin patients 
or patients with morbid obesity have been described. There is some descriptive literature 
for these specific patient groups. 
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the pregnant patient
Concerning pregnant patients, there are specific concerns for a higher likelihood of injury to 
the uterus or other intra-abdominal organs. From 12 weeks of gestation, the fundal height 
of the uterus increases rapidly. The Society of American Gastrointestinal and Endoscopic 
Surgeons (SAGES) published a guideline on laparoscopy in pregnancy (44,45). In this guideline 
the authors recommend that in the second and third trimesters of pregnancy, the site of 
entry should be adapted to the fundal height: from the umbilicus towards subcostal regions 
(46). In their opinion, through this adjustment together with elevation of the abdominal wall 
during insertion, both the Hasson technique and Veress needle entry could be safely and 
effectively utilized. 
the very thin patient
In children and extremely thin patients (BMI < 18 kg/m2), the aorta may lie less than 2.5 cm 
under the skin (47). These patients are at particular risk of retroperitoneal vascular injury 
during primary entry and for this reason, the open-entry technique or closed-entry at Palmer’s 
point are preferable.  
the obese patient
The site for primary entry, umbilicus or Palmer’s point, in obese patients should depend 
on the body habitus and distribution of fat. The location where the thinnest subcutis is 
expected is best used for inserting the Veress needle or trocar. The open as well as the closed-
entry technique can be applied. If the Veress needle is inserted vertically downward at the 
umbilicus, the mean distance from the lower margin of the umbilicus to the peritoneum is 6 
cm (with a standard deviation of 3 cm). In this way it is possible to use a Veress needle with 
standard length, even in extremely obese patients.
Conclusion 
Level 4
There is insufficient qualitative data comparing the safety of different 
entry techniques in pregnant patients, very thin patients and patients 
with morbid obesity.
Evidence level D (opinion of the MIS guideline development group)
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Considerations
In a pregnant patient, blind insertion of a Veress needle or trocar gives an additional risk of 
injury of the uterus. The SAGES describes a closed-entry can be considered, however, in our 
opinion, an open-entry technique is preferable. Since the fundal height can be increased in 
the first trimester due to a twin pregnancy or myomas, the open techniques is recommended 
in all trimesters. Attention should be paid to other aspects of laparoscopy in pregnancy as 
well: positioning, IAP, fetal monitoring and possibly medicinal tocolysis.
recommendations for specific patient groups
•	 In pregnant patients, the open-entry technique or closed-entry technique via Palmers’ 
point is preferred.
•	 In patients with underweight (BMI < 18 kg/m2 and children) the open-entry technique or 
closed-entry via Palmers’ point is preferred.
•	 In patients with morbid obesity (BMI > 40 kg/m2), the closed-entry technique via the 
umbilicus or Palmers’ point is preferred. 
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Appendix
Subject Database Search terms
Entry Medline 
(OVID) 
1950 – Aug 
2010
1. Laparoscopy/
2. exp *Laparoscopy/
3. Surgical Procedures, Minimally Invasive/
4. "lapar*scop*".m_titl.
5. "minimal invasive*".m_titl.
6. or/1-5
7. ("laparoscopic injur*" or "laparoscopic entr*" or "laparoscopic adj2 
complication*" or "closed laparoscop*" or "open laparoscop*" or 
"direct-entry adj2 laparoscop*").ti,ab.
8. 6 and 7
9. limit 8 to yr="2006 -Current"
10. RCT (filter)
11. SR (filter)
12. exp epidemiological studies/
Embase laparoscop*:ti OR ‘laparoscopy’/exp/mj OR ‘minimal invasive’:ti OR 
‘laparoscopic surgery’/exp AND ((laparoscopic NEAR/1 injur*):ab,ti 
OR (laparoscopic NEAR/1 entr*):ab,ti OR (laparoscopic NEAR/1 
complication*):ab,ti OR (closed NEAR/1 laparoscop*):ab,ti OR (open 
NEAR/1 laparoscop*):ab,ti OR ‘direct entry’:ab,ti) AND [embase]/lim AND 
[2006-2011]/py
Pneumo-
peritoneum
Medline 
(OVID) 1950 
– March 
2010
1. exp *Laparoscopy/ 
2. Surgical Procedures, Minimally Invasive/ 
3. "lapar*scop*".m_titl.
4. "minimal invasive*".m_titl. 
5. or/1-5 
6. Pneumoperitoneum, Artificial/ae [Adverse Effects]
7. 6 and 7 
Embase laparoscop*:ti OR ‘laparoscopy’/exp/mj OR ‘minimal invasive’:ti OR 
‘laparoscopic surgery’/exp AND (intraperitoneal NEAR/5 pressure OR 
intraperitoneal NEAR/5 insufflation) NOT [animals]/lim) 
Searchfilter RCTs
The literature search for entry techniques was based on the search strategy of the Green-top Guideline 
‘Preventing entry-related gynaecological laparoscopic injuries’ from the Royal College of Obstetricians and 
Gynaecologists. Medline and Embase were searched for relevant randomised controlled trials, systematic 
reviews and meta-analyses. The search was restricted to articles published in Dutch and English from 1966 
to Augustus 2010.
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Abstract
Background: Minimally invasive surgery (MIS) is practiced by different surgical disciplines 
applying similar basic techniques. In 2007, the Dutch Healthcare Inspectorate indicated the 
need for a guideline including multidisciplinary agreements for MIS aiming towards better 
patient care and safety. 
Methods: A multidisciplinary guideline development group was founded consisting of 
general surgeons, gynecologists, an anesthesiologist and a urologist. All members were 
authorized by their scientific professional associations. Clinically important aspects were 
identified and discussed. The best available evidence on these aspects was gathered by 
systematic review. Recommendations for clinical practice were formulated based on the 
evidence and a consensus of expert opinion. The guideline was externally reviewed by 
members of the participating scientific associations and their feedback was integrated. 
Results: Identified important topics were: laparoscopic entry techniques, intra-abdominal 
pressure, laparoscopic port instruments, electrosurgical techniques, prevention of trocar 
site herniation, patient positioning, anesthesiology, perioperative care, patient information, 
multidisciplinary user consultation, and complication registration. The text of each topic 
contains an introduction with an explanation of the problem and a summary of the current 
literature. The current available evidence on safety aspects in minimally invasive surgery is 
limited. Few conclusions could be deduced from evidence-based data. This underscores 
the need for larger studies with adequate design and methodology to define conclusions of 
importance. Above all, the development of this multidisciplinary guideline facilitated a rich 
discussion, which resulted in a very complete and implementable guideline. This is the second 
of two papers on the multidisciplinary guideline for minimally invasive surgery, in which we 
present our literature reviews, conclusions, and practical recommendations for the use of 
specific port instruments, port site closure and electrosurgical and ultrasonic techniques.
PArt 2 LAPArosCoPiC Port instrumEnts, troCAr sitE CLosurE 
And ELECtrosurGiCAL tEChniquEs
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introduction and methods
Since the early 1990s, minimally invasive surgery (MIS) or laparoscopic surgery has been 
used extensively to diagnose and treat a variety of conditions. The advancing technology 
and methods of laparoscopic surgery offer increasing surgical possibilities. Laparoscopic 
surgery is practiced in different surgical disciplines, general surgery, gynecology and urology, 
using relatively similar basic techniques. Despite these similarities, there is little cooperation 
between the different disciplines to assure and improve the quality of minimally invasive 
surgery. A number of monodisciplinary gynecological guidelines on laparoscopic entry 
techniques do exist, a well-known one is the guideline from the Royal College of Obstetricians 
and Gynaecologists (1). Though, transcending the boundaries of monodisciplinary knowledge 
and skills and criticizing the differences between disciplines should result in multidisciplinary 
agreements to optimize patient safety. The Dutch Healthcare Inspectorate encouraged the 
national scientific associations representing laparoscopically oriented surgeons to work 
together and develop a multidisciplinary guideline on MIS.
In our previous paper we described the Evidence-Based Guideline Development (EBGD) 
methodology (2). In short, the EBGD-process includes the following steps: 1) problem analysis; 
2) explicit formulation of the questions that the guideline is addressing (key questions); 3) 
defining eligibility criteria for evidence to be considered; 4) conducting a comprehensive 
search for evidence (search strategies are appended, see appendix); 5) evaluating study 
quality; 6) summarizing the evidence and drawing scientific conclusions; 7) balancing the 
benefits and downsides of the alternative management strategies, discussing values and 
preferences (other considerations); 8) formulating recommendations based on evidence and 
consensus clinical opinion; 9) discussion about the draft guideline within working group, 10) 
setting up a final draft guideline; 11) external review by members of the participating scientific 
associations; 12) revision and finalization of the guideline, and finally; 13) authorization 
and; 14) dissemination of the multidisciplinary guideline by the participating scientific 
professional associations.
In our first paper, we focused on primary entry techniques and the application of a 
pneumoperitoneum in laparoscopic surgery. The first technical step in laparoscopy is 
the primary entry: the introduction of a primary instrument (Veress needle or primary 
trocar) in the abdominal cavity, followed by the insufflation of carbon dioxide to create a 
pneumoperitoneum.
When the pneumoperitoneum is achieved, specific laparoscopic port instruments are 
introduced through the abdominal wall. Port instruments consist of several components: 
a central trocar, a corresponding peripheral cannula, a valve section, and a CO2 stopcock. 
After insertion of this instrument, the central trocar is removed and the remaining cannula 
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functions as an access port for laparoscopic instruments. The primary port, generally created 
in or near the umbilicus, is used for the introduction of the laparoscope. The creation of the 
primary laparoscopic port is called “primary entry”. Secondary or ancillary ports are intended 
for the introduction of other laparoscopic instruments. The creation of secondary ports is 
called “secondary entry”. The method of port creation, the port instruments’ design and the 
port location influence the risk of port-related complications. 
Laparoscopic port instruments include a myriad of device designs, including over 100 brands 
from more than 20 manufacturers (3,4). Differences in diameter, shape and material can result 
in an increased risk of laparoscopic port-related complications. An important postoperative 
port-related complication is port site herniation (PSH), a protrusion of intestine or omentum 
through a remaining defect at the laparoscopic port site. It is questionable whether closing 
the defect by suturing, can prevent these herniations. In the initial problem analysis for this 
guideline, differences in the use of port instruments and port site closure were identified 
as important topics within laparoscopic surgery as well as electrosurgical and ultrasonic 
modalities. These modalities are very useful for coagulation and hemostasis in laparoscopic 
surgery but have been associated with serious complications. In this second paper on the 
multidisciplinary guideline on MIS, we discuss the evidence and consensus clinical opinion 
for the use of specific port instruments, port site closure, and electrosurgical and ultrasonic 
techniques. 
Laparoscopic port instruments
Background
Laparoscopic port instruments are the most common device named in malpractice injury 
claims associated with laparoscopic procedures, representing one-third of all claims (5). The 
incidence is estimated to be 4.24 per 1,000 procedures (3). Typical port-related complications 
are: intra-abdominal vascular injury, visceral injury, port site bleeding, port site herniation, 
port site infection, and pain. In the last few decades, there has been continuous innovation 
of the instrument design aimed at reducing these complications.
distinguishing primary from secondary port entry and different entry techniques
A distinction between primary and secondary entry needs to be made. Within the primary 
entry technique it has to be taken into account whether the open/Hasson-, closed/Veress 
needle- or non-insufflated/direct entry technique has been used. Less frequently used 
instruments for the primary entry are: visual port systems and single port techniques. These 
different conditions may result in different outcomes. The type of primary port instrument 
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depends on the applied primary entry technique where the type of secondary port instrument 
generally does not. In the Veress needle entry technique or the direct insertion technique, 
the insertion of the primary port instrument is a blind procedure while secondary port 
instruments are mandatorily inserted under direct laparoscopic vision.
Laparoscopic port instruments
A distinction can be made between reusable and disposable port instruments. Reusable 
instruments are composed of metal. The perforator tip can be completely blunt (cone 
shaped), or sharp with a conical, pyramidal, triflanged or eccentric tip. Disposable 
instruments are usually made of plastic with bladed or bladeless tips. Shielded disposable 
port instruments are equipped with a retractable covering over the tip and were developed 
to protect against intra-abdominal vascular and visceral injury. These formerly called “safety 
trocars” are however also associated with major port-related complications (6). The FDA does 
not allow anymore that the shielded port instruments are called safety trocars.
Radially expanding access (REA) systems represent yet another alternative in design. These 
port instruments are equipped with a radially expanding sleeve that can be dilated from 
5 mm to 12 mm in diameter. The REA instrument is developed to minimize tissue trauma 
and, in theory, its use could result in fewer vascular injuries. The optical access instruments 
are designed to decrease the risk of injury to the intra-abdominal structures by allowing the 
surgeon to visualize abdominal wall layers during placement (7). A visual system that should 
be distinguished is the threaded visual cannula (TVC). The TVC enables body cavity access 
by applying a blunt cannula where a pointed or sharp central trocar is not required, linear 
penetration force is realigned to radial and the cannula houses the laparoscope without an 
intervening pointed crystal that distorts visual layer enunciation (8). The diameters of port 
instruments vary from 2 mm to 12 mm, depending upon the largest instrument needed for 
a particular port. For exceptional indications (for example extirpation of large cysts), larger 
or modified trocars are available (4).
Despite continuous innovation in the design of port instruments to enhance patient safety, 
port-related complications do still occur. The guideline development group indicated a need 
for advices on the use of specific laparoscopic port instruments to ensure patient safety. 
Key question
What specific port instrument can be recommended to minimize the risks of port-related 
complications?
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summary of the literature
major port-related complications
Major complications are mortality, visceral injury (such as perforation of the intestines or 
stomach, or injury of the bladder or liver), vascular injury (such as perforation of the aorta, 
vena cava, iliac artery or iliac vein); and other injuries that required intensive care (IC) or 
intensive care unit (ICU) management or a subsequent surgical, endoscopic or radiological 
intervention. In the recently updated Cochrane review from Ahmad et al., different 
laparoscopic port instruments were studied (9). Eight RCTs were included comparing 
different port instrument designs. In four, REA instruments were compared with standard 
port instruments for primary port entry (10-13). Two RCTs compared cutting and blunt port 
instruments for primary and secondary port entry (14,15), and in two RCTs the REA instrument 
was compared to a conventional instrument with cutting tip for secondary port entry (16,17). 
Trials that analyzed major complications with low incidences, had too small sample sizes to 
identify any differences (10,12,15-17). Meta-analyses demonstrated no significant differences 
for major complications (table 1). Comparative prospective and retrospective studies on 
different laparoscopic port instruments did not evaluate major complications (18) or were 
underpowered (19). 
Table 1 Results from meta-analyses in Ahmad et al. for major port-related complications comparing 
different port instruments (9)
Radially expanding instruments versus standard instruments for primary port entry
Vascular injury OR 0.24 (95% CI 0.05 – 1.21)
Visceral injury OR 0.13 (95% CI 0.00 – 6.37)
Solid organ injury OR 1.05 (95% CI 0.07 – 16.91)
Cutting instruments and blunt instruments for primary and secondary port entry
Visceral injury OR 7.67 (95% CI 0.15 – 386.69)
OR = odds ratio, 95% CI = 95% confidence interval.
minor port-related complications
Minor port-related complications are port site herniation, port site bleeding or postoperative 
wound hematoma, port site infection, extraperitoneal insufflation and other injuries that 
did not require IC or ICU management or a subsequent surgical, endoscopic or radiological 
intervention under general anesthesiology. In the meta-analyses of the Cochrane review, 
some differences were found for minor port-related complications. REA instruments 
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compared to standard port instruments for primary entry were associated with a reduction 
of port site bleeding (OR 0.31 [95% CI 0.15 – 0.62] 3 studies, 421 participants). Comparing 
instruments with a cutting versus a blunt tip for primary port entry, no difference in port 
site bleeding (OR 0.33 [95% CI 0.09 – 1.23] two studies, 195 participants) or wound infection 
(OR 7.76 [95% CI 0.15 – 386.69] 1 study, 165 participants) was found. For secondary entry, 
radially expanding instruments were associated with lower rates of port site bleeding 
compared to conventional instruments with a cutting tip (OR 0.12 [95% CI 0.02 – 0.92] 1 
study, 68 participants). No difference was found for port site infections after the use of REA 
instruments versus conventional instruments for secondary entry (OR 0.14 [95% CI 0.01 – 
2.21] one study, 61 participants).
A prospective cohort study comparing REA instruments to conventional sharp-shielded 
pyramidal instruments for secondary entry was probably underpowered to identify 
a difference in port site bleeding (OR 0.18 [95% CI 0.01 – 4.00] 19 participants) (19). A 
retrospective cohort study compared reusable steel cone shaped non-cutting instruments 
to a historical group where disposable sharp cutting shielded instruments were used (n = 
600) for secondary entry (18). A reduced risk was found for port site herniation (OR 0.09 [95% 
CI 0.01 – 0.69]) and for port site bleeding (OR 0.27 [95% CI 0.07 – 0.97]) when non-cutting 
instruments were used.
Port-related pain 
No systematic reviews on pain related to laparoscopic port instruments were found. A total 
of seven RCTs evaluated postoperative pain after the use of REA instruments to standard port 
instruments for primary and/or secondary port entry. For primary and secondary ports, two 
RCTs found no differences (n = 77 and n = 56) (11,15) and one was in favor of REA instruments 
(n = 87) (12). For primary ports specifically, one RCT found no difference (n = 244) (10) whereas 
another RCT indicated less postoperative pain up to 12 h postoperative in patients where 
REA instruments were used (n = 100) (13). For secondary ports specifically, two RCTs reported 
less postoperative pain when REA instruments versus conventional instruments were used 
(n = 68 and n = 54) (16,17). Two RCTs found no differences for postoperative pain when blunt 
or cutting instruments were used (15;20). A prospective cohort study from Turner et al. (n 
= 19) found less pain at secondary ports where REA instruments were used compared to 
conventionally cutting instruments (19).
There is substantial clinical and statistical heterogeneity between these trials. Within the 
studies, factors that could have influenced the results in these studies are: fascial closure, 
manipulation at the port site and postoperative analgesics. In most of the studies on pain 
regarding the use of different laparoscopic port instruments, no intention was made to 
identify any confounders neither to correct for confounders in the analysis.
Chapter_2_Claire.indd   51 13-11-2017   17:15:40
Chapter 2
52
Conclusions
Level 1
There is no evidence to suggest that any type of laparoscopic port 
instrument is more or less safe in terms of reducing severe complications 
either during primary or secondary entry.
Evidence level A1 (9) 
Level 1
The use of radially expanding access instruments compared to standard 
(cutting) port instruments for primary and secondary port entry leads to 
fewer port site bleedings.
Evidence level A1 (9)
Level 3
The use of blunt port instruments compared to cutting port instruments 
for secondary port entry possibly leads to fewer port site bleedings and 
port site herniations.
Evidence level C (18) 
Level 1
REA instruments compared to conventional port instruments result in 
a decrease in postoperative pain. This reduction was not consistently 
found for primary entry.
Evidence level A1 (10-13,16,17,19) 
Level 2
It remains unclear whether the use of cutting or blunt port instruments 
has different postoperative pain scores.
Evidence level A2 (15,20)
Considerations
In the preceding text, we described the best available data on different laparoscopic port 
instruments and specific port-related risks. The studies available to analyze are of very small 
numbers and basically no definite conclusions of importance can be deduced from their 
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data. The expert’s opinion in gynecology is that laparoscopic surgeons may continue to use 
their chosen technique for port creation (21).    
Noticeably, the majority of trials compared REA instruments to conventionally cutting port 
instruments, even though they are not widely used in practice. A simple explanation could 
be encouragement by the pharmaceutical industry, though only two studies report that the 
REA instruments were supplied free of charge by the industry (15,16). REA instruments appear 
to have advantages in terms of less port site bleedings and postoperative pain. Reasons for 
their rare application probably are the higher cost price and a more complicated insertion 
technique of REA instruments compared to conventional instruments (15). No appropriate 
cost-benefit analysis for REA instruments is available; therefore, one should be careful with 
the wide implementation of these systems.
Laparoscopic port instruments are either intended for single use (disposable instruments) or 
multiple uses (reusable instruments). Environmental concerns and spiraling health care costs 
generally encourage reusable instruments (22). A disadvantage of reusable instrument is that 
their adequate function could diminish through repetitive use and sterilization. For example 
reusable sharp instruments lose their sharpness through repetitive insertion; consequently, a 
relatively high puncture force for penetration through the abdominal wall is required, which 
could result in an abrupt and uncontrolled introduction of the laparoscopic port instrument 
leading to serious visceral and vascular injury (23). No clinical trials comparing disposable 
to reusable laparoscopic port instruments were found. Multiple use of disposable port 
instruments is not recommended (24).
Another practical consideration that should not be overlooked is the use port instruments 
with a smaller diameter (e.g. with 5 mm diameter compared to 10 mm) resulting in less 
postoperative pain and shorter convalescence (25). 
A study revealed that blunt-tipped conical port instruments have a significantly greater fixity 
to the abdominal wall compared to cutting port instruments, resulting in significantly lower 
numbers of spontaneous port dislodgement during surgery (14). Accordingly, the use of blunt-
tipped instruments could reduce antecedent gas leak and loss of pneumoperitoneum and 
the need for port replacement with its associated increase in risk of trauma to the abdominal 
wall. On the other side, it appeared from animal studies that the entry force needed to 
perforate the abdominal wall is higher for conical blunt-tipped than pyramidal sharp port 
instruments (26). The higher entry force could increase the risk of injuries to the intra- or 
retroperitoneal organs during insertion. The use of optical-access port instruments does 
not avoid serious injury despite having the ability to visualize tissue layers during insertion 
(7). The TVC is a different system of which some experts consider it could be a less damaging 
approach (8). We found insufficient evidence to formulate clear recommendations for safe 
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and cost-effective use of laparoscopic port instruments. Larger comparative studies, with 
good methodological quality, are needed to clarify the important safety issues. The guideline 
development group supposes that the selection of a port instrument should, above all, 
be based on weighing the advantages against disadvantages of its characteristics and the 
experience of the surgeon with a safe application.
recommendations
•	 The selection of a laparoscopic port instrument should be based on the benefits of 
its characteristics to the individual patient and the experience of the surgeon in a safe 
application of the particular instrument. 
•	 The use of blunt-tipped instruments is preferred for laparoscopic ports with a 10 – 12 
mm diameter.
•	 Whenever possible, it is recommended to use port instruments with small diameters.
Port site closure
Background
The introduction of a port instrument through the abdominal wall creates a fascial defect. 
The estimated prevalence of PSH is 0.5% (27). Closure of the fascial defect could reduce the 
risk of port site herniation. In clinical practice, there is a wide variety of suturing methods. No 
consensus exists regarding the closure of the fascial defect according to the port instrument 
diameter. Also, risk factors for PSH should be defined. Below, the available evidence on fascial 
closure of port sites is discussed.
Key questions
Does fascial closure of port sites prevent or reduce the risk of port site herniation?
What is the minimal port site diameter whereby fascial closure should be advised?
What fascial closure technique can be recommended?
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summary of the literature
No RCTs or prospective observational studies were found that investigated fascial closure as 
a measure to prevent PSH. In two retrospective cohort studies, the PSH prevalence among 
patients with or without fascial closure were compared (28,29). Mayol et. al. observed that 
PSH in 10 mm umbilical ports occurred among patients with (3.3%, n = 151) or without 
(1.9%, n = 52) fascial closure (OR 1.8, [95% CI 0.2 to 15]). Kadar et al. neither identified a 
difference in prevalence of PSH in 12 mm extraumbilical ports when the fascia was closed or 
left open (8.0%, n = 25 versus 2.2% n = 136, OR 3.9, [95% CI 0.6 to 24]). The study does show 
that PSH could not completely be prevented by fascial closure: three hernias were found in 
136 patients. Both studies were underpowered to detect statistically significant differences.
We then performed a search to identify the port site diameter from which the risk of herniation 
becomes significant. The majority of reported cases on PSH occurred at ≥ 10 mm ports 
(30,31) however, these studies did not compare this with the prevalence of PSH in ports with 
different diameters. Only one retrospective cohort study shows a relationship between port 
instrument size and PSH (28). The prevalence of PSH was higher when instruments with a 
diameter of 12 mm compared to 10 mm were used (OR 13.7 [95% CI 1.6 – 118.3]). For 5 mm 
instruments compared to 10 mm trocars, no differences were found.       
Closure technique
The standard closure technique for the fascia at the port site is a hand-sutured figure-of-eight. 
A variety of other methods have been described (32). We found two comparative studies 
wherein different port-closure techniques were compared with the standard technique 
(33,34). No PSHs were observed as the studies were underpowered to analyze for differences 
in prevalence of PSH. 
More recently, cases of intrafascial incisional hernia were found in patients where 12 mm 
bladeless radially dilating instruments (without fascial closure) had been used (35). In this type 
of hernia, also called partial-wall hernia, bowel herniates through a defect in the transversal 
and internal oblique fasciae, but the external oblique fascia is intact. These patients present 
with symptoms of bowel obstruction but lack the typical signs of herniation during physical 
examination. This could be an argument for full thickness closure of the port site, including 
all abdominal layers (27).  
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Conclusions
Level 3
It is unclear whether fascial closure of port sites reduces the risk of PSH.
Evidence level B (28,29) 
Level 3
The prevalence of PSH is significantly increased in port sites where 
instruments with a diameter of 12 mm are used compared to sites where 
instruments with a diameter of 10 mm are used. 
Evidence level B (28,29) 
Level 4
It is unclear which fascial closure technique results in the least PSHs.
Evidence level D (opinion of guideline development group)
Level 4
Full-thickness closure of port sites could reduce the risk of intrafascial 
herniation.
Evidence level D (opinion of the guideline development group)
Considerations
From data obtained from current literature, it is generally recommended to close fascial 
defects ≥ 10 mm to reduce the risk of PSH (28,31). However, current information is inadequate 
and no evidence confirms that fascial closure reduces PSH. On the other hand, the risk of 
nerve injury, superficial vascular injury, and inadvertent injury of the bowel should be taken 
into account. Some suggested risk factors for PSH are preexisting umbilical hernia (36) or 
a history of port site hernia, history of postoperative wound infection, poor wound healing 
(e.g., diabetes mellitus, wound infection, chemotherapy, steroid use or poor nutrition), 
ascites, obesity, cachexia, asthma, connective tissue disorders and manipulation of the 
port (e.g., to retrieve specimens) (31). The extent in which these factors may pose a risk has 
been insufficiently researched.
In daily laparoscopic practice, some variety exists in the cutoff point of the port site diameter 
which should be closed; however the fascia at port sites > 10 mm are generally closed in 
all laparoscopic disciplines. In the literature, it appears that the risk of PSH is significantly 
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increased in port site diameters ≥ 12 mm and it is supposed that fascial closure reduces 
the risk. The working group aligned their recommendation with current practice and 
recommends to close the fascia of port sites > 10 mm diameter. The closure of smaller port 
site diameters should be considered, specifically when assumed risk factors are present. 
As previously noted, the use of blunt trocars compared to cutting trocars for secondary port 
entry possibly leads to fewer TSHs. This is explained through the stretching and separating 
of tissues by blunt trocars rather than cutting through tissue layers by cutting trocars. This 
could be a reason for not closing a fascial defect with a diameter ≤ 12 mm, where a blunt 
trocar has been used.
It should be noted that single port surgery and robot assisted surgery is not included in 
this guideline. It should be anticipated that in those techniques, a different port creation 
method is applied, probably increasing the occurrence of port site herniation and other 
port-related complications. 
recommendations
•	 Fascial closure is recommended for port sites with a diameter > 10 mm. It could also 
be considered to close fascial defects of smaller ports, especially when assumed risk 
factors are present.
•	 When blunt port instruments of ≤ 12 mm diameter are applied, it is an option not to 
close the fascial defect.
•	 There are no recommendations for a specific fascial closure technique. Full-thickness 
closure of the port site could be considered, since it possibly reduces the risk of PSH.
Electrosurgical and ultrasonic energy techniques
Background
Electrosurgical and ultrasonic energy techniques have become indispensable in minimally 
invasive procedures. These techniques are used for coagulation, cutting and hemostasis. 
The traditional modalities are monopolar and bipolar electrosurgery. Bipolar vessel sealing 
systems and ultrasonic technologies further improved the efficiency of operations and 
facilitated the surgical abilities to perform certain procedures. However, each of these 
energy sources can be associated with distressing complications. Compared to open 
surgery, a hazard in laparoscopic procedures is the visual field: the electrical current may 
damage adjacent structures outside the view of the laparoscope. Laparoscopic surgery 
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presents additional hazards for electrosurgery, the primary ones being direct application, 
insulation failure, direct- and capacitive coupling. Both electrosurgical instruments and 
ultrasonic instruments generate heat with the risk of thermal injury. It is important for users 
to have knowledge of the principles, applications, and safety aspects of the energy sources 
used in laparoscopy. We reviewed the literature concerning hazards of electrosurgical and 
ultrasonic energy sources in laparoscopy. Here we describe the specific complications and 
offer guidance to minimize the risks.
monopolar electrosurgery
Monopolar electrosurgery is used for cutting, coagulation, and hemostasis. With monopolar 
electrosurgery, the active electrode is located at the surgical site while the return electrode (a 
dispersive pad) is attached elsewhere to the patient’s body. The current flows from the active 
electrode, into the target tissue, through the patient, the dispersive pad, and subsequently 
returns to the generator. With the dispersive pad properly placed, the electrosurgical effects 
occur at the active electrode. 
General surgeons rely more on monopolar than on bipolar electrosurgery because of its 
ease of use (37). Monopolar electrosurgery provides a better penetration of the current 
density, which can be advantageous for hemostasis in certain tissues. A “blended cut” (blend 
of surgical effects) can be applied with a combined modus of cutting and coagulation. 
Additional capabilities are enhanced cutting, rapid dissection and non-contact fulguration. 
With fulguration, a high voltage electric current is used to destroy tissue; this may be useful 
to control diffuse bleedings.
Bipolar electrosurgery 
With bipolar electrosurgery, both active and return electrodes are located close together 
within the tip of the surgical instrument. The current flows from one tip to the other; only the 
tissue between the two electrodes is exposed to the electric current. Tissue thermal energy 
can be localized more precisely and is effective at a lower voltage and power. This enables 
electrosurgical safety. Bipolar instruments cannot be used effectively for pure cutting, and 
for coagulating the tissue should be gripped between the two electrodes. Because of lower 
power settings, bipolar coagulation of large areas and dense tissues requires more time. In 
addition, spray coagulation (fulguration) is not possible.     
Vessel sealing
Vessel sealing technology is a type of bipolar electrosurgery developed to coagulate blood 
vessels from a diameter of 2 – 3 mm and with minimized collateral tissue damage. An 
electrothermal bipolar vessel sealer (EBVS) combines an advanced electrical current with 
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mechanical pressure, in order to fuse the vessel walls and create a seal. The EBVS allows 
the secure sealing of vessels with a diameter of up to 7 mm (38,39). The seals obtained with 
EBVS have proven to be stronger compared to those obtained with traditional bipolar and 
ultrasonic technology (40,41). The available instruments have a diameter of either 5 or 10 mm 
(40). EBVS rely on a computer-controlled tissue feedback system that senses tissue impedance 
or resistance and adjusts the current and output voltage: a consistent electrosurgical effect 
is obtained through all tissue types.  
ultrasonic technology
With ultrasonic technology, electrical energy is converted into vibration and heat. The 
combination of a vibrating blade together with the produced heat forms the mechanism 
by which the instrument cuts and coagulates tissue. The heat generated by ultrasonic 
instruments is typically less compared to mono- and bipolar electrosurgery, resulting in 
less thermal injury to surrounding tissues. This optimizes the histopathology assessment 
of surgical margins. An ultrasonic instrument ensues less smoke emission and probably 
less toxin production since tissue destruction is by vaporization and avoid charring (42). 
As no electrical current is applied, there is no risk of direct coupling or capacitive coupling 
injuries. There are some disadvantages of ultrasonic technology: the formation of steam 
from tissues being treated can interfere with visualization through a laparoscope. After 
prolonged use, the vibrating blade may remain hot for a long period and create a risk of 
inadvertent thermal injury. 
The ultrasonic technology enables the coagulation and sealing of blood vessels from 2 – 5 
mm in diameter (43). It has been shown that this modality can be used safely and effectively 
in different laparoscopic procedures such as myomectomy, hysterectomy, cholecystectomy 
and colorectal laparoscopic surgery (43-46).
Key questions
What are the potential complications related to electrosurgery and what is the incidence 
of recognized injuries?
What measures can be taken to reduce the risk of electrosurgery-related complications?
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summary of the literature
Electrosurgery-related complications
Although electrosurgery-related complications are widely described, no systematic reviews, 
prospective or retrospective cohort studies or case-control studies were identified that 
collected data on the incidence of electrosurgery-related complications in laparoscopy. 
Several studies retrospectively analyzed data on laparoscopic electrosurgery-related 
complications limited to specific procedures (47-49). Consequently, a reliable incidence 
rate of electrosurgery-related complications is missing. The estimated incidence is 2 to 5 per 
1000 procedures (50). One of the most serious complications is bowel perforation caused 
by an electrosurgical burn, frequently unrecognized at the time of occurrence. Symptoms 
of peritonitis are usually seen 4 to 10 days later and often lead to long term complications.
Several RCTs comparing different electrosurgical and ultrasonic techniques were identified 
(41,43,45,51-53). There is considerable heterogeneity in the investigated surgical procedures 
between studies. In the majority of the trials, no difference in electrosurgery- and ultrasonic-
related complications was found. However, the studies were generally underpowered to 
identify differences in complications. The use of distinct electrosurgical and ultrasonic 
instruments depends on the suitability of the instruments characteristics in the type 
of surgical procedure. Therefore, the following text is a delineated description of the 
electrosurgical mechanisms that may lead to complications and how to avoid potentially 
dangerous situations.
hazards in monopolar electrosurgery
With monopolar electrosurgery, the patient forms a major part of the electrical circuit. This 
causes additional risks: stray currents, insulation failure, direct coupling and capacitive 
coupling.
stray currents through insulation failure
Insulation failure occurs when the insulation covering of the shaft of the active electrode is 
damaged. This allows the current to flow through alternative pathways and non-target-tissue. 
Breakdown of insulation can be caused by the use of high-voltage currents, repeated use, 
frequent re-sterilization, inappropriate use, or mechanical damage of instrumentation. The 
small and undetectable defects in the insulation are more dangerous, because this creates 
a higher current density.
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open circuit and detachment of the dispersive pad 
When the electrosurgical unit is activated without the active electrode in contact with the 
tissue (i.e. open circuit activation) a high-voltage level emerges at the active instrument. 
This may cause stray currents. Poor quality of contact between the dispersive pad and the 
patient’s skin compromises a safe return of the current to the generator. The dispersive 
pad must be of low resistance with a large enough surface (> 20 cm2). When the dispersive 
pad is (partially) detached through bony prominences, adipose, excessive hair, scar tissue, 
presence of fluid or lotions or dryness of the pad, the current exiting the body can have a 
high density. This may produce heat and unintended burns at the site of the dispersive 
pad. The use of a return electrode monitoring (REM) system averts these burns. This system 
inactivates the electrosurgical unit if the resistance between the patient’s body and the 
dispersive pad is too high. 
direct coupling and capacitive coupling
Direct coupling occurs when the electrosurgical unit is accidentally activated while the active 
electrode is in close proximity to another secondary non-insulated instrument (e.g., a metal 
laparoscope). Electrical current flows from the active electrode to the secondary instrument, 
and potentially damages adjacent structures.
Capacitive coupling occurs when current is transmitted from the active electrode through 
intact insulation and into adjacent materials without direct contact. Activation of the active 
electrode produces an alternating current inducing an electrostatic field between two 
‘conductors’ (conductive elements). When the net charge exceeds the insulator’s capacity, 
that current is transferred from one conductor to the other. Hybrid cannulas are prone to 
induce capacitive coupling, since the plastic parts prevent the current dissipating from the 
metal part into the abdominal wall. This can result in electrical current passing through 
nearby structures. Longer instruments, thinner insulation, higher voltages, and narrow 
trocars increase the risk of injury (43,50,54).
interference with (cardiac) implantable electronic device and prosthetics
Implantable devices that use electric current may be affected by the use of electrosurgery. 
In monopolar surgery, interaction of the current with a cardiac implantable electronic 
device (CIED) may have life-threatening consequences. Adverse effects include damage 
to the device, inability to deliver pacing or shocks, lead-tissue interface damage, and 
electrical reset. The preoperative management of the CIED function should be guided by the 
cardiologist or anesthesiologist (42). The risk of interference is low in procedures where the 
path between the active electrode and dispersive pad does not cross the CIED or its leads. 
There may be some diffusion of current and it is therefore safer to use bipolar electrosurgery 
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or ultrasonic technology in patients with implantable electronic devices (55,56). Conductive 
prosthetics should as well be placed out of the direct path of the circuit since activation of 
the electrosurgical unit may cause heating of the prosthetic material.
thermal injuries in electrosurgery and ultrasonic technology
Prolonged activation of both mono- and bipolar electrosurgical instruments as well ultrasonic 
instruments generate heat (up to 80 – 100˚C). The instrument can remain hot for some time 
after activation with the risk of thermal injury when it unintentionally touches surrounding 
tissue. 
Conclusions
Level 4
Bowel perforation, biliary- and urinary tract injuries are among the most 
serious electrosurgical injuries.
Evidence level D (opinion of guideline development group)
Level 2
There is insufficient evidence to define the differences in electrosurgery- 
versus ultrasonic-related complications.
Evidence level A2 (41,44,45,51-53)
Level 4
Exact incidence rates of electrosurgery-related complications are un-
known. The estimated incidence is 2 to 5 per 1,000 procedures.
Evidence level D (opinion of guideline development group)
Level 3
Additional risks of monopolar electrosurgery, compared to bipolar 
electrosurgery and ultrasonic technology, include: stray currents, 
insulation failure, direct coupling and capacitive coupling. 
Evidence level C (37,43,50,54)
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Level 4
Based on electrophysiology, the following factors increase the risk of 
electrosurgical injuries:
– The use of high-power and high-voltage settings
– Inadequate placement of the dispersive pad
– Hybrid cannulas
– The intermingling use of plastic and metal cannulas
– Long instruments and narrow cannulas
– Insulation failure
– Char of coagulated tissue on the instrument
– Prolonged activation of an electrosurgical instrument
– Activation of an electrosurgical instrument in an open circuit
Evidence level C (37,42)
Level 4
When using electrosurgery, cardiac implantable electronic devices and 
conductive prosthetics are additional hazards.
Evidence level D (55,56)
Considerations
The current available evidence on electrosurgical and ultrasonic energy techniques is 
inadequate to formulate definite evidence-based conclusions. Therefore, larger scale studies 
are needed. With the current information available, a safe application of these techniques 
can be achieved by adequate education of the surgical team and supporting staff. The team 
should be aware of the physics and hazards associated to the use of different energy sources 
used in MIS. Another obstacle in safety is that biomechanical engineers involved in the 
purchase of minimally invasive instruments, are not routinely involved in the maintenance. 
Reusable trocars and instruments are often used until defects appear; this might represent 
a danger to the patient. Participation of biomechanical engineers in maintaining and testing 
instruments in use could possibly prevent those dangers. Instead of reusable instruments, 
disposable instruments could be used to prevent insulation failure through wear and tear. 
However, disposable instruments are often more expensive and not immune from insulation 
failures.
Finally, postoperative vigilance is required when a patient does not easily recover. The 
surgeon, physicians, and nurses on duty should be highly alert to the early manifestations 
of peritonitis. The warning signs may be insidious with atypical or mild symptoms such as 
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slight abdominal discomfort, slight temperature increase, and inability to void. Symptoms of 
bowel perforation following electrothermal injury are usually seen 4 to 10 days after surgery, 
leading to a delay in diagnosis and treatment, with sometimes fatal consequences (54). 
Laboratory results are often normal with a slight leukocytosis. Expedient evaluation and early 
intervention is demanded when a patient’s recovery is below what should be expected (50). 
recommendations
•	 When using electrosurgical or ultrasonic techniques, one must have knowledge of 
electrophysiological functioning and effects.
•	 To reduce the risk of electrosurgical complications, the following precautions are 
recommended:
- When both mono- and bipolar instruments are used, pedals and connections should 
be checked for accuracy before activating the electrosurgical units.
-  Instrument electrodes should be kept smooth and clean from char, to avoid 
disruption of current transfer.
- To prevent capacitive coupling, an isolated position of metal trocars from the 
abdominal wall should be avoided. Use all-metal or all-plastic cannula systems, the 
use of metal-plastic hybrids is discouraged.
- An instrument should be activated only when its electrode is fully visible and in 
contact with the target tissue. Do not activate in an open circuit.
- Preferably use brief intermittent activation versus prolonged activation.
- Use the lowest possible power setting and low-voltage waveform for the desired 
effect. 
•	 Prior to each MIS procedure, monopolar instruments should be tested for insulation 
failure with a porosity detector at the central sterilization department.
•	 With monopolar electrosurgery, the dispersive pad should be applied to well-perfused, 
dry skin over a large muscle away from bony prominences and conductive prostheses. 
When disinfecting the skin, be cautious no fluid leaks under the dispersive pad.
•	 In patients with conductive prosthesis, it is strongly recommended to place the prosthesis 
out of the direct path of the electrical circuit.
•	 For procedures in patients with a CIED, the use bipolar over monopolar electrosurgery 
is preferred.
•	 Alertness for electrothermal injury is needed when a patient presents with mild symptoms 
such as slight abdominal discomfort or slight temperature increase.
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Appendix
Table Literature searches
Subject Database Search terms
Laparoscopic 
port 
instruments
Medline 
(OVID) 
1950 – 
March 2012
Embase
(Elsevier)
1974 – 
March 2012
1. *Laparoscopy/ 
2. (trocar* or troicar* or trocard*).ti. 
3. ((secondary adj trocar*) or (classical adj trocar*) or cannula or 
(disposable adj3 trocar*) or (radially adj expanding adj trocar*) or 
(STEP adj trocar*) or (visual adj entry) or systems or (conical adj trocar) 
or (pyramidal adj trocar*) or (reusable adj trocars*) or (disposable adj 
trocar*) or (single adj2 trocars) or optiview or endotip or visiport or 
(bladeless adj trocar*) or (sharp adj trocar*) or (trocar adj valve*)).ab,ti. 
4. 2 or 3
5. *Surgical Instruments/ 
6. "Equipment Design"/ 
7. exp Gynecologic Surgical Procedures/is [Instrumentation] 
8. Laparoscopy/mt [Methods] 
9. or/5-9 
10. 1 and 4 and 9 
11. systematic reviews (filter) 
12. randomized controlled trials (filter)
13. exp longitudinal studies/ 
14. 10 and 13 (trocar* OR troicar* OR trocard* OR 'secondary trocar' OR 
'classical trocar' OR 'radially expanding trocar' OR 'step trocar' OR 
'visual entry system' OR 'conical trocar' OR 'pyramidal trocar' OR 
'reusable trocar' OR 'disposable trocar' OR 'single trocar' OR optiview 
OR endotip OR visiport OR 'bladeless trocar' OR 'sharp trocar' OR 'trocar 
valvë' OR 'secondary trocars' OR 'classical trocars' OR 'cannula'/exp OR 
'radially expanding trocars' OR 'step trocars' OR 'visual entry systems' 
OR 'conical trocars' OR 'pyramidal trocars' OR 'reusable trocars' OR 
'disposable trocars' OR 'single trocars' OR 'bladeless trocars' OR 'sharp 
trocars' OR 'trocar valves') AND 'surgical instrument'/exp/mj NOT 
[animals]/lim) AND ([dutch]/lim OR [english]/lim AND [embase]/lim
Port site 
closure
Medline 
(OVID) 
1950 – Nov 
2009
1. exp *Laparoscopy/
2. "laparascop*".m_titl.
3. "minimal invasive*".m_titl.
4. 1 or 2 or 3
5. Surgical Wound Dehiscence/ Obesity/”obes*”.m_titl./ Body Mass Index
6. deep sheath closure*.mp. or Surgical Wound Infection/
7. port closure*.mp.
8. port site hernia*.mp.
9. port infection*.mp.
10. hernia/ or hernia, abdominal/
11. herniation.mp.
12. fascia defects.mp. or Hernia, Ventral/
13. or/5-15
14. exp *Sutures/
15. exp *Suture Techniques/
16. "suture*".m_titl.
17. 17-19
18. 4 and 16 and 20
19. 9 or 10 or 11 or 12 or 14 or 15
Table 2 continues on next page
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Table Continued
Subject Database Search terms
20. *Laparoscopy/ae [Adverse Effects]
21. 22 and 23
22. 21 or 24
23. “ventral hernia repair*”.m_titl.
24. 25 not 26
25. Roux-en-Y Gastric Bypass.m_titl.
26. (suture* or closure* or port*).m_titl.
27. 27 and 29
28. 30 not 28
Embase
(Elsevier)
1974 – Nov 
2009
(laparoscop*:ti OR ‘laparoscopy’/exp/mj OR ‘minimal invasive’:ti 
AND (‘deep sheath closure’ OR ‘port closure’ OR ‘port site hernia’ OR 
‘port infection’ OR ‘herniation’/exp OR ‘fascia defect’ OR ‘deep sheath 
closures’ OR ‘port closures’ OR ‘port site hernias’ OR ‘port infections’ OR 
herniations OR ‘fascia defects’ OR ‘wound dehiscence’/exp OR ‘obesity’/
exp OR ‘body mass’/exp OR ‘surgical infection’/exp OR ‘abdominal wall 
hernia’/exp) AND (‘suture’/exp/mj OR ‘suture’/exp OR suture*:ti)) NOT 
(‘roux en y’ AND gastric AND bypass:ti)
 AND filter randomized controlled trials
Electrosur-
gical and 
ultrasonic 
techniques
Medline 
(OVID) 
1950 – Nov 
2009
1. Laparoscopy/
2. Laparoscopy.ti. 
3. 1 or 2 
4. Electrosurgery/ 
5. Electrosurgery.ti. 
6. 4 or 5 
10. 3 and 6 
11. limit 10 to (dutch or english) 
12.  limit 11 to (clinical trial, all or clinical trial or review or comparative 
study or consensus development conference or controlled clinical 
trial or evaluation studies or guideline or meta analysis or multicenter 
study or practice guideline or randomized controlled trial or research 
support, nih, extramural or research support, nih, intramural or research 
support, non us gov't or research support, us gov't, non phs or research 
support, us gov't, phs or technical report or validation studies)
13. exp Epidemiologic Studies/ 
14. 11 and 13
15. systematic reviews (filter)
43. randomized controlled trials (filter)
68. 12 or 14
69. 68 not (66 or 67)
Embase
(Elsevier)
1974-Nov 
2009
‘clinical study’/exp OR ‘comparative study’/exp OR ‘controlled study’/
exp OR ‘observational study’/exp AND (‘electrosurgery’/exp/mj OR 
electrosurg*:ti) AND (‘laparoscopy’/exp/mj OR laparoscop*:ti) NOT 
[animals]/lim) AND ([dutch]/lim OR [english]/lim AND [embase]/lim
Medline (OVID) and Embase were searched for relevant literature on the topics trocar use, trocar site closure 
and electrosurgical and ultrasonic techniques. The search was restricted to articles published in Dutch and 
English from 1966 to November 2009, with exception to the search for trocar use which we updated in March 
2012. Additionally, the reference lists of all included studies and systematic reviews pertinent to this topic were 
screened. Methodological filters of the Scottish Intercollegiate Guidelines Network (http://www.sign.ac.uk/
methodology/filters.html) were used to identify potential systematic reviews and randomized controlled trials.
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Abstract
Background: Laparoscopic surgery has led to great clinical improvements in many fields of 
surgery; however, it requires the use of trocars, which may lead to complications as well as 
postoperative pain. The complications include intra-abdominal vascular and visceral injury, 
trocar site bleeding, herniation and infection. Many of these are extremely rare, such as 
vascular and visceral injury, but may be life-threatening; therefore, it is important to determine 
how these types of complications may be prevented. It is hypothesised that trocar-related 
complications and pain may be attributable to certain types of trocars. This systematic 
review was designed to improve patient safety by determining which, if any, specific trocar 
types are less likely to result in complications and postoperative pain. 
Objectives: To analyze the rates of trocar-related complications and postoperative pain for 
different trocar types used in people undergoing laparoscopy, regardless of the condition. 
Search methods: Two experienced librarians conducted a comprehensive search for 
randomised controlled trials (RCTs) in the Menstrual Disorders and Subfertility Group 
Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, 
EMBASE, PsycINFO, CINAHL, CDSR and DARE (up to 26 May 2015). We checked trial registers 
and reference lists from trial and review articles, and approached content experts.
Selection criteria: RCTs that compared rates of trocar-related complications and postope-
rative pain for different trocar types used in people undergoing laparoscopy. The primary 
outcomes were major trocar-related complications, such as mortality, conversion due to any 
trocar-related adverse event, visceral injury, vascular injury and other injuries that required 
intensive care unit (ICU) management or a subsequent surgical, endoscopic or radiological 
intervention. Secondary outcomes were minor trocar-related complications and postope-
rative pain. We excluded trials that studied non-conventional laparoscopic incisions.
Data collection and analysis: Two review authors independently conducted the study 
selection, risk of bias assessment and data extraction. We performed sensitivity analyses 
and investigation of heterogeneity, where possible.
Main results: We included seven RCTs (654 participants). One RCT studied four different 
trocar types, while the remaining six RCTs studied two different types. The following trocar 
types were examined: radially expanding versus cutting (six studies; 604 participants), conical 
blunt-tipped versus cutting (two studies; 72 participants), radially expanding versus conical 
blunt-tipped (one study; 28 participants) and single-bladed versus pyramidal-bladed (one 
study; 28 participants). The evidence was very low quality: limitations were insufficient power, 
very serious imprecision and incomplete outcome data.
Chapter_3_Claire.indd   76 13-11-2017   22:13:46
77
Trocar Types in laparoscopy
3
Primary outcomes: Four of the included studies reported on visceral and vascular injury (571 
participants), which are two of our primary outcomes. These RCTs examined 473 participants 
where radially expanding versus cutting trocars were used. We found no evidence of a 
difference in the incidence of visceral (Peto odds ratio (OR) 0.95, 95% confidence interval 
(CI) 0.06 to 15.32) and vascular injury (Peto OR 0.14, 95% CI 0.0 to 7.16), both very low quality 
evidence. However, the incidence of these types of injuries were extremely low (i.e. two cases 
of visceral and one case of vascular injury for all of the included studies). There were no cases 
of either visceral or vascular injury for any of the other trocar type comparisons. No studies 
reported on any other primary outcomes, such as mortality, conversion to laparotomy, 
intensive care admission or any re-intervention.
Secondary outcomes: For trocar site bleeding, the use of radially expanding trocars was 
associated with a lower risk of trocar site bleeding compared to cutting trocars (Peto OR 0.28, 
95% CI 0.14 to 0.54, five studies, 553 participants, very low quality evidence). This suggests 
that if the risk of trocar site bleeding with the use of cutting trocars is assumed to be 11.5%, 
the risk with the use of radially expanding trocars would be 3.5%. There was insufficient 
evidence to reach a conclusion regarding other trocar types, their related complications 
and postoperative pain, as no studies reported data suitable for analysis.
Authors’ conclusions: Data were lacking on the incidence of major trocar-related compli-
cations, such as visceral or vascular injury, when comparing different trocar types with one 
another. However, caution is urged when interpreting these results because the incidence 
of serious complications following the use of a trocar was extremely low. There was very low 
quality evidence for minor trocar-related complications suggesting that the use of radially 
expanding trocars compared to cutting trocars leads to reduced incidence of trocar site 
bleeding. These secondary outcomes are viewed to be of less clinical importance. 
Large, well-conducted observational studies are necessary to answer the questions 
addressed in this review because serious complications, such as visceral or vascular injury, 
are extremely rare. However, for other outcomes, such as trocar site herniation, bleeding 
or infection, large observational studies may be needed as well. In order to answer these 
questions, it is advisable to establish an international network for recording these types of 
complications following laparoscopic surgery.
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Plain language summary
Complications of trocar types for laparoscopic surgery
Review question
Laparoscopy is a modern operative technique to perform abdominal (belly) surgery through 
small incisions in the skin. Specific instruments, called trocars, are used to gain access to 
the abdominal organs through the skin. We reviewed the evidence to find out whether the 
use of different types of trocar for laparoscopic surgery leads to fewer complications and 
less pain in the first month following surgery.
Background
In laparoscopic surgery, trocars are needed to seal the skin openings, while permitting entry 
and removal of the surgical instruments. The introduction of trocars through the skin into the 
abdominal cavity is usually safe, yet, in a small minority of people, life-threatening complications 
can occur. The two most serious complications are puncture into a large blood vessel (occurs 
0.9 times per 1,000 operations) and puncture into abdominal organs (e.g. the intestine, stomach 
or liver) (occurs 1.8 times per 1,000 operations). Less serious but more frequent complications 
include bleeding or infection of the skin at the trocar insertion site. Also, the degree of pain 
following laparoscopy could depend on the type of trocar used. It is unclear whether specific 
trocar types are less likely to be associated with complications and postoperative pain.
Study characteristics
We identified seven randomised controlled studies (clinical studies where people are ran-
domly put into one of two or more treatment groups) that compared two or more different 
trocar types in 654 people undergoing laparoscopy. The evidence is current to May 2015.
Key results
From the data available in these studies, there appears to be no advantage from one trocar 
type over another for serious complications, which include visceral and vascular injury. 
However, caution is urged when interpreting these results because very few cases were 
identified for these types of complications.
Quality of the evidence
Most of our results are based on very low quality evidence, mostly due to the limited number 
of studies identified and low number of complications. Therefore, no specific trocar type 
can be recommended over another for laparoscopic surgery.
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Background
Description of the condition
Surgery is by nature invasive and inevitably associated with complications and trauma. 
Laparoscopic surgery, also known as minimally invasive surgery, was developed tominimise 
surgical trauma as opposed to the open abdominal surgical technique (i.e. laparotomy). A 
laparoscopic procedure is an abdominal or pelvic operation conducted through small incisions 
in the abdominal wall. In gynaecology, laparoscopy began in the late 1970s and was primarily 
used for diagnostic procedures. The first widely accepted laparoscopic procedure was tubal 
ligation (Hulka 1977). Thereafter, gynaecological surgeons began to explore other applications, 
including diagnostic procedures for pelvic pain and ectopic pregnancy. In the early 1980s, 
additional operative procedures were introduced including adnexal surgery, uterine 
myomectomy and hysterectomy (DeSimone 2008). Less visible scarring, less postoperative 
pain and rapid recovery have fuelled patient advocacy and enabled an increasing use of 
laparoscopy. For healthcare providers, laparoscopy has the benefit of shorter hospital stays 
and thus reduced inpatient costs. The benefits for the surgeon include the magnified optics and 
no-touch operative technique (Ahmad 2015; DeSimone 2008). There is indeed evidence that 
laparoscopy has advantages compared to laparotomy, which include fewer surgical injuries, 
fewer postoperative complications, less postoperative pain and shorter hospital stays (Kulier 
2004; Medeiros 2009; Metwally 2012). At present, with advanced laparoscopic operations for 
pelvic organ prolapse, urinary incontinence and gynaecological cancers, laparoscopy has 
become completely integrated into the field of gynaecologic surgery. In general surgery and 
urology, laparoscopy is increasingly being used for different purposes as well.
Description of the intervention
The first step in a laparoscopic procedure involves the introduction of a primary instrument 
(i.e. a Veress needle or trocar) followed by the insufflation of carbon dioxide into the peritoneal 
cavity. This is called the primary entry, which is applied to create a pneumoperitoneum. 
Different primary entry techniques are used in practice. Ahmad et al. performed a Cochrane 
review on laparoscopic entry techniques and compared the different techniques in terms of 
their influence on intraoperative and postoperative complications (Ahmad 2015). They found 
no evidence of benefit in terms of safety of one technique over another. Intraperitoneal access 
for laparoscopic instruments is provided via ’ports’. Specific cannulas, called trocars, are 
introduced through the abdominal wall to create these ports. A distinction needs to be made 
between primary and secondary trocar ports. The first port for primary entry is located in or 
near the umbilicus. This port is used for the introduction of the laparoscope. Secondary or 
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ancillary ports are intended for the introduction of laparoscopic instruments. The secondary 
port locations depend upon the location in the abdomen where the surgical procedure is to 
take place. In general, a minimum of two secondary ports are created. The trocars are placed 
to facilitate operating in line with the camera while maintaining a comfortable operating 
position for the surgeon with triangulation of the instruments around the surgical focal point 
within the abdomen. The rapid evolution of instrumentation has led to the development of 
new minimally invasive techniques such as natural orifice transluminal endoscopic surgery 
(NOTES), laparo-endoscopic single-site surgery (LESS) and mini laparoscopy. NOTES refers 
to surgery via natural orifices, where procedures are performed with transluminally placed 
instruments to gain access to the abdominal cavity. Transvaginal, transanal, transvesical, 
transoesophageal, transgastric and transoral approaches for NOTES are described (Moris 
2012). LESS surgery is an advanced minimally invasive approach that allows laparoscopic 
operations to be undertaken through a single small (12 mm to 15 mm) incision, typically 
placed at the person’s umbilicus (Rao 2011). Mini laparoscopy involves the use of smaller 
incisions, smaller instruments and fewer ports to reduce perioperative morbidity further 
and enhance cosmesis. Other terms for mini laparoscopic surgery include mini port or micro 
laparoscopic surgery (Thakur 2011). NOTES, LESS and mini laparoscopy are in their early 
stages of development. NOTES, LESS and mini laparoscopy are not included in this review 
since these techniques are different from traditional laparoscopy.
How the intervention might work
Trocar designs include a myriad of device designs, including over 100 brands from more than 
20 manufacturers (Fuller 2003). There is a distinction between reusable and disposable trocars. 
Reusable trocars are made of metal and have a perforator tip. Completely blunt trocars, with a 
cone-shaped perforator tip, and sharp or cutting trocars with a conical, pyramidal, triflanged 
or excentric tip can be differentiated. Disposable trocars are made of plastic materials and are 
provided with bladed or blade-less tips. Shielded disposable trocars have a retractable shield 
that covers the tip before and after insertion. Dilatation systems represent yet another technical 
alternative in trocar techniques. These trocars are equipped with a radially expanding sleeve 
that can be dilated from 5 mm to 12 mm in diameter. This radially expanding access (REA) 
trocar was developed to minimise tissue trauma and, in theory, its use would result in fewer 
vascular and visceral injuries. Optical access trocars allow laparoscopists to view the cutting 
tip as it penetrates the tissues. Many other different trocar designs are described, for example 
trocars with a threaded sleeve or an expandable arm (Fuller 2005; Leibl 2001; Ternamian 1998; 
Vilos 2007). The diameters of trocars vary from 2 mm to 12 mm, depending on the largest 
instrument needed for a particular port. For exceptional indications (e.g. extirpation of large 
cysts) larger or modified trocars are available (Leibl 2001).
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Why it is important to do this review
Laparoscopic trocars are the most common device named in malpractice injury claims 
associated with laparoscopic procedures, representing one-third of all claims (Fuller 2005). 
The incidence is estimated to be 3 to 4 per 1,000 procedures (Cardin 2011; Champault 1996). 
Trocar-related complications represent all types of complications due to the contribution 
of the trocar, including intra-abdominal vascular injury, intra-abdominal visceral injury, 
trocar site bleeding, trocar site herniation and trocar site infection. Of all trocar-related 
complications, vascular and visceral injuries are associated with the highest morbidity and 
mortality (Jansen 1997). By inserting a trocar, the trocar tip can damage abdominal wall 
vessels (e.g. the epigastric artery), intra-abdominal vessels (e.g. the aorta, vena cava, iliac 
artery or iliac vein) or visceral organs (e.g. bowel, stomach and bladder). Although vascular 
injury is often noticed directly during laparoscopy, bowel injuries are more likely to go 
undetected during the procedure (Fuller 2005). When vascular or visceral injury occurs, 
additional surgical intervention is often required. Cardin et al. reported vascular and 
visceral injuries in 51 out of 4,007 (1.3%) people undergoing a laparoscopic procedure. At 
least 14 (27.5%) of these people required a subsequent surgical, endoscopic or radiological 
intervention under general anaesthesia (Cardin 2011). Mortality is reported occasionally 
after vascular or visceral injury (Cardin 2011; Jansen 2004). 
An important postoperative trocar-related complication is trocar site herniation. A trocar 
site hernia (TSH) is a protrusion of intestine or omentum through a remaining defect in 
the peritoneum, abdominal fascia or musculature at the trocar insertion site. TSHs occur 
postoperatively, which can vary from shortly following surgery to several years postoperation. 
Whereas TSH is uncommon, with an estimated prevalence of 0.5% in people operated on 
laparoscopically, it is a potentially serious complication. People with TSH may require 
emergency re-operation for bowel obstruction or strangulation (Swank 2012). Less severe 
trocar-related complications are trocar site bleeding, trocar site infection and pain. Although 
pain is not always classified as a complication, it is considered clinically important and is 
an indicator for recovery. 
The use of trocars inevitably leads to risks of trocar-related complications. Major complications 
such as vascular and visceral injury can have serious consequences including conversion from 
laparoscopy to laparotomy, other invasive interventions, medical therapies and prolonged 
hospitalisation. When discovered postoperatively, occasionally emergency or revision surgery is 
required, resulting in longer hospital stay or re-admission and additional costs. Minor complica-
tions might also result in the need for additional pharmacological treatment and compromise 
postoperative recovery. All these deviations from a normal intra- and postoperative course 
after laparoscopy potentially have a negative effect on people’s quality of life and satisfaction.
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A difference in trocar-related complications may be attributable to different types of trocars 
and the experience of the surgeon according to the trocar type. The Cochrane review from 
Ahmad et al. studied different trocar systems. They found eight randomised controlled trials 
(RCTs) where different trocar designs were compared. In four RCTs, REA trocars were compared 
with standard trocars. One meta-analysis demonstrated fewer trocar site bleeding episodes 
when using REA trocars compared to standard trocars for the primary laparoscopic entry 
(Ahmad 2015). Two RCTs compared cutting trocars to blunt trocars for primary and secondary 
port insertion, and there was no difference in any type of complication. Two RCTs compared 
the REA trocar to a conventional cutting tip trocar for secondary port entry. REA trocars were 
associated with lower rates of trocar site bleeding compared to standard secondary port 
trocars. Our review differs from Ahmad et al. in that we searched for differences in the outcome 
of postoperative pain. Specific types of trocars could relate to higher or lower risks on any 
of the trocar-related complications or for postoperative pain. The sharpness of disposable 
cutting trocars is usually better compared to that of reusable cutting trocars. This sharpness 
of disposable trocars facilitates smooth insertion. Reusable trocars do lose their sharpness 
through repetitive insertion. Reusable trocars require a relatively high puncture force for 
penetration through the abdominal wall. Increased entry force could result in an abrupt and 
uncontrolled introduction of the trocar that may result in a deeper penetration and potential 
serious visceral and vascular injury (Tansatit 2006). The cutting trocar mechanism of sharp 
trocars may result in occasional bleeding from the trocar port. Conical blunt-tipped trocars 
are designed to stretch, rather than cut, the abdominal wall to enable port placement. The 
use of conical reusable trocars compared to sharp cutting disposable trocars was associated 
with fewer trocar-related bleeding events and TSHs in one non-randomised prospective 
study (Leibl 1999). A larger trocar diameter creates a larger defect in the abdominal wall and 
potentially results in an increased risk of trocar site herniation. In 1993, one retrospective 
study demonstrated an increased risk of trocar site herniation when trocars with a diameter 
of 12 mm were used compared to 10 mm (Kadar 1993). 
This Cochrane review aimed to determine whether specific trocar designs can be recom-
mended for use in people undergoing laparoscopy, with a goal to minimise trocar-related 
complications and postoperative pain.
Objectives
To analyse the rates of trocar-related complications and postoperative pain for different trocar 
types used in people undergoing laparoscopy, regardless of the condition.
Chapter_3_Claire.indd   84 13-11-2017   22:13:47
85
Trocar Types in laparoscopy
3
Methods
Criteria for considering studies for this review
Types of studies
We included only RCTs. We excluded quasi-randomised (e.g. randomised by birth date, chart 
number, alternating inclusion), cluster randomised studies and studies with a ’split-mouth 
design’.
Types of participants
Inclusion criteria
We included adults (aged 18 years and older) who underwent elective or emergency 
diagnostic, therapeutic ormixed laparoscopy for surgical, gynaecological or urological 
conditions.
Exclusion criteria
We excluded animal studies.
Types of interventions
Inclusion criteria
•	 Studies on different trocar designs used in laparoscopy, performed by either surgeons, 
gynaecologists or urologists;
•	 Studies on trocars used for both primary and for secondary entry.
•	 All variations of trocar types, for example, sharp-tipped trocars, blunt-tipped trocars, 
pyramidal-tipped or conical-tipped trocars, disposable (plastic) trocars, reusable (metal) 
trocars, trocars with a shielded tip, radially expanding trocars, trocars with a threaded 
sleeve, an expandable arm or an optical view.
Exclusion criteria
•	 Studies wherein other (than conventional) laparoscopic incisions were made (e.g. single 
port surgery (single-incision laparoscopic surgery (SILS), LESS), natural orifice surgery 
(NOTES) and mini laparoscopy).
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Types of outcome measures
Primary outcomes
•	 Major trocar-related complications:
- mortality;
- conversion to laparotomy due to any trocar-related adverse event; 
- visceral injury (such as perforation of the intestines or stomach, or injury of 
the bladder or liver);
- vascular injury (such as perforation of the aorta, vena cava, iliac artery or iliac 
vein); and 
- other injuries that required intensive care (IC) or intensive care unit (ICU) man-
agement or a subsequent surgical, endoscopic or radiological intervention.
Secondary outcomes
•	 Minor trocar-related complications, such as trocar site herniation, trocar site bleeding 
or postoperative wound haematoma, trocar site infection, extraperitoneal insufflation 
and other injuries that did not require IC or ICU management or a subsequent surgical, 
endoscopic or radiological intervention under general anaesthesia.
•	 Postoperative pain, expressed on a self reported scale (e.g. visual analogue scale (VAS), 
numerical rating scale (NRS)).
Search methods for identification of studies
Electronic searches
Search methods for identification of studies
The clinical librarian (MW) developed a comprehensive literature search strategy in 
consultation with the Trials Search Co-ordinator of the Cochrane Gynaecology and Fertility 
Group (formerly Cochrane Menstrual Disorders and Subfertility Group). We based the search 
strategy on that in the Cochrane Gynaecology and Fertility Group module. We identified the 
relevant subject indexing terms used within individual databases and added them to the 
strategy as appropriate. Where databases offered facilities such as truncation, explosion and 
proximity searching, we used these as appropriate. We focused the searches to the study 
designs of interest by using RCT search filters. We used no publication or language restrictions.
We searched the following databases:
•	 Gynaecology and Fertility Group Specialised Register (inception to 26 May 2015) (Appendix 
1);
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•	 Ovid Cochrane Central Register of Controlled Trials (CENTRAL) (inception to 26 May 
2015) (Appendix 2);
•	 Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and 
Ovid MEDLINE® (1950 to 26 May 2015) (Appendix 3);
•	 Ovid EMBASE (January 2010 to 26 May 2015) (Appendix 4);
•	 Ovid PsycINFO (inception to 26 May 2015) (Appendix 5);
•	 CINAHL via EBSCO (inception to 26 May 2015) (Appendix 6);
•	 Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects 
(DARE, Wiley) (inception to 26 May 2015) (Appendix 7).
We used both indexed and free-text terms. The MEDLINE search was combined with the 
Cochrane highly sensitive search strategy to identify randomised trials (Higgins 2011). 
The EMBASE and CINAHL searches were combined with trial filters developed by the 
Scottish Intercollegiate Guidelines Network (SIGN) (www.sign.ac.uk/mehodology/filters.
html#random).
Searching other resources
We also:
•	 screened the reference lists of all included studies and systematic reviews pertinent to 
this topic;
•	 searched the main electronic sources of ongoing trials, World Health Organization 
International Clinical Trials Registry Platform (apps.who.int/trialsearch/), Current 
Controlled Trials (www.controlled-trials.com/), Clinicaltrials.gov (federally and privately 
supported clinical trials conducted in the US) and European Clinical Trials database 
(EudraCT) (www.clinicaltrialsregister.eu/ctr-search/); and
•	 searched the US Food and Drug Administration (FDA) website (www.fda.gov/MedicalDe-
vices) and contacted the US FDA by email for regulatory trial data.
Data collection and analysis
Two review authors (HS and CC) independently performed the selection of studies, risk of 
bias assessment, and extraction of qualitative and quantitative data. They had a background 
in surgery (HS), gynaecology and clinical epidemiology (CC). A third review author (FWJ or 
SMR) acted as arbiter when necessary.
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Selection of studies
We screened the titles and abstracts from the search results and obtained potentially relevant 
studies in full text and independently assessed them for inclusion. We evaluated full papers, 
abstracts, proceedings from congresses and any other ’grey literature’. A third review author 
(FWJ or SMR) resolved disagreements by discussion.
Data extraction and management
Two review authors (HS and CC) independently extracted data, applying the inclusion 
and exclusion criteria. We used a pre-defined and tested data selection list. We extracted 
the methodological details (concealed assignment, technique of randomisation, time of 
randomisation (pre- or intraoperatively), number of randomised participants, number of 
participants not randomised with explanation, the presence of blinding) and descriptive 
study characteristics (e.g. country where the study was conducted, recruitment modality, 
source of funding), characteristics of the participants (e.g. age, gender, body mass index (BMI), 
previous abdominal surgery), description of the trocar type and size (diameter), description 
of the entry method, description of the port creation and closure (desufflation, closure of 
peritoneum, fascia and skin), co-interventions (e.g. local anaesthetics at trocar sites), and 
outcomes (types of outcomes, documentation of drop-outs, follow-up, standardisation of 
outcome assessment, and whether an intention-to-treat analysis was employed), and the 
authors’ results and conclusions. We discussed disagreements and consulted an arbiter (FWJ 
or SMR) when necessary. We summarised key findings in a narrative format. We extracted the 
outcome per study. We made a differentiation of outcomes regarding primary trocar ports and 
secondary trocar ports and differentiated primary port outcomes for open, Veress needle and 
direct entry methods. We assessed data relating to the defined outcomes for inclusion in the 
meta-analyses. We extracted final scores for means and measures of variance for continuous 
outcomes (e.g. VAS) while we extracted the number of participants experiencing an event 
and the number randomised for adverse events (e.g. incidence of trocar site bleeding).
Assessment of risk of bias in included studies
We used Cochrane’s tool for assessing risk of bias (Higgins 2011, Section 8.5) and produced a 
’Risk of bias’ summary. We evaluated: random sequence generation, allocation concealment, 
blinding of participants and personnel, blinding of outcome assessment, incomplete 
outcome data, intention to treat analysis, selective reporting, group similarity at baseline, 
co-interventions and timing of outcome assessment. We judged for the presence of a ’high’, 
’low’ or ’unclear’ risk of bias. When trials appeared to meet the eligibility criteria but aspects of 
the methodology were unclear or unsuitable for statistical analysis, we contacted the authors 
of those trials and asked for the additional information. We resolved any disagreements of 
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opinion by discussion, and when necessary we included the input from a third independent 
review author (FWJ or SMR). 
Measures of treatment effect
We conducted the review using the standard Cochrane software Review Manager 5 (RevMan 
2014). For dichotomous data (rates of trocar-related complications), we used the number 
of events in the control and intervention groups of each study to calculate Peto estimated 
odds ratios (ORs). The Peto method, which uses an inverse variance approach but utilises an 
approximate method of estimating the log OR, and uses different weight, works well when 
intervention effects are small (OR are close to one), events are not particularly common and 
the studies have similar numbers in experimental and control groups (Higgins 2011). We 
expected this would match our findings. For continuous data (pain scales), we planned to 
calculate mean difference (MDs) between treatment groups. We allowed pain scales other 
than VAS if we thought that the construct measured was consistent with the evaluated 
outcome. We would have used standardised mean difference (SMD) instead of MD if studies 
used multiple scales to measure the same outcome (e.g. VAS and verbal scale). We presented 
95% confidence intervals (CIs) for all outcomes. 
Unit of analysis issues
Analysis was per person randomised. We excluded trials where body parts or sites were 
randomised for trocar introduction.
Dealing with missing data
To deal with missing data, we planned to use the strategies described in Chapter 16, Section 
16.1 (missing data) and Section 16.2 of the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins 2011). When summary data were missing, we attempted to contact 
the author. In the absence of additional information, we looked for statistics that allowed 
calculation or estimation of the standard deviation (e.g. test statistics, P values). When these 
were not available, we planned that imputation could be reasonable for a small proportion 
of studies comprising a small proportion of the data if it enabled the data to be combined 
with other studies for which full data were available, but that was not the case.
We collected and reported drop-out rates in the ’Risk of bias’ table. For dichotomous data, 
we assumed that all missing participants did not experience the event (based on clinical 
judgement). We could not perform sensitivity analyses to assess howsensitive results were 
to changes in the drop-out rates since there were too few study data.
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Assessment of heterogeneity
We identified and qualified statistical heterogeneity among the results informally by visual 
inspection (eye-ball test) and formally by calculating the I2 statistic. The decision regarding 
heterogeneity was dependent upon the I2 statistic, with a value of 50% or greater indicating 
substantial heterogeneity. Where I2 was 50% or greater, we did not pool results, but described 
the effect of the interventions.
Assessment of reporting biases 
We used online trial registers to investigate trials that had not been published. There were 
not sufficient studies to construct funnel plots to investigate possible publication bias.
Data synthesis
If studies were sufficiently similar, we planned to combine the data using Peto’s method 
in a fixed-effect model, for the dichotomous outcomes of trocar-related complications. 
For the continuous outcome pain, we planned to combine data for meta-analysis using 
a random-effects model. An increase in the odds of a particular outcome, which may be 
beneficial (e.g. live birth) or detrimental (e.g. adverse effects), is displayed graphically in the 
meta-analyses to the right of the centre-line and a decrease in the odds of an outcome to 
the left of the centre-line.
Subgroup analysis and investigation of heterogeneity
We intended to perform subgroup analyses for type of surgery (e.g. general versus gynaeco-
logical versus urological surgery), age groups, gender, obesity, presence of co-morbidities, 
primary entry technique, secondary entry technique and differing trocar diameters. However, 
there were insufficient details to extract data about separate participant types.
Sensitivity analysis
We planned the following sensitivity analyses a priori to determine whether the conclusions 
were robust to arbitrary decisions made regarding the eligibility of studies and analysis. We 
considered if conclusions would have differed if:
•	 eligibility were restricted to studies without high risk of bias: this analysis was not possible 
because of insufficient data; 
•	 eligibility were restricted to studies with blinded outcome assessment; this analysis was 
not possible because of insufficient data;
•	 alternative imputation strategies had been adopted; this analysis was not possible since 
we could not impute any data;
•	 a random-effects model had been adopted for meta-analysis of dichotomous data.
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Overall quality of body of evidence: ‘Summary of findings’ table
We generated ’Summary of findings’ tables for analyses of all primary and secondary outcome 
measures. When statistical heterogeneity was present, we noted this. We used GRADEpro to 
prepare the tables (GRADEpro). 
We used GRADE (Grading of Recommendations, Assessment, Development and Evaluation) 
to evaluate the overall quality of the evidence and strength of recommendations (Guyatt 
2008). We based the quality of evidence for a specific outcome upon performance against 
five principal domains:
•	 limitations in design (downgraded when more than 25% of the participants were from 
studies with a high risk of bias);
•	 inconsistency of results (downgraded in the presence of substantial statistical 
heterogeneity (I2 greater than 50%) and inconsistent findings (in the presence of widely 
differing estimates of a specific trocar type A versus type B);
•	 indirectness (i.e. generalisability of the findings; downgraded when a participant-
important outcome is represented by a surrogate); 
•	 imprecision (downgraded when the total number of participants was insufficient to 
determine any significant statistical difference. The required power of a study depended 
on the questioned outcome);
•	 other (e.g. publication bias).
The quality of the evidence was defined as:
•	 high quality: further research is very unlikely to change the estimate of effect or our 
confidence in it. There were sufficient data with narrow CIs. There were no known or 
suspected reporting biases;
•	 moderate quality: further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate; one of the domains was not met; 
•	 low quality: further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change it; two of the domains were not met;
•	 very low quality: great uncertainty about the estimate, three of the domains were not met; 
•	 no evidence: no evidence for this outcome from RCTs.
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Results
Description of studies
Results of the search
We identified 1,858 references of possible interest by searching the Menstrual Disorders and 
Subfertility Group Specialised Register (31 references), CENTRAL (552 references), MEDLINE 
(540 references), EMBASE (434 references), PsycINFO (10 references), CINAHL (135 references), 
Cochrane Database of Systematic Reviews (69 references), DARE (24 references) and other 
sources (63 references). We excluded 448 duplicates and 1397 clearly irrelevant references 
by reading the abstracts. Accordingly, we retrieved 13 references for further assessment. Of 
these, we excluded six references because they were not RCTs or did not fulfil our review 
protocol inclusion criteria. In total, seven RCTs fulfilled our inclusion criteria (figure 1). We 
contacted four study authors to ask fort he missing information and recieved answers from 
two authors.
Included studies
Trial characteristics
All the included trials randomly assigned participants individually. Three trials were multi-
centre (Bhoyrul 2000; Feste 2000; Mettler 2000), and four were single centre (Bisgaard 2007; 
Hamade 2007; Lam 2000; Venkatesh 2007). The trials were published from 2000 to 2007. 
The trials were conducted in the US (Feste 2000; Venkatesh 2007), Australia (Mettler 2000), 
China (Lam 2000), the UK (Hamade 2007), Denmark (Bisgaard 2007), and Germany (Feste 
2000; Mettler 2000). In one trial the study location was not specified (Bhoyrul 2000). In two 
trials, the study trocars were supplied free of charge by a pharmaceutical company (Lam 
2000; Venkatesh 2007). The other five trials did not report funding.
Participants
The trials included 654 participants. Sample size ranged from 30 to 250. The age range of 
participants was from 18 to 80 years. A total of 314 women and 90 men were included; one 
study did not report sex of the 250 participants (Bhoyrul 2000). Three studies reported a 
mean or median BMI (Bisgaard 2007; Hamade 2007; Venkatesh 2007), while the other four 
other studies did not report any data on body mass (Bhoyrul 2000; Feste 2000; Lam 2000; 
Mettler 2000). Laparoscopic procedures included surgical (405 procedures), gynaecological 
(187 procedures) and urological (56 procedures). Three studies did not refer to exclusion 
criteria (Feste 2000; Hamade 2007; Venkatesh 2007). The other trials excluded people on 
the presence of acute inflammatory conditions (Bhoyrul 2000; Lam 2000; Mettler 2000), 
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Figure 1. Study flow diagram.
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Figure 1 Study flow diagram.
and conversion to laparotomy (Bhoyrul 2000; Bisgaard 2007). Exclusion was also based on 
gallbladder malignancy (Lam 2000), American Society of Anaesthesiologists (ASA) physical 
class 4, pregnancy, participant age, chronic pain diseases, use of opioids or tranquillisers, 
foreign language, mental disorder and history of alcoholism or drug abuse (Bisgaard 2007).
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Interventions
Trials compared the following trocar types:
•	 radially expanding trocar versus cutting trocar: two studies used reusable cutting trocars 
(Lam 2000; Mettler 2000), three studies used disposable cutting trocars (Bhoyrul 2000; 
Bisgaard 2007; Venkatesh 2007), and one study used both reusable and disposable 
cutting trocars were used (Feste 2000);
•	 conical blunt-tipped versus cutting trocar (Hamade 2007; Venkatesh 2007); 
•	 radially expanding trocar versus conical blunt-tipped trocar (also called axially dilating) 
(Venkatesh 2007);
•	 single-bladed trocar versus pyramidal-bladed trocar (Venkatesh 2007).
Three studies did not refer to the diameter of the trocars (Bhoyrul 2000; Feste 2000; Mettler 
2000), two studies evaluated 5 mm and 10 mm trocars (Bisgaard 2007; Hamade 2007), 
one study evaluated 10 mm trocars (Lam 2000) and one study evaluated 12 mm trocars 
(Venkatesh 2007). 
Four studies examined primary entry and secondary entry ports (Bisgaard 2007; Feste 2000; 
Mettler 2000; Venkatesh 2007), two studies examined secondary ports only (Hamade 2007; 
Lam 2000), and one study examined primary ports only (Bhoyrul 2000). Primary entry used 
the Veress needle technique.
Co-interventions
Two studies reported gallbladder extraction through a port (Bhoyrul 2000; Lam 2000), one 
study documented the morcellation site, specimen extraction, and hand-assist device site 
location (Venkatesh 2007). The other studies did not report specimen extraction or other 
mechanisms of port manipulation. The indications for fascial closure were specified in five 
studies (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Mettler 2000; Venkatesh 2007), two studies 
did not report on fascial closure (Hamade 2007; Lam 2000). Intraoperative anaesthesia was 
not described in five studies (Bhoyrul 2000; Feste 2000; Hamade 2007; Mettler 2000; Venkatesh 
2007), two studies reported that the participants received general anaesthesia (Bisgaard 2007; 
Lam2000). A standardised postoperative analgesics regimen was mentioned in two studies 
(Bisgaard 2007; Lam 2000) and in Bisgaard 2007 the amount of postoperative analgesics was 
clearly specified. Other studies did not report the use of postoperative analgesics.
Outcomes
Studies reported the following outcome measures. 
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Primary outcomes: major trocar-related complications
•	 Visceral injury (e.g. perforation of the intestines or stomach, or injury of the bladder or 
liver) (571 participants) (Bhoyrul 2000; Feste 2000; Mettler 2000; Venkatesh 2007).
•	 Vascular injury (e.g. perforation of the aorta, vena cava, iliac artery or iliac vein) (571 
participants) (Bhoyrul 2000; Feste 2000; Mettler 2000; Venkatesh 2007).
No studies reported mortality, conversion to laparotomy and other injuries that required 
IC or ICU management or a subsequent surgical, endoscopic or radiological intervention.
Secondary outcomes: minor trocar-related complications
•	 Minor trocar-related complications (trocar site herniation (533 participants), trocar site 
bleeding (583 participants) or postoperative wound haematoma (161 participants) and 
trocar site infection (56 participants) (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Hamade 
2007; Lam 2000; Mettler 2000; Venkatesh 2007).
•	 Postoperative pain, expressed on a self reported scale (e.g. VAS, NRS (348 participants) 
(Bhoyrul 2000; Bisgaard 2007; Feste 2000; Mettler 2000; Venkatesh 2007).
No studies reported measures for extraperitoneal insufflation and other injuries that did 
not require IC or ICU management or a subsequent surgical, endoscopic or radiological 
intervention under general anaesthesia.
Excluded studies
We excluded five studies from the review, for the following reasons:
•	 two were not RCTs (Herati 2011; Huang 2012);
•	 two had randomised different sites of the abdomen to different trocars (’Split-mouth’ 
design) (Stephanian 2007; Yim 2001);
•	 one study did not examine the types of outcome measures defined for this review 
(Tchartchian 2010).
Risk of bias in included studies
The results for risk of bias for the individual studies are summarised in figure 2, for assessment 
with GRADE see the ’Summary of findings’ tables. See also figure 3.
Allocation
Five RCTs reported that they used randomisation tables or lists (Bhoyrul 2000; Bisgaard 
2007; Hamade 2007; Lam2000; Mettler 2000). Two RCTs did not describe the method used 
for sequence generation (Feste 2000; Venkatesh 2007).
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Figure 2 Risk of bias summary: review authors’ judgements about each risk of bias item for each 
included study.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation concealment
Three studies described that their allocation concealment was performed by independent 
investigators using sealed envelopes (Bhoyrul 2000; Bisgaard 2007; Hamade 2007). The other 
four studies did not report their method of concealment (Feste 2000; Lam 2000; Mettler 2000; 
Venkatesh 2007).
Blinding
There was a low risk of performance bias through blinding issues. Six studies reported that 
blinding of participants and outcome assessors was well performed. Six studies blinded the 
participants for the type of trocars used (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Lam 2000; 
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Mettler 2000; Venkatesh 2007). One study did not report details on blinding of participants. 
This study did not have subjective outcomes that could be influenced by the participant 
(Hamade 2007). Blinding of the surgical personnel was not applicable in any of the studies. 
Blinding of the outcome assessors was reported in the six studies that performed participant 
blinding (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Lam 2000; Mettler 2000; Venkatesh 2007). 
One study did not report the use of a blinded outcome observer. This study measured 
objective outcomes only (Hamade 2007). 
There was a substantial risk of performance bias through variance in co-interventions in all 
studies. None of the studies specified the applied degree of port manipulation during the 
operation, for example for morcellation or extraction of a surgical specimen. Only two authors 
reported the intra- or postoperatively applied standard analgesics (Bisgaard 2007; Lam 
2000). We judged there to be a high risk of performance bias in five of the studies, because 
of significant differences between study groups in the application of fascial closure (Bhoyrul 
2000; Bisgaard 2007; Feste 2000; Mettler 2000; Venkatesh 2007). Two other studies did not 
provide details on the application of fascial closure (Hamade 2007; Lam 2000). There was a 
low risk of detection bias for short-term outcomes. These were all equally assessed between 
the groups. We rated three studies that performed a long-term assessment of TSH at high 
risk on detection bias: the duration and completeness of follow-up was unclear or uneven 
between the studied groups (Bhoyrul 2000; Bisgaard 2007; Venkatesh 2007).
Figure 3 Risk of bias graph: review authors’ judgements about each risk of bias item presented as 
percentages across all included studies.
Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Sequence generation
Five RCTs reported that they used randomisation tables or lists
(Bhoyrul 2000; Bisgaard 2007; Hamade 2007; Lam 2000;Mettler
2000). Two RCTs did not describe the method used for sequence
generation (Feste 2000; Venkatesh 2007).
Allocation concealment
Three studies described that their allocation concealment was
performed by independent investigators using sealed envelopes
(Bhoyrul 2000; Bisgaard 2007; Hamade 2007). The other four
studies did not report their method of concealment (Feste 2000;
Lam 2000; Mettler 2000; Venkatesh 2007).
Blinding
There was a low risk of performance bias through blinding issues.
Six studies reported that blinding of participants and outcome as-
sessors was well performed. Six studies blinded the participants
for the type of trocars used (Bhoyrul 2000; Bisgaard 2007; Feste
2000; Lam 2000; Mettler 2000; Venkatesh 2007). One study did
not report details on blinding of participants. This study did not
have subjective outcomes that could be influenced by the par-
ticipant (Hamade 2007). Blinding of the surgical personnel was
not applicable in any of the studies. Blinding of the outcome as-
sessors was reported in the six studies that performed participant
blinding (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Lam 2000;
Mettler 2000; Venkatesh 2007). One study did not report the
use of a blinded outcome observer. This study measured objective
outcomes only (Hamade 2007).
There was a substantial risk of performance bias through variance
in co-interventions in all studies. None of the studies specified the
applied degree of port manipulation during the operation, for ex-
ample for morcellation or extraction of a surgical specimen. Only
two authors reported the intra- or postoperatively applied stan-
dard analgesics (Bisgaard 2007; Lam 2000). We judged there to
be a high risk of performance bias in five of the studies, because of
significant differences between study groups in the application of
fascial closure (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Mettler
2000; Venkatesh 2 07). other studies id not provide details
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Incomplete outcome data
We rated two studies at a substantial risk of attrition bias (Bhoyrul 2000; Lam 2000). In one 
of these studies, data on intraoperative complications, postoperative pain and wound 
complications (trocar site bleeding and haematoma) were either missing or unclear (Bhoyrul 
2000). In the second of these studies, approximately 10% of the laparoscopies in both groups 
were converted to open surgery and a substantial percentage of outcome data from the radially 
trocar group was missing (Lam 2000). It remained unclear how they dealt with themissing data 
and data of converted procedures. We rated two studies at unclear risk of attrition bias, because 
they did not present the numbers of participants that were excluded for participation (Feste 
2000) or analysis (Venkatesh 2007). No loss of data or participants was apparent in the remaining 
studies and we judged them at a low risk of attrition bias (Bisgaard 2007; Hamade 2007; Mettler 
2000). However, loss to follow-up was unclear and thus resulted in a high risk for attrition bias 
on long-term outcomes (Bisgaard 2007; Mettler 2000). Six studies applied an intention-to-treat 
analysis, and analysed all data according to the randomisation result (Bhoyrul 2000; Bisgaard 
2007; Feste 2000; Hamade 2007; Lam 2000; Mettler 2000). In one study, unit-of-analysis issues 
were evident: the trocar sites rather than the participants were analysed (Venkatesh 2007).
Selective reporting
We judged all included studies at unclear risk of selective reporting. One study had published 
a study protocol; however, they published it after finishing the study (Hamade 2007). All 
studies analysed their outcomes as they planned in the methods sections.
Other potential sources of bias
Surgeon’s experience
Two trials described the surgeons as “experienced” (Bisgaard 2007) and “well trained” (Feste 
2000). Only one study reported that the surgeons were equally distributed between the two 
study groups (Bisgaard 2007). The other five studies were unclear about the experience of 
the surgeons (Bhoyrul 2000; Hamade 2007; Lam 2000; Mettler 2000; Venkatesh 2007). Two 
studies provided the number of surgeons that had performed the laparoscopies: seven (Feste 
2000) and 16 (Bhoyrul 2000). The remaining studies did not report the number of surgeons. 
This substantial lack of clarity of the number and experience of surgeons created a potential 
risk of bias. This limits the external validity of the included studies.
Source of funding
Two studies reported their sources of funding. Lam 2000 received all radially trocars from 
Kojima Healthcare Asia Ltd; Venkatesh 2007 received all the trocars used in the study from 
manufacturing companies.
Chapter_3_Claire.indd   98 13-11-2017   22:13:47
99
Trocar Types in laparoscopy
3
Effects of interventions
See: Summary of findings for the main comparison Radially expanding trocars compared to 
cutting trocars for laparoscopy; Summary of findings 2 Conical blunt-tipped trocar compared 
to cutting trocar for laparoscopy; Summary of findings 3 Radially expanding trocar compared 
to conical blunt-tipped trocar for laparoscopy; Summary of findings 4 Single-bladed trocar 
compared to pyramidal-bladed trocar for laparoscopy.
1. Radially expanding trocar versus cutting trocar
Primary outcomes: major trocar-related complications
1.1 Visceral injury
Four studies with 473 participants provided data for analysis of visceral injury (Bhoyrul 
2000; Feste 2000; Mettler 2000; Venkatesh 2007). One study reported two cases of visceral 
injury, one in each group (Bhoyrul 2000). The combined results from the four trials showed 
no evidence of a difference in visceral injury between the use of the two trocars (Peto OR 
0.95, 95% CI 0.06 to 15.32).
1.2 Vascular injury
Vascular injuries were infrequent in the four studies that reported them (473 participants) 
(Bhoyrul 2000; Feste 2000; Mettler 2000; Venkatesh 2007). There was only one case of vascular 
injury in a participant where a disposable cutting trocar was used for primary entry (Bhoyrul 
2000). The combined results from the four trials showed no evidence of a difference in vascular 
injury (Peto OR 0.14, 95% CI 0.00 to 7.16).
Secondary outcomes: minor trocar-related complications
Six studies provided data for analysis of minor trocar-related complications (Bhoyrul 2000; 
Bisgaard 2007; Feste 2000; Lam 2000; Mettler 2000; Venkatesh 2007).
1.3 Trocar site herniation
There was no trocar site herniation in four studies (463 participants) (Bhoyrul 2000; Bisgaard 
2007; Mettler 2000; Venkatesh 2007).
1.4 Trocar site bleeding
See figure 4. Five trials (553 participants) reported trocar site bleeding within radially 
expanding versus cutting trocar use (Bhoyrul 2000; Bisgaard 2007; Feste 2000; Lam 2000; 
Mettler 2000). There was a decreased risk for trocar site bleeding in the radially expanding 
trocar group (Peto OR 0.28, 95% CI 0.14 to 0.54) without substantial heterogeneity (I2 = 46%). 
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Subgroup analyses for surgical and gynaecological participants revealed a beneficial effect 
for the use of radially expanding trocars in people undergoing general surgery (Peto OR 0.29, 
95% CI 0.15 to 0.58) but not for people undergoing gynaecological surgery (Peto OR 0.14, 
95% CI 0.01 to 2.24). We could not perform a subgroup analysis for primary entry, secondary 
entry or trocar diameter because there were too few data. One included study reported a 
remarkably high incidence of bleeding at radially expanding trocar sites. More participants 
in the radially expanding trocar group had needed an additional incision to retract the 
gallbladder compared to the cutting group. One study reported one single trocar site bleeding 
at 43 radially trocar sites versus five at 84 cutting trocar sites. Because of unit-of-analysis 
issues, we could not use these data for statistical analysis (Venkatesh 2007).
1.5 Trocar site haematoma
See figure 5. Two studies described trocar site haematoma (Bhoyrul 2000; Bisgaard 2007). 
One study (77 participants) reported no evidence of a difference between radially expanding 
trocars and cutting trocars in the occurrence of trocar site haematoma at two days 
postoperative (Peto OR 0.96, 95% CI 0.39 to 2.36) (Bisgaard 2007). However, in this study, 
more participants in the radially expanding group needed an additional incision to retract 
the gallbladder compared to the cutting group. The other study (161 participants) reported 
no evidence of a difference four hours postoperative, but at 24 hours postoperative fewer 
participants in the radially expanding trocar group compared to the cutting trocar group, 
had haematomas (Peto OR 0.32, CI 0.13 to 0.80) (Bhoyrul 2000). We could not pool these 
data because of the clinical heterogeneity.
1.6 Trocar site infection
One study reported indistinct findings on a single trocar site infection (Venkatesh 2007).
1.7 Postoperative pain
Four studies reported statistical data on postoperative pain. None of these studies provided 
sufficient data, making it inappropriate to pool the data (Bisgaard 2007; Feste 2000; Mettler 
2000; Venkatesh 2007). Two studies found no evidence of a difference in pain at six hours, 
one day and two days postoperative (Bisgaard 2007), and three hours, 24 hours and one 
week postoperative (Venkatesh 2007). One study found no evidence of a difference four 
hours postoperative, but did find differences in pain eight, 12 and 24 hours postoperative 
(Feste 2000). The other study found differences for pain at four, eight and 12 hours, but no 
evidence of a difference at 24, 48 and 72 hours postoperative (Mettler 2000). The differences 
all favoured the participants that had received radially expanding trocars for primary and 
secondary ports. Another study reported no evidence of differences at four, eight, 12 and 24 
hours postoperative, no statistical data were provided (Bhoyrul 2000).
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2. Conical blunt-tipped trocar versus cutting trocar
Primary outcomes: major trocar-related complications
2.1 Visceral injury
One study provided data on visceral injury, and reported no visceral injuries in either the 
conical blunt-tipped trocars or cutting trocars groups (42 participants) (Venkatesh 2007).
2.2 Vascular injury
One study provided data on vascular injury, and reported no vascular injuries in either the 
conical blunt-tipped trocars or cutting trocars groups (42 participants) (Venkatesh 2007).
Secondary outcomes: minor trocar-related complications 
2.3 Trocar site herniation
One study provided data on trocar site herniation, and reported no herniations in either the 
conical blunt-tipped trocars or cutting trocars groups (42 participants) (Venkatesh 2007).
2.4 Trocar site bleeding
Two studies reported occurrences of trocar site bleeding (Hamade 2007; Venkatesh 2007). 
One study with 30 participants, found no evidence of a difference between conical blunt-
tipped trocars and cutting trocars (Peto OR 0.13, 95% CI 0.01 to 2.12) (Hamade 2007). The 
other study reported one single trocar site bleeding at 43 conical blunt-tipped trocar sites 
versus five trocar site bleedings at 84 cutting trocar sites. Because of unit-of-analysis issues, 
we could not use these data for statistical analysis (Venkatesh 2007). The trocar site of a 
single wound infection is indistinct (Venkatesh 2007).
2.5 Postoperative pain
One study reported mean VAS scores at three hours, 24 hours and one week postoperative 
(Venkatesh 2007), and found no evidence of a difference between conical blunt-tipped and 
cutting trocars. The data provided were insufficient for calculation of adequate measures 
and also unit of analysis issues are present.
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3. Radially expanding trocar versus conical blunt-tipped trocar
Primary outcomes: major trocar-related complications
3.1 Visceral injury
One study (28 participants) provided data on visceral injury, and reported none within either 
the radial expanding trocar or conical blunt-tipped trocar groups (Venkatesh 2007).
3.2 Vascular injury
One study (28 participants) provided data on vascular injury, and reported none within 
either the radial expanding trocar or conical blunt-tipped trocar groups (Venkatesh 2007).
Secondary outcomes
3.3 Minor trocar-related complications
One study provided data on minor trocar-related complications. It reported no herniations 
and two ports with trocar site bleeding: one out of the 43 radially trocar sites and one out of 
the 38 conical blunt-tipped trocar sites. These study data presented unit-of-analysis issues 
and data were insufficient to present in meta-analysis (Venkatesh 2007).
3.4 Postoperative pain
One study reported mean VAS scores at three hours, 24 hours and one week postoperative 
(Venkatesh 2007), and found no evidence of a difference between radially expanding 
and conical blunt-tipped trocars. We could not calculate adequate measures because of 
insufficient statistical data and issues on unit-of-analysis.
4. Single-bladed trocar versus pyramidal-bladed trocar
Primary outcomes: major trocar-related complications
4.1 Visceral injury
One study (28 participants) provided data on visceral injury, and reported none within either 
the single-bladed trocar or pyramidal-bladed trocar groups (Venkatesh 2007).
4.2 Vascular injury
One study (28 participants) provided data on vascular injury, and reported no vascular injuries 
within either the single-bladed trocar or pyramidal-bladed trocar groups (Venkatesh 2007).
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Secondary outcomes: minor trocar-related complications
One study provided data on minor trocar-related complications and postoperative pain 
(Venkatesh 2007). There were no herniations and five ports with trocar site bleeding (one 
of the 41 single-bladed trocar sites and four of the 43 pyramidal-bladed trocar sites). This 
study reported mean VAS scores at three hours, 24 hours and 1 week postoperative. They 
found no evidence of a difference between single-bladed and pyramidal-bladed trocars. We 
could not calculate adequate measures because of insufficient statistical data and issues 
on unit-of-analysis.
Sensitivity analyses
We could not perform planned sensitivity analyses due to the small number of included 
studies.
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Discussion
Summary of main results
This systematic review evaluated the rates of trocar-related complications and postoperative 
pain for different trocar types used in people undergoing laparoscopy. We divided the 
outcomes into primary outcomes (including major trocar-related complications), and 
secondary outcomes (including minor trocar-related complications and postoperative pain). 
For major trocar-related complications, the studies reported events of vascular and visceral 
injury. The reported minor trocar-related complications were trocar site herniation, trocar 
site bleeding and trocar site infection. The trocar designs assessed in this review were radially 
expanding, cutting, conical blunt-tipped, single-bladed and pyramidal-bladed trocars. The 
result of seven RCTs (654 participants) showed no advantage of the use of a specific trocar 
design to minimise major trocar-related complications. Concerning minor trocar-related 
complications, very low quality evidence demonstrated a lower risk of trocar site bleeding 
with the use of radially expanding trocars in comparison to cutting trocars (five studies, 553 
participants). There was no advantage of a specific trocar design in terms of reducing the 
incidence of trocar site herniation, haematoma and infection with very low quality evidence 
(five studies, 477 participants). Very low quality evidence suggested less postoperative pain 
after the use of radially expanding trocars compared to cutting trocars (two studies, 187 
participants). However, these findings could not be imputed in a meta-analysis because of 
incompleteness and heterogeneity of the statistical data. Very low quality evidence indicated 
no difference in postoperative pain between participants who had received conical blunt-
tipped trocars, radially expanding trocars, single-bladed trocars or pyramidal-bladed trocars.
Overall completeness and applicability of evidence
Vascular and visceral injuries are the most serious trocar-related complications and therefore 
our main interest. These major complications often require additional surgical intervention, 
conversion to laparotomy and are associated with postoperative morbidity and mortality 
(Jansen 1997). This review included seven studies (654 participants), representing insufficient 
power to demonstrate a beneficial effect of one trocar type over another effectively. 
Minor trocar-related complications, such as trocar site herniation, trocar site bleeding or 
postoperative wound haematoma and trocar site infection, are generally more common and 
can be studied with smaller study populations. This could also be applied to the outcome 
of postoperative pain, depending on the clinically relevant difference in pain score that 
should be identified. However, with the exception of trocar site bleeding, the studies were 
not sufficient to address (all of) the defined outcomes in this review.
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Apparently, the included studies focused on short-term outcomes as their primary outcome 
parameter. The study data particularly concerned complications that occurred intraopera-
tively or within the first 24 hours after surgery. Longer-term complications such as haema-
toma, wound infection and trocar site herniation, were studied with very limited precision. 
The trocar types included in this review for comparisons were limited to the radially expanding 
trocar, the cutting trocar, the conical blunt-tipped trocar, the single-bladed trocar and the 
pyramidalbladed trocar. A myriad of device designs exists (Fuller 2003), but this review only 
evaluated a small number of these types. RCTs have not studied other types of trocars. 
Remarkably, we found no comparison between reusable and disposable trocars. The 
sharpness of disposable cutting trocars is usually better compared to that of reusable cutting 
trocars, which may lose their sharpness through repetitive insertion. Therefore, reusable 
trocars may require a relatively high puncture force for penetration through the abdominal 
wall, with a higher chance of resulting in an abrupt and uncontrolled introduction of the trocar 
that may result in a deeper penetration and potentially serious visceral and vascular injury 
(Tansatit 2006). None of the studies analysed the disposability of the trocars as a confounding 
factor for trocar-related complications. It is notable that six of the seven included RCTs 
studied radially expanding trocars, which does not seem in proportion to current practice. 
In view of the higher cost of radially expanding devices, it can be questioned whether this 
scientific attention can be regarded as clinically relevant. Another shortcoming was that 
many studies did not report the diameter of the trocars used. In the studies that did report 
diameters, there was much variety. To assess whether the trocar diameter affects the outcome 
of trocar-related complications, future studies should analyse individual participant data. 
A larger trocar diameter creates a larger defect in the abdominal wall and probably results 
in an increased risk of trocar site herniation and bleeding. In 1993, one retrospective study 
demonstrated an increased risk of trocar site herniation when trocars with a diameter of 12 
mm were used compared to 10 mm (Kadar 1993). More recent studies on cholecystectomy 
did not show clear clinical advantages of mini laparoscopy (Gurusamy 2013; Sajid 2009). 
We studied trials on traditional laparoscopy. We did not include newer techniques such 
as robot-assisted laparoscopy, LESS and NOTES. The results of this review should not be 
extrapolated to these other techniques. 
Various types of participants were included in the studies for this review, all undergoing 
laparoscopy. The vast majority of the participants underwent laparoscopy for surgical 
indications, fewer for gynaecological conditions and fewer for renal conditions. Many 
different exclusion criteria were applied in the included studies and there was a wide 
age range. This large heterogeneity of included studies means there were too few data to 
perform a sensitivity analysis. From a clinical perspective, we do not expect a difference in 
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trocar-related complications in people undergoing laparoscopy for different conditions. 
This should be examined when more studies become available and adequate sensitivity 
analyses can be conducted.
Quality of the evidence
The quality of the evidence was generally very low as shown in the ’Summary of findings’ 
tables, the main limitation being very serious imprecision. This systematic review did 
not allow a robust conclusion regarding the rates of trocar-related complications and 
postoperative pain for different trocar types used in people undergoing laparoscopy. The 
main methodological limitation was the small number of included participants, due to the 
small number of RCTs included in this review. The incidences of trocar-related complications 
are low; particularly the incidence of major trocar-related complications is very low. To 
detect a risk difference for bowel injury from 0.3% to 0.2%, over 800,000 participants would 
be needed for inclusion in a trial (Garry 1999). Obviously, RCTs are not the design of choice to 
detect risk differences for major trocar-related complications. In our opinion, interventions 
to prevent events that occur only infrequently may be best assessed by good-quality 
observational studies such as cohort and case-control studies. 
With respect to minor complications with a higher incidence (trocar site herniation, trocar 
site bleeding and haematoma) and postoperative pain, other study limitations came into 
view: heterogeneity of intervention and comparator within and between studies. Within the 
included studies, there was a considerable risk of performance bias: differences or ambiguities 
between study groups for closure of the fascial defect at trocar sites. This could have resulted 
in the inconsistencies in outcome trocar site bleeding, haematoma and postoperative 
pain. A third type of risk of performance bias resulted from limited reporting on the use of 
analgesics to prevent postoperative pain. In three of the studies, the type and amount of 
used analgesics was not reported, while pain was one of the evaluated outcomes. Another 
notable limitation was the high risk of attrition bias in most studies: short-term outcome 
data were incomplete, and this is even more pronounced for longer-term outcomes including 
trocar site infection and herniation. 
One issue particularly arose in the analysis of the outcome postoperative pain, which was 
heterogeneity in the measures of postoperative pain. This was caused by different timings 
of measurements, use of different assessment tools and different presentations of data. 
No single study provided sufficient pain data, making it inappropriate to pool the data. 
Contacting the authors for missing data did not result in sufficient data for pooling.
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Potential biases in the review process
There was a number of limitations to this review. The primary limitation was the lack of 
studies with a low risk of bias. The second limitation was the possibility of publication bias, 
which we attempted to minimise through an extensive database search. We also searched 
the main electronic sources for ongoing trials and contacted the US FDA for regulatory trial 
data without relevant result. Surprisingly, with the exception of one study, all studies did 
not have a published protocol and, to our knowledge, had not registered their study in one 
of the many trial registries. This indicates that many trials conducted in the 21st century 
still do not conform to international procedure as outlined by the International Committee 
of Medical Journal Editors (ICJME). The third weakness is the outcomes information in the 
included studies. Most outcome measures were not properly defined. The reliability of meta-
analyses is depending on the reliability with which these complications were measured by 
the authors. Furthermore, we could not obtain all relevant data. We were unable to obtain 
some data on the outcome of postoperative pain and missing data to calculate or estimate 
the standard deviations were not available even though we contacted the study authors. 
Since this concerned the majority of the pain data, imputation was not possible. Strengths of 
this review include the methodological rigor applied according to our published protocol: the 
search was guided and adapted by the Cochrane Menstrual Disorders and Subfertility Group. 
Two review authors independently conducted the study selection, risk of bias assessment and 
data collection. We resolved any disagreements by discussion with a third review author. We 
attempted to deal with missing information and data by contacting the primary authors of 
Bhoyrul 2000, Bisgaard 2007, Feste 2000, and Mettler 2000, and we received partial responses.
Agreements and disagreements with other studies or reviews
We identified two systematic reviews that have included this topic (Ahmad 2015; Antoniou 
2013). In an update of their Cochrane review on laparoscopic entry performed during the 
development of this review, Ahmad et al. also included the outcomes of secondary ports, 
and, as a result, there is agreement between their review and ours. Their results are consistent 
with this review in finding an advantage of radially expanding trocars compared to standard 
trocars in terms of trocar site bleeding (Peto OR 0.31, 95% Cl 0.15 to 0.62). They found no other 
evidence suggesting more or less safety of radially expanding, cutting or blunt trocars (Ahmad 
2015). Antoniou 2013 evaluated the risk of abdominal wall bleeding, visceral injuries and overall 
complications with the use of bladed and blunt-tipped laparoscopic trocars. Radially expanding 
trocars were included in the ’blunt-tipped’ group. Meta-analysis resulted in a lower risk of 
abdominal wall bleeding for the blunt-tipped trocar group (OR 0.42, 95% CI 0.21 to 0.88). We 
believe that the expanding function of the radially expanding trocar may have a different effect 
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on trocar-related complications and, therefore, did not pool data from blunt-tipped trocars with 
radially expanding trocars. However, their results for trocar site bleeding are consistent with 
the results in this review since most of their included studies used radially expanding trocars.
Authors’ conclusions
Implications for practice
We found no evidence of a difference in the incidence of major trocar-related complications, 
such as visceral or vascular injury, when comparing different trocar types with one another. 
However, caution is urged when interpreting these results because the incidence of serious 
complications following the use of a trocar is extremely low. There was very low quality 
evidence for minor trocar-related complications suggesting that the use of radially expanding 
trocars compared to cutting trocars leads to reduced incidence of trocar site bleeding. These 
secondary outcomes are viewed to be of less clinical importance.
Implications for research
Large, well-conducted observational studies are necessary in order to answer the questions 
addressed in this review because serious complications, such as visceral or vascular injury, 
are extremely rare. However, for other outcomes, such as trocar site herniation, bleeding 
or infection, large observational studies may be needed as well. In order to answer these 
questions, it is advisable to establish an international network for recording these types of 
complications following laparoscopic surgery.
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Appendices
Appendix 1. Menstrual Disorders and Subfertility Group (MDSG) search strategy
Keywords CONTAINS “laparoscopic”or“laparoscope size”or“laparoscopy”or“laparoscopically 
assisted hysterectomy”or “laparoscopically assisted vaginal hysterectomy”or“laparoscopy-
assisted vaginal hysterectomy”or“mini-laparoscopy” or Title CONTAINS“laparoscopic”or“lapa
roscope size”or“laparoscopy”or“laparoscopically assisted hysterectomy”or “laparoscopically 
assisted vaginal hysterectomy”or“laparoscopy-assisted vaginal hysterectomy”or“mini-
laparoscopy”
AND
Keywords CONTAINS “trocar” or “trocar - dilating-tip” or “trocar - non-shielded-bladed” or 
“trocar ports” or “pneumoperitoneum” or Title CONTAINS“trocar” or “trocar - dilating-tip” 
or “trocar - non-shielded-bladed” or “trocar ports” or “pneumoperitoneum”
Appendix 2. Ovid Cochrane Central Register of Controlled Trials (CENTRAL)
Database searched 28 February 2011, 1 February 2012, 15 January 2014, 24 July 2014 and 
26 May 2015.
1. exp Laparoscopy/ (3605)
2. exp Laparoscopes/ (92)
3. (Laparoscop$ or Laparascop$).tw. (7064)
4. (minimal$ adj invasive).tw. (1544)
5. or/1-4 (8532)
6. (trocar$ or troicar$ or trochar$).tw. (306)
7. cannula$.tw. (1757)
8. (visual adj2 entry system$).tw. (3)
9. pneumoperiton$.tw. (455)
10. exp Pneumoperitoneum, Artificial/ (225)
11. (optiview$ or endotip$).tw. (3)
12. visiport$.tw. (0)
13. access technique$.tw. (22)
14. (Veress or veress-needle$).tw. (35)
15. Hasson.tw. (8)
16. or/6-15 (2535)
17. 5 and 16 (729)
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Appendix 3. Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Ovid MED-
LINE® Daily and Ovid MEDLINE®
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid 
MEDLINE(R) (1950 to present)
Database searched 28 February 2011, 1 February 2012, 15 January 2014, 24 July 2014 and 
26 May 2015.
1. exp Laparoscopy/ (72404)
2. exp Laparoscopes/ (3453)
3. (Laparoscop$ or Laparascop$).tw. (88645)
4. (minimal$ adj invasive).tw. (40910)
5. or/1-4 (132344)
6. (trocar$ or troicar$ or trochar$).tw. (5224)
7. cannula$.tw. (35322)
8. (visual adj2 entry system$).tw. (6)
9. pneumoperiton$.tw. (5927)
10. exp Pneumoperitoneum, Artificial/ (3860)
11. (optiview$ or endotip$).tw. (38)
12. visiport$.tw. (15)
13. access technique$.tw. (530)
14. (Veress or veress-needle$).tw. (387)
15. Hasson.tw. (153)
16. or/6-15 (47827)
17. randomized controlled trial.pt. (395860)
18. controlled clinical trial.pt. (89548)
19. randomized.ab. (321300)
20. placebo.tw. (167185)
21. clinical trials as topic.sh. (173005)
22. randomly.ab. (231296)
23. trial.ti. (138894)
24. (crossover or cross-over or cross over).tw. (64217)
25. or/17-24 (984055)
26. exp animals/ not humans.sh. (4043807)
27. 25 not 26 (906186)
28. 5 and 16 and 27 (774)
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Appendix 4. Ovid EMBASE
Ovid EMBASE (January 2010 to present)
Database searched 28 February 2011, 1 February 2012, 15 January 2014, 24 July 2014 and 
26 May 2015.
1. exp Laparoscopy/ (108007)
2. (Laparoscop$ or Laparascop$).tw. (131384)
3. (minimal$ adj invasive).tw. (59604)
4. exp laparoscope/ (2885)
5. or/1-4 (199188)
6. exp trocar/ (5725)
7. (trocar$ or troicar$ or trochar$).tw. (9064)
8. (Veress or veress-needle$).tw. (657)
9. Hasson.tw. (270)
10. gastrointestinal radiography/ (4308)
11. pneumoperiton$.tw. (7441)
12. cannula$.tw. (42077)
13. (visual adj2 entry system$).tw. (6)
14. (optiview$ or endotip$).tw. (99)
15. visiport$.tw. (43)
16. access technique$.tw. (777)
17. or/6-16 (62302)
18. Clinical Trial/ (844393)
19. Randomized Controlled Trial/ (370996)
20. exp randomization/ (66369)
21. Single Blind Procedure/ (20206)
22. Double Blind Procedure/ (120351)
23. Crossover Procedure/ (42869)
24. Placebo/ (256309)
25. Randomized controlled trial$.tw. (116070)
26. Rct.tw. (16937)
27. random allocation.tw. (1411)
28. randomly allocated.tw. (22280)
29. allocated randomly.tw. (2019)
30. (allocated adj2 random).tw. (726)
31. Single blind$.tw. (15724)
32. Double blind$.tw. (150401)
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33. ((treble or triple) adj blind$).tw. (449)
34. placebo$.tw. (213796)
35. prospective study/ (290100)
36. or/18-35 (1459024)
37. case study/ (31673)
38. case report.tw. (281336)
39. abstract report/ or letter/ (923420)
40. or/37-39 (1230185)
41. 36 not 40 (1419880)
42. 5 and 17 and 41 (1495)
Appendix 5. Ovid PsycINFO
Ovid PsycINFO (inception to present)
Database searched 28 February 2011, 1 February 2012, 15 January 2014, 24 July 2014 and 
26 May 2015.
1. (Laparoscop$ or Laparascop$).tw. (282)
2. (minimal$ adj invasive).tw. (284)
3. or/1-2 (542)
4. (trocar$ or troicar$ or trochar$).tw. (7)
5. cannula$.tw. (1976)
6. (visual adj2 entry system$).tw. (0)
7. (optiview$ or endotip$).tw. (0)
8. visiport$.tw. (0)
9. pneumoperiton$.tw. (3)
10. or/4-9 (1986)
11. 3 and 10 (6)
Appendix 6. CINAHL, Cumulative Index of Nursing and Allied Health Literature
CINAHL search for CC1505 15 January 2014, and updated on 26 May 2015.
#  Query       Results
S27  S11 AND S25       18
S26  S11 AND S25       97
S25  S12 OR S13 or S14 or S15 OR S16 OR S17 OR S18OR S19
 OR S20 OR S21 OR S22 OR S23 OR S24   Display
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S24  TX allocat* random*      Display
S23  (MH “Quantitative Studies”)      Display
S22  (MH “Placebos”)       Display
S21  TX placebo*       Display
S20  TX random* allocat*      Display
S19  (MH “Random Assignment”)     Display
S18  TX randomi* control* trial*      Display
S17  TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl*
 n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*)
 or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1
 mask*) )       Display
S16  TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )    Display
S15  TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )    Display
S14  TX clinic* n1 trial*       Display
S13  PT Clinical trial       Display
S12  (MH “Clinical Trials+”)      Display
S11  S4 AND S10       471
S10  S5 OR S6 OR S7 OR S8 OR S9     892
S9  TX Pneumoperiton*      572
S8  TX endotip*       2
S7  TX visual entry system*      2
S6  TX trochar*       14
S5  TX trocar*       329
S4  S1 OR S2 OR S3       16,899
S3  (MM “Minimally Invasive Procedures”) OR “tx minimal* invasive” 2,714
S2  TX Laparoscop*       14,593
S1  (MM “Laparoscopy”# OR “laparoscopy” OR 
 #MH “Surgery, Laparoscopic”#    11,161
Appendix 7. Cochrane Database of Systematic Reviews, DARE, Wiley - Database of 
Abstracts of Reviews of Effects (reference lists)
#1  MeSH descriptor Laparoscopy explode all trees
#2  MeSH descriptor Laparoscopes explode all trees
#3  (Laparoscop* or Laparascop*):ti,ab,kw
#4  (minimal* invasive*):ti,ab,kw
#5  (#1 OR #2 OR #3 OR #4)
#6  (trocar* or troicar* or trochar):ti,ab,kw
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#7  MeSH descriptor Pneumoperitoneum, Artificial explode all trees
#8  (pneumoperiton*):ti,ab,kw
#9  (access technique*):ti,ab,kw
#10  (cannula*):ti,ab,kw
#11  (“visual entry system” or “visual entry systems”):ti,ab,kw
#12  (optiview* or endotip*):ti,ab,kw
#13  (visiport*):ti,ab,kw
#14  (Veress or veress-needle*):ti,ab,kw
#15  (Hasson*):ti,ab,kw
#16  (#6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15)
#17  (#5 AND #16)
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Laparoendoscopic single-site surgery versus 
conventional laparoscopy for hysterectomy: 
a systematic review and meta-analysis
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Abstract
Purpose: To assess the safety and effectiveness of LESS compared to conventional 
hysterectomy. 
Methods: The systematic review and meta-analysis was performed according to the 
MOOSE guideline, and quality of evidence was assessed using GRADE. Different databases 
were searched up to 4th of August 2016. Randomized controlled trials and cohort studies 
comparing LESS to the conventional laparoscopic hysterectomy were considered for 
inclusion. 
Results: Of the 668 unique articles, 23 were found relevant. We investigated safety by 
analyzing the complication rate and found no significant differences between both 
groups [OR 0.94 (0.61, 1.44), I2 = 19%]. We assessed effectiveness by analyzing conversion 
risk, postoperative pain, and patient satisfaction. For conversion rates to laparotomy, no 
differences were identified [OR 1.60 (0.40, 6.38), I2 = 45%]. In 3.5% of the cases in the LESS 
group, an additional port was needed during LESS. For postoperative pain scores and patient 
satisfaction, some of the included studies reported favourable results for LESS, but the 
clinical relevance was non-significant. Concerning secondary outcomes, only a difference 
in operative time was found in favor of the conventional group [MD 11.3 min (5.45 – 17.17), 
I2 = 89%]. The quality of evidence for our primary outcomes was low or very low due to the 
study designs and lack of power for the specified outcomes. Therefore, caution is urged 
when interpreting the results.
Conclusion: The single-port technique for benign hysterectomy is feasible, safe, and equally 
effective compared to the conventional technique. No clinically relevant advantages were 
identified, and as no data on cost effectiveness are available, there are currently not enough 
valid arguments to broadly implement LESS for hysterectomy.
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Introduction
Since the early 1990s, “minimally invasive surgery” (MIS) has been rapidly implemented into 
a variety of surgical disciplines. The main advantage of minimally invasive procedures is the 
absence of a large abdominal wound, which results in fewer wound-related complications, 
less postoperative pain, and a shorter hospital stay (1). In an effort to extend these benefits, 
an increasing enthusiasm has emerged for the laparoendoscopic single-site surgery (LESS). 
In LESS, multiple laparoscopic instruments are placed through one single abdominal incision 
at the place of the umbilicus. The hypothesis is that single incision technique might offer 
advantages over the standard multi- port laparoscopy as abdominal wall trauma is decreased, 
potentially leading to less postoperative pain and improved cosmesis (2-4). The potential 
drawbacks of the single-port approach are a larger umbilical incision and the proximity of the 
instruments resulting in a technical challenge, especially for advanced surgery (5,6). It was 
only in 1991 that Pelosi et al. performed the first LESS hysterectomy (7), more than 20 years 
after the first publication on the LESS procedure in 1969 (6). Reports have currently shown the 
feasibility of LESS surgery in many benign gynecologic procedures (8,9). However, it remains 
debatable whether this new technology has added value over the existing conventional 
laparoscopic technique and whether it should be broadly implemented for hysterectomy. 
The proportion of laparoscopic hysterectomies (LH) has significantly increased the last 
decades: from 3% in 2002 to 36% in 2012 in the Netherlands (10), and similar numbers 
have been observed in other countries (United States (11) and Finland (12)). Regarding 
the proportion of hysterectomies performed using the LESS approach, no national 
overviews have been published on this topic so far. In some parts of the world, single-port 
hysterectomy seems well implemented. A retrospective single-hospital study from Korea 
showed for example that in 2013, 80% of their hysterectomies were LESS hysterectomies 
(13). Hysterectomy in general is one of the most performed advanced surgeries in gynecology 
with approximately 600,000 procedures a year in the United States (11). As a result, defining 
the surgical approach with the most advantages is essential. In this light, the aim of this 
study is to provide a systematic review and meta-analysis of the current comparative studies 
evaluating specifically LESS hysterectomy and conventional laparoscopy. We particularly 
focused on the safety and effectiveness of the two techniques.  
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Materials and methods
Eligibility criteria, information source, search strategy 
This systematic review was conducted according to the MOOSE guidelines (14). We 
identified original published studies through a search of Medline (PubMed version), EMBASE 
(Ovid version), Cochrane, Web of Science, Central, CINAHL, Academic Search Premier and 
Science Direct up to 4th of Augustus 2016 without restriction. The search terms included 
‘gynecology’, ‘hysterectomy’, and all acronyms of LESS. The exact search terms are presented 
in supplemented material (Appendix 1). In addition, relevant studies cited in the reference 
lists of the selected papers were evaluated. Only comparative studies (randomized controlled 
trials, prospective and retrospective cohort studies) evaluating LESS versus hysterectomy for 
benign indications were considered for inclusion. LESS procedures had to be strictly performed 
through one single (umbilical) port as opposed to the conventional laparoscopic hysterectomy 
performed through more than one port. Studies on animals or patients aged < 18 years were 
excluded as well as studies comprising endoscopic surgery with different techniques (e.g., 
hand- or robot-assisted, isobaric pneumoperitoneum). We also excluded descriptive review 
articles, surveys, technical reports, published abstracts without a full manuscript, reports from 
meetings, and trials with less than ten included participants per arm or 20 in total. 
Study selection 
Two reviewers independently screened the titles and abstracts for their relevance (ES and 
CC). Potentially relevant studies were obtained in full text and assessed for inclusion. We 
included studies wherein the effectiveness and/or safety of LESS compared to conventional 
laparoscopy for hysterectomy were investigated. To assess the safety of a procedure, we 
considered complication rates as primary outcome. Effectiveness refers to the potential 
success of a surgical procedure, and therefore, we considered: success rate (defined by the 
chance for a successful procedure without conversion to laparotomy and for the use of an 
additional port in the single-site group), postoperative pain scores, cosmetic outcomes, and 
patient satisfaction (including sexual function) as relevant primary outcomes. The following 
secondary perioperative outcomes were considered: operative time, intraoperative blood 
loss, and length of hospital stay. Although less important, these are also relevant identifiers 
for the effectiveness of a procedure. 
Complications were defined according to the classification of the Dutch Society of Obstetrics 
and Gynecology and further divided into ‘major complications’ and ‘minor complications’ 
(15). Major complications included: major hemorrhage or hematoma (requiring transfusion); 
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urinary tract or bowel injury; pulmonary embolism; major anesthesia problems; vaginal 
cuff dehiscence; port site hernia; and re-operation. Minor complications were defined as 
hemorrhage (not requiring transfusion) or hematoma (with spontaneous drainage); infection 
to the chest, urinary tract, wound, pelvic, other, or pyrexia 38 °C; deep vein thrombosis; and 
other minor complication requiring treatment (including voiding dysfunction and ileus). 
We distinguished two types of conversion: an unintended conversion to laparotomy and 
the need for an additional port in the single-site group. The postoperative pain should be 
expressed on a self-reported scale (16) (e.g., visual analogous scale (VAS), numerical rating 
scale (NRS)), and for cosmetic outcomes, validated questionnaires should be used. 
Data extraction 
Outcome data as mentioned in the previous heading as well as study and patient 
characteristics were extracted from the included studies. These baseline findings included 
study design, number of included participants, country where the study was conducted, 
source of funding, relevant characteristics of the participants (age, body mass index, and 
uterine weight), description of the procedural setting, and experience of the physician. Data 
related to the defined outcomes were assessed for inclusion in the meta-analysis. Sensitivity 
analyses were performed for randomized studies and cohort studies when relevant subgroup 
analyses were accomplished for TLH and LAVH. 
Assessment of risk of bias 
The study limitations in randomized trials and observational studies were assessed using 
the checklists adapted from Guyatt et al. (17): (1) random sequence generation; (2) allocation 
concealment; (3) blinding of participants, surgeons, and investigators; (4) attrition bias: loss 
to follow- up (5) reporting bias: selective reporting and/or missing per protocol analysis; (6) 
other, e.g., use of non-validated outcome measures, difference in baseline characteristics 
between the groups and influence of co-interventions, or differing surgical experience in 
the compared procedures. For the first three points of the checklist, retrospective studies 
were rated as ‘high risk’, whereas attrition bias and reporting bias were marked as ‘unclear’, 
unless there was an additional reason to judge them as ‘high risk’. The quality of evidence 
was then rated following the Grading of Recommendations Assessment, Development, and 
Evaluation (GRADE) approach (18). The quality of evidence was classified into one of four 
categories: high quality, moderate quality, low quality, or very low quality. We used the online 
GRADE program (GRADEpro Guideline Development Tool [Software], McMaster University, 
2015, developed by Evidence Prime, Inc., available from gradepro.org). Any discrepancies 
between reviewers were addressed by an open discussion. 
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Evidence synthesis and statistical analysis 
Meta-analysis was conducted using Review Manager (Version 5.2. Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2012). For continuous data, we calculated 
mean differences (MDs) and standard deviations (SDs); for dichotomous data, we calculated 
odds ratio (OD) with their 95% confidence intervals (CIs). When summary data were missing, 
e.g., only the median and range were available, data were transformed as appropriate 
according to the definitions described by Hozo (19). We applied the random-effects model 
to combine data for meta-analysis.
Results
Study selection 
Figure 1 shows the flow diagram of the literature selection for this review. The initial search 
yielded 668 unique references, and twenty-three studies fulfilled our inclusion criteria. 
Eleven studies compared LESS hysterectomy to conventional TLH (13,20-29), eleven studies 
compared LESS hysterectomy to LAVH (30-40), and in one study, both procedures were 
included (41). Two studies also included supra-cervical hysterectomies (20,21). The study by 
Koyanagi (42) was excluded as all data were already included in another study by the same 
author (40). The selected papers were published between 2010 and 2015. 
Study characteristics 
A total of 1,985 women in the LESS group and 2,466 women in the conventional hysterectomy 
were included in six randomized controlled trials (23,24,26,30,39,41), five prospective cohort 
studies (21,27,32,36,37), and 12 retrospective cohort studies (13,20,22,25,28,29,31,33-
35,38,40). Twenty of the studies (86.9%) were performed in Asia (fifteen in Korea (13,23-
25,27,28,31,32,34,35,37-39,41), one in China (26), two in Japan (29,40), and two in Taiwan 
(30,33), and the other three studies originated from the United States (20), Italy (22), and France 
(21). Fourteen studies had a single center design (20-24,26-30,33,36,37,39), one RCT was multi-
center (41), and in the other eight studies, the setting was unclear (13,25,31,32,34,35,38,40). 
Fifteen studies stated that there was no potential conflict of interest to disclose (13,20-27,30-
33,35,38), five studies reported financial support (from a grant of Samsung Medical Center 
(39), from a grant of Korea Health Care technology (36,37), from Covidien (41), and from Kyung 
Hee University Research Fund (34)), and three studies remained unclear about their potential 
conflicts (28,29,40). 
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Women in the LESS group aged between 40.3 and 53 years, their BMI ranged from 22.0 to 28.7 
kg/m2, and their uterine weight ranged from 105 to 642 grams. In the conventional group, the 
age range of the patients, their BMI, and uterine weight varied, respectively, between 41.26 
and 63 years; 22.0 – 28.8 kg/m2 and 9 – 613 g. In two studies from Lee et al., the same cohort 
was partially used: the smaller cohort study focused on outcomes of sexual function. We 
used the data from the largest cohort (37), but for analysis of the outcome ‘sexual function’, 
we extracted the data from the partial cohort (36). 
Risk of bias of the included studies 
A summary of risk of bias for the individual studies is depicted in figure 2. For the overview 
of GRADE findings, see table 1.  
Figure 1 Flow diagram of the study selection.
                                  
                           
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
PubMed n = 659
Embase n = 1,887 
Web of Science n = 223 
Cochrane n = 31 
Central n = 53 
CINAHL n = 15 
Academic Search Premier n = 75 
Science Direct n = 127 
TOTAL n = 3,070
Title and abstract screening 
n = 668 
Duplicates n = 2,402 
Full-text screening 
n = 36 
Included studies n = 23 
- RCT n = 6 
  (TLH n = 3, LAVH n = 2, mixed n = 1) 
- Prospective studies n = 5 
  (TLH n = 2, LAVH n = 3) 
- Retrospective studies n = 12 
  (TLH n = 6, LAVH n = 6) 
Excluded n = 541 
No hysterectomy 
Malignancy  
No original data 
Excluded n = 13 
Not specific hysterectomy (n = 7) 
Not comparative (n = 4) 
Duplicate data (n = 1) 
No original data (n = 1) 
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Figure 2a Risk of bias summary LESS versus conventional laparoscopic hysterectomy.
Figure 2b Risk of bias per study, LESS versus conventional 
laparoscopic hysterectomy.
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Safety: complications 
We found no differences between complication rates when comparing LESS hysterectomy 
to conventional hysterectomy when clustering into major complications (23 studies, OR 0.94 
(0.61, 1.44), I2 = 19%, figure 3a) and minor complications (13 studies, OR 0.76 (0.46 – 1.27), 
I2 = 11%, figure 3b). Sub-analysis specific for TLH and LAVH showed no difference (data not 
shown). None of the studies reported a port site herniation, though only one study mentioned 
that they had collected data on herniation (26).
Effectiveness: success rate, postoperative pain scores, cosmetic results, and patient 
satisfaction 
Conversion to laparotomy occurred in 22 of 1,835 patients (1.2%) in the LESS group, compared 
to 8 of 2,289 (0.35%) patients in the conventional group, which was not statistically significant 
(total 21 studies, OR 1.60 (0.40, 6.38), I2 = 45%, figure 3c). The six RCTs included reported two 
conversions in both groups. For the 15 cohort studies, 17 of the 20 conversions in the LESS 
Figure 3a Major complications, LESS versus conventional laparoscopic hysterectomy.
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Figure 3b Minor complications, LESS versus conventional laparoscopic hysterectomy.
 
group were observed in one study (13). Reason for conversions was extensive adhesions (n 
= 18), bladder injury (n = 1), bladder and bowel injury (n = 1), retroperitoneal bleeding (n = 
1), and unspecified (n = 9). When evaluating the rate of additional ports needed during LESS 
surgery, 48 of the 1344 (3.5%) patients included had at least one additional port during LESS 
surgery versus one in the conventional group (0.06%) (38). Fourteen of these cases can be 
attributed to Fridman et al. where additional port was needed in 38% of the cases (20). In 
the study by Jung et al. one patient had an additional port due to an incidental finding of 
an appendiceal mucinous adenoma (34). 
Thirteen studies assessed the pain scores of their patients at various postoperative moments 
(direct after surgery up to one week) using VAS scores. Five of these studies were RCTs 
and one had appropriate double blinding. That specific RCT found no difference between 
the two groups at any of the reported moments (direct, 12, 24, and 48 h post- operative) 
(23). The pain scores direct, 12 and 24 h after surgery were most frequently studied and, 
therefore, pooled for meta-analysis. Data that analyzed pain scores in the recovery unit, thus 
immediately after surgery, showed significantly lower pain scores after LESS hysterectomy 
compared to conventional hysterectomy (5 studies, MD -1.09 (-1.66, -0.52), I2 = 80%, figure 
4a) (21-23,28). The only randomized controlled trial included in this sub-analysis showed 
no difference between the two groups. At 12 h, a non-significant difference was observed (5 
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studies, MD -0.19 (-0.41, 0.03), I2 = 0%, figure 4b). At 24 h, meta-analysis showed a significant 
difference between the two groups (11 studies, MD -0.45 (-0.87, -0.03), I2 = 90%, figure 4c) 
(21,23,25,28). Though, the subgroup analysis including five RCTs showed non-significant 
results (MD -0.15 [-0.58, 0.28]. I2 = 64%). Ten studies reported on data regarding analgesic use 
(22-25,28,30,33,38,39,41). Chung et al. and Jung et al. showed that the LESS group requested 
significantly more (additional) analgesics, but the VAS scores revealed no difference (23,24). 
In contrast, the (rescue) analgesic requirement was significantly lower in the LESS group in 
four studies (22,28,30,38). Similarly, Hong et al. calculated a pain-relief score based on the 
amount and type of analgesic used and the effectiveness on pain relief and their results 
were also in favor of the single-port surgery (33). Finally, Lee et al., Kim et al. and Song et al. 
showed no difference in analgesic use between the two groups (25,39,41). 
 
Figure 3c Conversion to laparotomy, LESS versus conventional laparoscopic hysterectomy.
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Figure 4a Pain scores direct postoperative, LESS versus conventional laparoscopic hysterectomy.
 
Figure 4b Pain scores 12 hours postoperative, LESS versus conventional laparoscopic hysterectomy.
 
Figure 4c Pain scores 24 hours postoperative, LESS versus conventional laparoscopic hysterectomy.
 
Chapter_4_Claire.indd   139 13-11-2017   22:17:16
Chapter 4
140
Three studies reported on cosmetic results (21,39,41), and two used the validated Body 
Image Questionnaire at one, four and 24 week postoperative. Patients in the LESS group were 
significantly more satisfied with their scars and had higher satisfaction with their own body 
at the three measured moments. Kim et al. studied the scar satisfaction using the patient 
and observer scar assessment scale (POSAS) one week and two months after surgery and 
showed no difference between the single-site group and the multi-port one. Li et al. studied 
patient satisfaction and demonstrated a higher patient satisfaction rate in the single-port 
group, although it was unclear which questionnaire was used (26). Lee et al. compared the 
sexual function of premenopausal women by using the female sexual function index and 
showed no difference between women that underwent LESS compared to LAVH (36).
Secondary outcomes 
The operative time was significantly longer in the single-port group compared to the multi-
port group (20 studies, MD 11.3 min (5.45 – 17.17), I2 = 89%, figure 5a. When comparing 
Figure 5a Operative time, LESS versus conventional laparoscopic hysterectomy.
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separately TLH and LAVH, a significant difference of 21 minutes was seen in favor of the TLH 
group, compared to a non-significant difference of two minutes after LAVH (data not shown). 
No difference was seen for the intraoperative blood loss (19 studies, MD 1 mL (-6.03, -7.81), I2 
= 27%, figure 5b). For the length of hospital stay, a small significant difference was seen (15 
studies, MD -0.22 (-0.43, -0.01), I2 = 86%, figure 5c). This difference was not seen when looking 
separately at the RCTs and cohort studies.
Figure 5b Total blood loss, LESS versus conventional laparoscopic hysterectomy.
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Discussion
Main findings 
In this systematic review, we evaluated the safety and effectiveness of LESS hysterectomy 
compared to the conventional laparoscopic hysterectomy (TLH and LAVH). Twenty-three 
studies on LESS versus conventional hysterectomy showed no differences for safety with 
very low quality evidence. Concerning effectiveness, very low quality evidence indicated no 
difference for the risk of conversion to laparotomy in the LESS group compared to TLH and 
LAVH. In 3.5%, the LESS approach failed as an additional port was needed. For postoperative 
pain, low quality of evidence indicated a lower VAS score of 1.09 and 0.45, respectively, directly 
and 24 h after LESS hysterectomy, though with substantial statistical heterogeneity. Two out 
of three studies with low-quality evidence indicated a better cosmetic outcome after LESS 
versus conventional hysterectomy. A major shortcoming in these studies is the lack of a 
pre-operative assessment. Without a pre-operative assessment, it remains unclear whether 
Figure 5c Length of hospital stay, LESS versus conventional laparoscopic hysterectomy.
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there were any differences between the groups prior to their surgery. The third study, a RCT 
showed no difference with respect to scar satisfaction. 
Strengths and limitations 
Though there are some RCTs available comparing LESS to conventional hysterectomy, 
we decided to include other comparative study designs as well. The inclusion of non-RCT 
designs results in less homogenous groups, but when outcomes of interest are infrequent 
(e.g., conversion to laparotomy risk, complication risks); RCTs are rarely large and lengthy 
enough to measure infrequent outcomes accurately. Cohort studies facilitate a larger study 
population and adequate power to identify significant differences. Therefore, the inclusion 
of study designs other than RCTs can be seen as a limitation but also as strength. In addition, 
to limit bias, we performed sensitivity analysis for the study design for the meta-analysis. 
Another strength of this review is the assessment of the quality of evidence using GRADE 
methodology. We believe that the use of GRADE results in additional clinical value of this 
review: GRADE optimizes the presentation of evidence for clinical practice. The results of 
this systematic review are strengthened through the findings of other reviews published 
on the subject that as well found no significant difference in the frequency of perioperative 
complications and postoperative pain scores (8,9,43). Though, other reviews described 
a higher rate of ‘failures’ in the LESS group. These studies defined ‘failure’ as the need to 
convert to laparotomy and/ or to add an extra port, without differentiating. We found that 
in 3.5% of the LESS procedures, an additional port was needed compared to < 1% in the 
conventional procedures. 
Interpretation 
The feasibility of LESS surgery for benign gynecologic procedures seems proven.8;9 The meta-
analyses in this review showed no significant differences in complication and conversion 
rate to laparotomy between LESS and conventional hysterectomy. Without substantial 
statistical heterogeneity, we consider these findings reliable. Besides complication risk, 
the pain experienced after surgery is an important consideration and usually an important 
argument in favor of LESS. Though, we did not find any clinically significant differences in 
postoperative pain. Directly and 24 h after LESS hysterectomy, a significant lower VAS score 
was observed. This difference was not observed when analyzing only the RCTs. Furthermore, 
the mean difference did not exceed 1.09 and studies have shown that a mean difference of 
2 points on a 10-point scale should be considered as clinically relevant (44). In addition, it 
cannot be excluded that enrolled patients in the study are biased with respect to their pain 
outcomes as, except in one study, the included patients were not blinded to the type of 
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surgery. One single randomized controlled trial applied accurate blinding (23): patients and 
anesthesiology staff who measured the postoperative pain scores did not know which type 
of approached had been performed and similar pain scores were found. Cosmetic outcomes 
are also suggested as important improvement in the single-site approach but surprisingly few 
studies on LESS hysterectomy reported on this topic (21,39,41). We judged the assessment 
in the two studies on patient satisfaction insufficient, since baseline assessment of body 
image and cosmetic satisfaction was not performed. The largest RCT published so far for 
hysterectomy reported no significant differences regarding scar satisfaction between the 
LESS and ‘conventional’ hysterectomy group (41). When looking at studies published in 
other fields than benign gynecology, inconsistent results are found for the self-scar rating 
in patients who underwent LESS or conventional laparoscopic surgery (45-47). In Tuschy 
et al. patients who underwent conventional gynecological laparoscopy were asked which 
scar they would prefer to eliminate, and for most patients, it was the umbilical one (48). 
In the study by Bush et al. patients were asked their aesthetic preference regarding scars, 
and no differences were observed between the single-site and conventional incisions (6). 
In LESS surgery, higher forces are applied on the umbilical port during tissue handling and 
irreversible umbilical deformation has been described (29). It is also suggested that LESS 
would lead to a higher risk of port herniation as the opening of the umbilical port is larger 
(49-51). Though, this could not be confirmed in the current literature, as within the short 
study follow-up, only one case of port herniation was reported (31). 
Evaluating the secondary surgical outcomes, a notable finding is the increased operative 
time found in the LESS versus conventional hysterectomy group: an overall mean difference 
of 11 minutes was observed, though with substantial heterogeneity. For the TLH, the 
mean difference was 21 minutes, whereas for the LAVH, a non-significant difference of two 
minutes was observed. The reason for the prolonged operative time during TLH is most 
probably related to the difference in surgical experience. For the LAVH, it makes sense that 
the operative time was similar as a large part of the LESS and conventional procedure 
is performed vaginally, thus using exactly similar techniques. It is well known that LESS 
surgery is technically more challenging (8,9,43) and studies reporting on the learning curve 
in LESS have suggested that sufficient skills are acquired after 10 to 15 (3) up to 40 cases (52), 
especially when surgeons are already well-trained in laparoscopy. In five studies included 
in this review, the surgical experience of the surgeons was not described (13,28,30,35,38). 
In the other included studies, the experience of surgeons was defined by terms, such as 
‘very experienced’, ‘senior surgeon’, or by the number of laparoscopic and/or LESS surgeries 
performed in one’s career. Hence, it is difficult to interpret the impact of the skills on the 
outcomes. It is noteworthy mentioning that we found substantial differences in baseline 
characteristics between compared groups in the non-randomized studies (uterine weight 
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(20,21,28), age (20), BMI (31), previous surgeries, and co-morbidities (28,38)). This could be 
explained by the surgeon’s specific selection when performing a new technique in a non-
randomized setting. Yet, an increased uterine weight, a high BMI, and/or previous surgical 
interventions are known to directly influence surgical outcomes (53) and this could lead to 
an overestimation of effectiveness, safety, and secondary outcomes (e.g., operative time, 
blood loss) for LESS outcomes. In addition, it should also be taken into account that 20 
of the 23 studies originated from Asian, and therefore, the impact of Asian demographics 
should not be underestimated. 
Remarkably, none of the included studies has taken the costs of the surgery into account, 
and currently, it is unknown if the LESS approach is cost effective. Despite the lack of data 
for LESS versus conventional hysterectomy, it can be reasoned that implementing the 
LESS technique in a hospital is costly as the conventional instruments do not fit and new 
instruments need to be purchased. 
As seen with previous devices and or techniques (54), implementing new technologies in the 
medical field is a challenge. In contrast to the introduction of new drugs, the latest techniques 
and devices are usually implemented in clinical practice without proper systematic evaluation 
regarding their safety, effectiveness, costs, and benefits. Advantages and disadvantages only 
become clear with the passage of time and after the implantation phase. Considering this, it 
is complex to answer the question whether the single-port surgery should be an additional 
possibility for the minimally invasive surgery. Most of studies in the review were single center 
and from the same region in the world, where a lot of experienced has already been acquired 
with the LESS technique. Despite the amount of experience with LESS in these centers, there 
is still no clear added value. 
In conclusion, current evidence shows that the single-port technique for benign hysterectomy 
(TLH and LAVH) is feasible, safe, and equally effective compared to the conventional 
technique. Caution is urged when interpreting the results of studies on LESS because the 
evidence is of low to very low quality. Potential benefits are sought in patient satisfaction, 
cosmetic satisfaction, and postoperative pain, but the small differences for these outcomes 
appear not to be of clinical relevance. Furthermore, surgeons and patients should be aware 
that in up to 3.5% of LESS hysterectomies an additional port is required resulting in failure of 
the “single-site” approach and affecting the less invasive purpose. As no clinically relevant 
advantages were identified, and no data on cost effectiveness were available, there are 
currently no solid arguments to implement the single-port technique worldwide.
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Appendix 1 Search up to 4th of August
PubMed: 
(“gynaecology”[All Fields] OR “gynecology”[MeSH Terms] OR “gynecology”[All Fields] OR 
gynaecologic[All Fields] OR gynecologic[All Fields] OR “Genital Diseases, Female”[Mesh] OR 
“female genital disease”[all fields] OR “female genital diseases”[all fields] OR “Gynecologic 
Surgical Procedures”[Mesh]) AND ((“Single Incision Laparoscopic Surgery”[All Fields] OR 
“laparo-endoscopic single-site surgery”[all fields] OR “One port umbilical surgery”[all 
fields] OR “Natural orifice transluminal endoscopic surgery”[all fields] OR “Single-incision 
minimally invasive surgery”[all fields] OR “Single laparoscopic incision transabdominal 
surgery”[all fields] OR “Single-port access”[all fields] OR “Single-port laparoscopy”[all 
fields] OR “Single-port incisionless conventional equipment-utilizing surgery”[all fields] 
OR “Umbilical laparoendoscopic single-site surgery”[all fields]) OR ((“laparoscopy”[MeSH 
Terms] OR “laparoscopy”[All Fields] OR “laparoscopic”[All Fields] OR laparoendoscopic[All 
Fields]) AND ((“single”[All Fields] AND (site[All Fields] OR port[all fields] OR incision[all fields] 
OR umbilical[all fields] OR transumbilical[all fields])) OR (single-port[all fields] OR single-
site[all fields] OR single-incision[all fields])) AND (“surgery”[Subheading] OR “surgery”[All 
Fields] OR “surgical procedures, operative”[MeSH Terms]))) AND (“2012/05/01”[PDAT] : 
“3000/12/31”[PDAT])
Embase: 
(gynaecolog*.mp. OR gynecolog*.mp. OR exp gynecology/ OR exp gynecologic disease/ OR 
female genital disease*.mp. OR exp gynecologic surgery/) AND ((“Single Incision Laparoscopic 
Surgery”.mp. OR “laparo-endoscopic single-site surgery”.mp. OR “One port umbilical surgery”.
mp. OR “Natural orifice transluminal endoscopic surgery”.mp. OR “Single-incision minimally 
invasive surgery”.mp. OR “Single laparoscopic incision transabdominal surgery”.mp. OR 
“Single-port access”.mp. OR “Single-port laparoscopy”.mp. OR “Single-port incisionless 
conventional equipment-utilizing surgery”.mp. OR “Umbilical laparoendoscopic single-site 
surgery”.mp.) OR ((exp laparoscopy/ OR exp laparoscopic surgery/ OR “laparoscopy”.mp. OR 
“laparoscopic”.mp. OR laparoendoscopic.mp.) AND ((“single”.mp. AND (site.mp. OR port.mp. 
OR incision.mp. OR umbilical.mp. OR transumbilical.mp.)) OR (single-port.mp. OR single-
site.mp. OR single-incision.mp.)) AND (exp surgical technique/ OR surgery.mp. OR surgical.
mp.))) AND (201236 OR 201237 OR 201238 OR 201239 OR 20124* OR 20125* OR 2013* OR 
2014* OR 2015* OR 2016*).ew
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Abstract
Objective: To assess whether hysteroscopic sterilization is feasible and effective in preventing 
pregnancy. Secondarily to identify risk factors for failure of hysteroscopic sterilization. 
Design: A systematic review and meta-analysis. 
Setting: Not applicable.
Patients: Women undergoing hysteroscopic sterilization.
Intervention: Hysteroscopic sterilization with a commercially available system (Ovabloc 
Intra Tubal Device, Essure system or Adiana Permanent Contraception system).
Main outcome measures: Successful placement at first attempt, confirmed correct 
placement, complications, incidence of pregnancy and risk factors for placement failure in 
hysteroscopic sterilization.
Results: Of the 429 citations identified, 45 articles were eligible for analyses, no randomised 
controlled trials (RCTs) were identified, just cohort studies. Six articles concerned Ovabloc, 
37 Essure and two Adiana sterilization. The probabilities for successful bilateral placement 
in a first attempt for Ovabloc, Essure and Adiana, were respectively ranging: 78% – 84%, 
81% – 98% and 94%. The probabilities of successful bilateral placement could not be pooled 
because of substantial heterogeneity. The 36 months cumulative pregnancy rate of Adiana 
was 16/1,000. Reliable pregnancy rates after sterilization with Ovabloc or Essure method could 
not be calculated. For all three hysteroscopic techniques, the incidence of complications 
and their severity has not been studied adequately and remains unclear. We also found too 
little evidence to identify risk factors for placement failure.
Conclusion(s): Sterilization by hysteroscopy seems feasible, but the effectiveness and risk 
factors for failure of sterilization remain unclear due to the poor quality evidence. Both 
currently applied hysteroscopic sterilization techniques and the coming new techniques must 
be evaluated properly for feasibility and effectiveness. Appropriate RCTs and observational 
studies with sufficient power and complete and long-term (> 10 years) follow up data on 
unintended pregnancies and complications are needed.
Chapter_5_Claire.indd   154 13-11-2017   16:51:35
155
Sterilization by hySteroScopy
5
Introduction
The hysteroscopic approach to female sterilization has been studied for more than a century. 
The initial techniques often proved to be difficult and inefficient. Failure rates were high and 
serious complications by perforation and thermal bowel lesions were reported in clinical 
trials (1,2). Nevertheless there was continuing belief that hysteroscopic sterilization would 
be a suitable method for permanent contraception. This was prompted by the fact that the 
hysteroscopic route avoids the transabdominal route and the risks of entering the peritoneal 
cavity are thereby avoided. Hysteroscopic sterilization is supposed to result in less morbidity and 
a quicker return to normal activities. Another advantage of hysteroscopic sterilization compared 
to laparoscopic sterilization is the reduced need for anaesthesia, which facilitates sterilization 
in an ambulatory setting. These advantages make that hysteroscopic sterilization is a good 
option for women with contraindications to laparoscopy (e.g. with a history of laparotomy) or 
who just wish to avoid incisional surgery or general anaesthesia.
In the past decades, three systems became available on the commercial market: in 1988 the 
Ovabloc Intra Tubal Device (Advanced Medical Grade Silicones BV, Reeuwijk, the Netherlands) 
(3), in 2002 the Essure system (Conceptus Incorporated, Mountain View, CA, USA) (4,5) and in 
2009 the Adiana Permanent Contraception system (Hologic, Inc, Bedford, MA, USA) (6). The 
Ovabloc device is a silicon mixture that is instilled into the tubal ostium and solidifies within 
five minutes into a rubber plug. The Essure device is a 4 cm expanding spring made of a 
nitinol outer coil and stainless steel inner coil with PET fibres, placed in the proximal section 
of the fallopian tube. The Adiana sterilizatio technique is a combination of 60 seconds of 
radiofrequency appliqued to the mucosa of the fallopian tube followed by deployment of 
a 3.5 mm matrix into the created lesion. These distinct mechanisms of action may lead to 
differences in feasibility and effectiveness.
The above described techniques all require a so called ‘confirmation test’ three-months 
post-procedure to verify proper placement. While conventional laparoscopic approach and 
sterilization via mini-laparotomy are considered to be effective immediately, hysteroscopic 
systems require a period of three months after the procedure for the fallopian tubes to undergo 
fibrosis leading to occlusion and contraceptive effectiveness (5,6,7). During these three months 
women have to use alternative contraception. A hysterosalpingogram (HSG), pelvic X-ray or 
ultrasound is used to verify correct placement, depending on the instructions for use supplied 
by the manufacturer.
Long-term studies on large cohorts of women have assessed laparoscopic sterilization and 
sterilization via mini-laparotomy, though less is known about the feasibility and effectiveness 
of the hysteroscopic approach. Data from phase II and III clinical trials with Adiana and Essure 
showed high feasibility and effectiveness (4,5,6). It is questionable if daily practice results are 
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comparable with these earlier results. Additionally, identifying risk factors for placement failure 
will be important in patient selection and to identify cases at risk for failure of hysteroscopic 
sterilization. We conducted a systematic review to examine the feasibility and effectiveness 
of hysteroscopic sterilization. Secondarily, we tried to identify risk factors for failure of 
hysteroscopic sterilization.  
Methods
This systematic review was conducted according to the PRISMA guidelines. All longitudinal 
studies addressing hysteroscopic sterilization were considered for inclusion, both prospective 
and retrospective. Studies were included if successful placement rate, safety, effectiveness 
or risk factors for failure of hysteroscopic sterilization were investigated. Only original 
studies with > 20 consecutively included participants were selected to allow pooling of data. 
Descriptive articles, case-series (with non-consecutively included participants), reviews, 
surveys, technical reports and congress abstracts were excluded. No language restriction 
was applied. All types of participants undergoing tubal sterilization by hysteroscopy 
were included. Animal studies and studies wherein electrocoagulation or chemicals (e.g. 
quinacrine) were used to obliterate the tubes were excluded.
To assess feasibility we considered successful placement rate, percentage of confirmed proper 
placements and the occurrence of procedural complications as important outcomes. As 
effectiveness refers to the ability to prevent conception, we evaluated the rate of unintended 
pregnancies after confirmation of correctly placed devices. Hence we formulated the 
following research questions:  
1. What is the probability of a successful bilateral placement at the first attempt 
of a hysteroscopic sterilization?
2. What percentage of women have a confirmed correct bilateral placement of 
the devices three months after the procedure?
3. What are the risk factors for placement failure of the devices used for 
hysteroscopic sterilization?
4. What are the complications of hysteroscopic sterilization and what are the 
corresponding incidences?
5. What is the incidence of pregnancy after confirmed correct bilateral 
placement?
We defined successful placement rate as the percentage of women that had successful 
bilateral procedures in a first attempt. There are some differences in the definitions of 
successful placement applied by the manufacturers. For Ovabloc the bilateral instillation 
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is immediately followed by a satisfactory X-ray showing adequate filling, continuous from 
the tip to the ampulla. For Essure, successful placement is a hysteroscopically verified 
bilateral correct position of the inserts during the procedure, by counting the number of coils 
protruding in the uterine cavity. For Adiana successful bilateral placement includes bilateral 
insertion and confirmation of placement at one week post-procedure using transvaginal 
ultrasonography. 
Confirmed correct placement rate was recorded as the percentage of women with good 
results of the three-months post-procedure ‘confirmation test’, out of the total number of 
women who had a successful placement. There are also differences in the confirmation tests 
prescribed by the manufacturers. After the Ovabloc procedure the required confirmation test 
is a second X-ray to evaluate for correct position of the devices. After Essure procedures, an 
X-ray or transvaginal ultrasonography to confirm appropriate retention and location of both 
devices or confirmed bilateral tubal occlusion on HSG is required. For Adiana the confirmation 
test includes verification of bilateral occlusion with an HSG. For all techniques, we excluded 
successful single placements in patients with a history of salpingectomy, because the higher 
chance for successful single placement would confound the outcome successful placement.
The related risk factors for placement failure were abstracted from both uni- and multi-
variate analyses. We studied safety (covered by feasibility) through recording intra- and 
post procedural complications other than failed sterilization. We defined complications as 
an unintended and undesirable event or condition during or following medical intervention 
to such an extent it is disadvantageous to the patient’s health that medical intervention 
is necessary and/or irreparable damage has occurred. Symptoms related to patient 
tolerance of the procedure (e.g. pain, vasovagal reaction, nausea, vaginal spotting or post 
procedure bleeding) were not classified as complications. Ineffectiveness was recorded 
as the cumulative pregnancy rate per specified unit of time as part of the total number of 
participants. All outcomes were evaluated per specific sterilization technique.
Search methods for identification of studies
Medline (PubMed version), EMBASE (OVID version), Web of Science and the Cochrane library 
were searched by a clinical librarian up to February the 25th 2014 without language restriction 
or methodological filters. The exact search is supplemented to this article (supplement 1). 
Two reviewers (C.C. and S.V.) independently screened titles and abstracts for relevance. The 
bibliographies of included articles were then hand-searched for other relevant references. 
The same reviewers independently extracted study and patient characteristics and outcome 
data. The methodological details, number of included patients and descriptive study 
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characteristics (country where the study was conducted, recruitment modality, source of 
funding), characteristics of the participants (age, body mass index, parity), description of the 
device (type, version), description of the procedural setting (in-office or Operation Room, type 
of anaesthesia, experience of the physician), co-interventions (for example polypectomy, 
endometrial ablation), and outcomes (types of outcomes, documentation of drop-outs, 
follow-up, standardization of outcome assessment) were extracted. Disagreements were 
reconciled by discussion with an arbiter (F.W.J or H.B.). Data related to the defined outcomes 
were assessed for inclusion in the meta-analyses. 
The methodological quality of the included studies was assessed using a checklist adjusted 
from the Newcastle-Ottawa Scale (8). We customized the items to the review questions of 
interest. Study limitations were reviewed for appropriate eligibility criteria (item selection), 
adequate measurement of outcomes (item outcome), selective reporting and other bias 
(e.g. confounding factors) (item comparability). Pooled probability of successful placement, 
confirmed placement and pregnancy were conducted using ‘R’ version 3.0.2. (http://www.r-
project.org). Statistical heterogeneity among the results of the included studies was identified 
and quantified formally with I2 statistic. A value of ≥ 50% indicates substantial heterogeneity. 
Where I2 ≥ 50%, results were not pooled but described. The probabilities are shown with their 
95 per cent confidence interval (CI). Outcomes for dichotomous risk factors for placement 
failure are expressed as odds ratios (OR), continuous outcomes for risk factors are expressed 
as mean difference (MD), both with 95% CI.
Results
The search produced 429 unique references, of which 66 were considered relevant to the 
topic based on title and abstract. Figure 1 shows the flow diagram of the selection process. 
Finally, a total of 45 articles were eligible for analyses: six articles concerned Ovabloc, 37 
Essure and two Adiana sterilization. The eligible studies included: no RCTs, 30 prospective, 
13 retrospective, one partly retro- and partly prospective cohort study and one study with 
unclear perspective.  
Ovabloc
A total of 2,039 women were included in two prospective and four retrospective studies 
(7,9,10,11,12). The articles were published between 1983 and 1999. Two studies were 
multi-centre and four were single-centre. Two articles included cohorts that had 
overlap with each other (7,12). None of the studies reported a potential conflict of 
interest. The number of participants in each trial ranged from 115 to 438. The age range 
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was 18 to 46 years. The exclusion criteria were clearly defined in five articles. Three 
studies included nulliparous women (9,12,13). There were considerable differences 
in exclusion criteria between studies. In one study tubal patency was tested with 
perfusion of diluted methylene blue dye (MBPT) before instillation. Women with no 
tubal patency in one or both tubes were excluded for an installation attempt (13). 
All procedures were performed with a paracervical block. One study reported pre-medication 
of naproxen 12 hours and 2 hours before the procedure and intramuscularly atropine 30 
minutes before the procedure (9). In three studies office hysteroscopy was performed with 
an 8 mm single flow (SF) system (Hyskon or CO2) (7,11,12), while in two studies a continuous 
flow (CF) system with low viscosity distension medium was used (10,13). In one study both 
SF and CF techniques were used (9).
Figure 2 shows the risk of bias graph for included Ovabloc studies. Follow-up data for 
pregnancies and complications other than failed sterilization were undefined, mainly based 
on self-reporting, and presumably incomplete.
Figure 1 Flow diagram.
 
 Articles included: 45 
 
Adiana: 2 
Essure: 37 
Ovabloc: 6 
 
 
Case reports and series:  7  
Non-consecutive cohort: 4 
No follow–up or missing data: 5 
Overlapping cohort: 4 
Review:  1 
 
Not relevant to the topic based on title or abstract:  
363 
Retrieved to read full text article: 66 
Identified articles based on search 
strategy: 429 
Figure 1. Flow diagram 
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Table 1 Feasibility of Ovabloc, Essure and Adiana. Feasibility includes the success rates for place-
ment at the first placement attempt and confirmed correct placement assessed with the 
three-month confirmation test. The last column shows the cumulative number of unin-
tended pregnancies.
Technique
Successful bilateral 
procedure rates at the 
first attempt
Satisfactory outcome 
rates at 3 months 
confirmation
Cumulative number 
of pregnancies after 
satisfactory confirmation
Ovabloc range 78 – 84%
(5 studies, n = 1,601)
range 91 – 100%
(5 studies, n = 1,312)
N.A.
Essure range 81 – 98%
(31 studies, n = 12,961)
range 90 – 100%
(24 studies, n = 9,112)
N.A.
Adiana 94%
(1 study, n = 645)
91%
(1 study, n = 551)
12 months: 6/ 547
24 months: 9/ 523
36 months: 9/ 505
Feasibility of Ovabloc
The number of successful bilateral Ovabloc placements at first attempt was reported in five 
studies (n = 1,601 women) (9,10,11,12,13) (table 1). The probability varied between 78% and 
84%. Due to substantial statistical heterogeneity, the results could not be pooled. In one 
study, the lower success rate was explained by the inclusion of women with retroflexed uterus, 
minor intrauterine pathology and nulliparity, resulting in a more difficult catheterization of 
the tubes. Also the use of single flow hysteroscopy was cited as explanation (9). In a second 
study with a lower probability for successful placement, 50/411 (12.2%) of women were did 
not undergo an installation attempt because the methylene blue perfusion test showed no 
tubal patency in one or both tubes or because of technical problems (13). One study reported 
uterine wall perforation during the procedure in 5/438 cases (7).
Figure 2 Risk of bias graph: review authors’ judgements about each risk of bias item presented 
across all included Ovabloc studies.
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After successful bilateral placement the probability for confirmed correct placement three 
months post-procedure varied between 91% and 100%, there was substantial statistical 
heterogeneity between the results.
Effectiveness of Ovabloc
Approximately 46/1,312 (3.5%) of women could not rely on Ovabloc after successful 
placement, based on results of three-months confirmation tests. A pooled total of 12/1212 
(1.0%; 95% CI: 1 – 2%; I2 = 0%) pregnancies were reported in women who passed the 
three-months confirmation test (figure 3) (7,9,10,12,13). The majority of pregnancies (n = 
8; 67%) was registered in the first three to 24 months after the procedure. Other reasons 
for discontinuation of reliance on Ovabloc sterilization were spontaneous expulsions or 
migrations (n = 26/750) (10,13) and removal or damage by D & C of the silicon plugs (n = 
36/870) (7,12,13).Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Number of pregnancies for included Ovabloc studies. Probabilities are shown with 95% CIs. 
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Figure 3 Number of pregnancies for included Ovabloc studies. Probabilities are shown with 95% CIs.
Risk factors for Ovabloc placement failure 
Univariate analyses for risk factors were performed in two studies (9,13). Van der Leij et al. 
compared 71 failed to 340 successful procedures and found nulliparity (OR 3.87, 95% CI: 1.89 
– 7.92), intrauterine pathology (OR 4.5, 95% CI: 2.38 – 8.51) and an asymmetric uterine cavity 
(OR 3.65, 95% CI: 1.50 – 8.91) to be associated with failure (13). De Blok et al. compared Ovabloc 
sterilizations performed with single flow to continuous flow hysteroscopies. Procedures 
performed with continuous flow hysteroscopy had lower failure rates due to failed instillation 
of silicon in the tubes or insufficient visualization. The failed procedure rate decreased from 
29% to 12% when continuous flow hysteroscopy was used (OR 0.33, 95% CI: 0.12 – 0.97) (9).
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Essure
A total of 14,126 women were included in 37 studies: 26 prospective, nine retrospective, 
one partly retro- and partly prospective and one with unclear relation between enrol-
ment and occurrence of the outcomes. The articles were published from 2003 to 2012. 
Ten studies were multi-centre, 27 were single-centre. Nine articles studied a cohort that 
overlapped with a cohort in another article: seven of these were performed in centres in 
France (14,15,16,17,18,19,20) and two in Spain (21,22). In thirteen studies a potential conflict 
of interest was reported, in four studies it was stated there was no potential conflict and in 
twenty studies this remained unclear. 
The number of participants in each trial ranged from 24 to 4,306. The age ranged from 
19 to 57 years. The exclusion criteria were not described in 26 articles, in 11 articles the 
exclusion criteria were reported, three studies (14,23,24) referred to the criteria defined in 
the instructions for use. The version of the device used was not defined in 29 articles, ESS 
305 was used in three articles (19,24,25), ESS 205 in one article (26), and the version know as 
STOP (Selective Tubal Occlusion Procedure) was used in two articles (4,5). In two articles both 
the ESS 205 and 305 (20) and the ESS 105 and 205 (27) were used. In one study concomitant 
procedures were excluded (23), seven studies included patients whom received concomitant 
procedures (16,17,18,19,20,28,29), all other studies did not specifically report on concomitant 
procedures. The type of analgesics differed from only pre-medication to paracervical block, 
intravenous analgesics or general anaesthesia.   
Figure 4 shows the risk of bias graph of included Essure studies. The methods of assessment 
for follow-up data on pregnancies were unspecified and primarily based on self-reporting. 
In some studies the risk of bias was judged high for assessment of confirmation because it 
was unclear whether single placements were also included in the evaluation (14,16).  
Feasibility of Essure
Successful placement and successful confirmation rates were reported in 31 and respectively 
24 of the included Essure studies (table 1). The successful placement rate at first attempt 
varied between 81% and 98%, with substantial statistical heterogeneity. There seems to 
be a tendency for higher successful placement rates for studies published since 2007. The 
chance of confirmed correct placement after successful bilateral placement ranged from 
90% to 100%, with substantial statistical heterogeneity between the results. One cervical 
perforation (30) and one fundal perforation (31) during the procedure were reported. In one 
case the microinserts were removed because of the suspicion of a nickel allergy (32).
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Effectiveness of Essure
In figure 5 the number of pregnancies after a confirmed Essure procedure are shown. Eight 
pregnancies were registered in 7,706 patients who relied on the sterilization after a satisfactory 
confirmation (22,29). In one case, the three-months control pelvic X-ray and vaginal ultrasound 
scan had suggested well placed devices, and an HSG performed post-partum showed an 
apparent bilateral occlusion. Though, at laparoscopy a unilateral tubal perforation was found. 
Figure 4 Risk of bias graph: review authors’ judgements about each risk of bias item presented 
across all included Essure studies.
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Figure 5.  Number of pregnancies for included Essure studies. Probabilities are shown with 95 %CIs. 
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Figure 5 Number of pregnancies for included Essure studies. Probabilities are shown with 95% CIs.
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In a second case, a post-partum radiographic examination demonstrated complete expulsion 
of one device. In a third case the pregnancy was terminated and followed by laparoscopic 
sterilization, where one device was found located intramurally under the serosa due to partial 
perforation. In a fourth case of pregnancy, the Essure device was only placed in one tube as 
placement in the contralateral tube was unsuccessful. The patient underwent HSG at which 
time the contralateral tube appeared occluded and the patient was instructed incorrectly 
to cease alternative contraception (23). A fifth patient became pregnant 32 months after the 
procedure, the 3-month control pelvic X-ray and vaginal ultrasound scan suggested correct 
placement of both devices and the HSG performed after delivery showed an apparent 
bilateral occlusion. However, laparoscopy demonstrated a unilateral tubal perforation (29). 
No data were available for analysis of the other three pregnancies. In all analyzed cases, 
pregnancy was related to incorrect position of at least one device.
Risk factors for Essure placement failure
In ten studies the risk factors for placement failure of Essure microinserts were analysed 
(5,15,17,23, 24,25,26,30,33,34). Age was examined as a risk factor for placement failure in 
five studies. In one prospective multicentre study on 578 women seeking hysteroscopic 
sterilization a statistically significant difference in the average age of patients was observed: 
35.3 years for patients with successful placement versus 39.4 years for patients with failures 
(MD 4.1 95% CI: 1.45 – 6.75) (24). Four other studies did not find any relation between age 
and placement failure (23,25,26,33). The influence of body mass index on placement failure 
was examined in five studies and no significant difference was found (24,25,26,30,33). 
Five studies examined parity as a risk factor for placement failure, no differences between 
nulliparous compared to multiparous women were found (17,24,25,26,33). In the majority 
of the studies, the procedures were scheduled in the follicular phase or women should 
be taking oral contraceptives. Three studies explored the cycle phase at the time of the 
procedure as a risk factor for failure. Two studies: a phase II study (5) and phase III study 
(26) found no differences between placements timed in the follicular versus luteal phase. 
One study reported higher odds for successful placement in the follicular phase with both 
a uni- and multi-variable analyses (OR 11.2, 95% CI: 1.35 – 92.6 and OR 10.2, 95% CI: 1.13 – 
91.0) (30). One study examined the effect of hormonal contraception and concluded that 
a receipt of hormonal contraception before the procedure was not significantly related to 
higher bilateral placement rates (23). In two articles a history of sexually transmitted infection 
(STI) or pelvic inflammatory disease (PID) was studied (25,26). One study (n = 316) found no 
statistically significant differences in the prevalence of women with a history of STI or PID 
between the group with successful placement and failed placement (26). The other study 
(n = 310) reported a remarkable high percentage of women who reported to have had a 
STI (26.8%) and found a higher risk of placement failure in these women (OR 2.64, 95% CI: 
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1.01 – 6.90) (25). In another study the rates of successful bilateral placement in relation to 
uterine size was analysed. Both uni- and multi-variable analyses found significantly better 
success rates in women with uterine sizes ≤ 8 weeks compared to uterine sizes > 8 weeks (OR 
15.7, 95% CI: 3.19 – 77.1 and OR 14.0, 95% CI: 2.5 – 79.5 respectively) (30). This single study 
examined the effect of uterine axis, which was not associated with failure of placement. One 
case control study found no lower placement rates in patients with concomitant bipolar 
endometrial ablation (17).  
In almost all Essure studies patients received premedication, generally a combination of 
non-steroidal anti-inflammatory medications combined with diazepam. In three studies 
the effect of premedication was investigated (17,23,34). Two studies showed that the use of 
NSAIDs before the procedure significantly reduces the risk for failure of bilateral placement 
(OR 0.44, 95% CI: 0.21 – 0.93, respectively OR 0.17, 95% CI: 0.03 – 0.89) (23,34). Whereas one 
study did not find a difference (17). In this last study a relatively small group of women 
had not received NSAIDs pre-procedure (OR 1.71, 95% CI: 0.22 – 13.35) (17). Four studies 
examined the effect of different analgesic regimes, such as general anaesthesia, IV sedation, 
spinal anaesthesia, paracervical block or nothing, no statistically significant differences in 
placement failure were found (15,17,24,26).
In three studies, the influence of experience with Essure sterilization on successful placement 
was evaluated and no statistically significant differences were calculated (24,26,33). Three 
studies compared the influence of the inpatient versus outpatient setting on the success of 
placement (23,24,33). In two studies (n = 319 and n = 578) no differences in placement rates 
were observed (23,24). One study reported a significantly higher successful placement rate 
in the outpatient setting (97.3% versus 92.8%, no CIs provided, p = 0.004) (33). 
Adiana
The included articles for Adiana both concerned the Evaluation of the Adiana System for 
Transcervical Sterilization (EASE) trial from 2002 through May 2005, a prospective, single-
arm, international study, involving 18 investigators at 16 sites (6,35). A total of 645 women 
participated in the study. Women were eligible to participate if they were 18 – 45 years of 
age, generally healthy, had established fertility, and were seeking permanent contraception. 
Exclusion criteria included major medical conditions, use of cortisone or cytostatic 
medication, any underlying health condition that would adversely affect the ability to 
undergo surgical procedures (e.g. cardiovascular conditions), pelvic inflammatory disease, 
intrauterine conditions that may affect tubal access (e.g., synecchiae), significant cervical or 
uterine pathology, or any condition that might compromise compliance or long-term study 
follow-up. Each participant underwent a complete physical examination, with documentation 
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of normal cervical cytology, negative testing for sexually transmitted infections, and a negative 
pregnancy test to confirm study eligibility. The mean age was 31 years (range: 20 – 45 years), 
with a mean parity of 2.2 (range: 0 – 7). Different analgesic regimes used during the procedure 
ranged from topical or local to intravenous sedation. Three months post-procedure a HSG was 
performed to confirm bilateral occlusion. Thereafter, women were evaluated by office visits 
at three, six, and nine months and at one, two and three years. Women with an unsuccessful 
sterilization (n = 75) were excluded from the study or were followed for safety evaluation only. 
The assessment of successful placement was clearly defined. A small number of women 
were lost to follow up for the three-months HSG (7/ 611). Of the 570 women who were able 
to rely on the sterilization, 97% (n = 547), 92% (n = 523), and 89% (n = 505) were compliant 
with the follow up at one, two and three years respectively. Concerning safety, the method 
of assessing and recording complications is unclear. Additionally, it remains unclear how 
many women unable to rely on Adiana sterilization were followed for safety evaluation. We 
found a low risk of bias for the outcome measurements of successful placement, confirmed 
correct placement and incidence of pregnancy and an unclear to high risk of bias for outcome 
complications.      
Feasibility of Adiana
The results on feasibility and effectiveness are presented in table 1. Successful bilateral 
placement in a first attempt was achieved in 607 of 645 women (94%). In seven women 
successful placement was achieved in a second attempt. An HSG was used to confirm 
reliability in 604 women. In 91% (n = 551) bilateral occlusion after a successful first placement 
was confirmed three months post procedure (table 1). Re-evaluation of the remaining women 
by HSG at six months confirmed bilateral occlusion in an additional 19 women. According 
to the protocol 611 women with successful bilateral placement, 93% (n = 570) were able to 
rely on Adiana for pregnancy prevention and cease additional contraception. No uterine 
or tubal perforations or injuries related to RF energy or matrix placement were reported. 
No analysis for risk factors in placement or failures or learning curve were performed in the 
selected studies.
Effectiveness of Adiana
A total of six pregnancies were reported in the first 12 months of the reliance phase, three in 
the second year and none in the third year (table 1). Three pregnancies that occurred during 
the first year were determined to be due to misinterpretation of the HSG.
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Discussion
Though the first studies on hysteroscopic sterilization date back to the turn of the century, and 
the approach is widely applied in female sterilization, it is remarkable that the currently available 
evidence is still poor. To evaluate the effectiveness of an intervention a RCT is the appropriate 
design. We did not find any RCT. When the outcomes of interest are infrequent and/or far in the 
future (e.g. 0.5% pregnancies in the first year post sterilization) RCTs are rarely large and lengthy 
enough to accurately measure infrequent outcomes. A prospective cohort study will facilitate a 
larger study population and adequate power to identify significant differences. In this review, 
the available evidence on effectiveness of hysteroscopic sterilization techniques comes from 
observational studies. Unfortunately, these studies are lacking sufficient power, complete and 
long term (> 10 years) follow up data on unintended pregnancies and complications. 
Additional to the methodological quality of the included studies, another limitation is the 
inclusion of nine Essure articles and two Ovabloc articles that probably included women 
who may also be included in other included articles. We could not correct our calculations 
for this potential overlap. The potential conflict of interest in a large portion of the studies 
is a third limitation. 
Considering feasibility, the 78% – 98% probability of successful placement at first attempt 
and 90% – 100% verified by a proper confirmation test, all three hysteroscopic sterilization 
techniques have sufficient feasibility. With a low risk of bias for these outcomes, we consider 
these rates reliable. Adiana and Essure have the highest successful placement rates, 94% 
and range: 81% – 98% respectively versus Ovabloc range: 78% – 84%. This is explained by 
differences in patient selection and different hysteroscopic systems. For all three techniques, 
complications during the procedures were incidentally reported. The reported complications 
concerned perforations or expulsions typically related to incorrect placements. The quality 
of evidence for the outcome complications is very low, since the definition and assessment 
of this outcome is not clear in the majority of the studies.   
The reported incidence of unintended pregnancies after confirmed successful hysteroscopic 
sterilization with Adiana are considered reliable, though this does not apply to the Essure and 
Ovabloc studies. To demonstrate the effectiveness of a sterilization technique, pregnancy 
rates may be calculated by either life table analysis or the Pearl Index. The latter, also 
called the Pearl rate is the most common technique used in clinical trials for reporting the 
effectiveness of a birth control method but it assumes a constant failure rate over time. In the 
U.S. Collaborative Review of Sterilization, a prospective study that included 10,685 women 
who underwent tubal sterilization, the risk of pregnancy was assessed by cumulative life-
table probabilities. Cumulative 1-year probabilities of pregnancy ranged from 0.6 – 18.2 per 
1,000 procedures, cumulative 2-year probabilities ranged from 2.3 – 23.8 per 1,000 procedures 
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(36). The highest probabilities were calculated for the spring clip application (Hulka) and 
the interval partial salpingectomy, techniques that are not commonly used in daily practice 
anymore. Today, laparoscopic sterilizations using Filshie Clips are performed more frequently. 
A prospective study that followed 822 women after a laparoscopic sterilization with Filshie 
clips found a cumulative 1-year probability of 1.2 per 1,000 procedures. Compared to the 
cumulative 1-year and 2-year probabilities of Adiana which are 11 and 17.2 respectively per 
1,000 procedures, these latter probabilities are relatively high. Both for Essure and Ovabloc, 
but as well for Adiana, better quality of longer term (up to ten years) follow up is needed to 
assess the cumulative risk of failure and effectiveness.    
Many factors have been explored as a risk factor for placement failure. In single Ovabloc 
studies it is suggested that intrauterine pathology, an asymmetric uterine cavity, nulliparity 
(13) and single flow compared to continuous flow (9) are risk factors for placement failure. 
These findings are however, not confirmed with multivariate analysis or within other studies. 
For Essure, single studies found timing of placement in the follicular phase compared to 
luteal phase (30), a history of sexually transmitted infections (25) and uterine size of more 
than 8 weeks (30) to be associated with a higher risk for placement failure. These findings 
are again not supported by other studies. Two retrospective studies found a higher risk for 
placement failure in women that had not received NSAIDs before the procedure (23,33). A 
Cochrane review in 2012 concluded that the available literature insufficient is to determine 
the appropriate pain regimen for outpatient sterilization by hysteroscopy (37). Patient-related 
risk factors should be investigated in prospective cohort studies with good methodological 
quality. Technical risk factors e.g. timing of the procedure should preferably be analysed 
in RCTs. In clinical practice it is preferable to perform a hysteroscopic sterilization prior to 
ovulation in order to minimize the risk of pregnancy occurring following ovulation.
Future perspectives
Since 1988 three methods have become commercially available. Two methods were later 
withdrawn from the market. In 2009, reports of disappointing results, technical problems 
with the cold storage of the silicon and a histological study that could not confirm the claim 
of reversibility of the technique resulted in withdrawal of Ovabloc. In March 2012, Adiana 
was withdrawn as part of an agreement to settle ongoing patent infringement litigation (38). 
Currently, Essure is the only system used for hysteroscopic sterilization. There is continuing 
innovation of hysteroscopic sterilization devices. In the near future, two new hysteroscopic 
sterilization methods will be launched. Both methods are based on an intra-tubal device 
with immediate mechanical occlusion of the fallopian tubes, which should eliminate the 
need for a three-months confirmation test (39,40).
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A third new hysteroscopic sterilization method has been announced. It is described as a 
redesigned Ovabloc Intratubal Device System. Challenges related to the design include 
storage under room temperature and incorporating a contrast agent to facilitate visibility 
for evaluation. For every new technique, we adhere an appropriate evaluation of feasibility 
and effectiveness, including well defined, complete and long term (≥ 10 years) follow up for 
unintended pregnancies and complications. 
For some techniques, it is argued that the post-procedure imaging should be eliminated 
based on the fact that in the original clinical trials, 96% and 100% of patients with successful 
bilateral placement had complete tubal occlusion at respectively three and six months (4,5). 
Since reliable cumulative long term probabilities for pregnancy could not be calculated, it 
is still not justifiable to rely on an uncomplicated bilateral successful procedure. At least 
confirmation tests are indicated to detect failed hysteroscopic sterilization and reduce the 
risk of pregnancy. 
Alternative, less invasive diagnostic tests, like 3D ultrasound, have yet to replace HSG for 
confirmation of proper placement, though the results from preliminary studies are promising 
(29,41). Other new non-radiation techniques such as Contrast Infusion Sonography or 
Hysterosalpingo Contrast Sonography (HyCoSy) (42) or Hysterosalpingo-Foaminfusion 
Sonography (HyFoSy) also have potential as confirmation tests for tubal occlusion (43,44). 
Above all, appropriate RCTs and observational studies with sufficient power and follow up 
are needed for relevant and complementary information to the body of evidence on the 
effectiveness of hysteroscopic sterilization techniques.
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Supplement 1
Search:
((((Hysteroscopy[mesh] OR hysteroscop*[tiab] OR uteroscop*[tiab] OR transcervical[tiab])) 
AND ((sterilization, tubal[mesh]) OR ((Sterilization, reproductive[MeSH] OR 
sterilization*[tiab] OR sterilization*[tiab]) AND (Fallopian tubes[MeSH] OR tube[tiab] 
OR tubes[tiab] OR tubal[tiab] OR intratubal[tiab]))))) OR (ovabloc[tiab] OR essure[tiab] 
OR microinserts[tiab])
429 hits. FEBRUARY 25th  2014
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Abstract
More than 10 years after its first introduction, robot-assisted surgery is now performed in 
17 Dutch hospitals. Robotic-assisted radical prostatectomy (RARP) is the most frequently 
performed, though its clinical superiority compared to open (RRP) and laparoscopic 
prostatectomy (LRP) has not been demonstrated. One randomized controlled trial showed 
better outcome in erectile function after RARP compared to LRP. The quality of the other 
studies into RARP is too limited to draw reliable conclusions on clinically relevant outcome 
measures such as survival, disease-free survival and quality of life. Given the high costs and 
small scientific evidence, the introduction of robotic surgery has been irresponsibly quick. 
Better scientific research of robotic surgery is needed before this technology can be broadly 
applied in clinical practice.
Samenvatting
Robot geassisteerde operaties worden, ruim 10 jaar na de introductie ervan, in 17 Nederlandse 
ziekenhuizen uitgevoerd. De meest uitgevoerde robot geassisteerde operatie is de radicale 
prostatectomie (RARP), maar de meerwaarde van deze ingreep ten opzichte van de open 
en de laparoscopische variant is niet aangetoond. 1 RCT, laat een betere uitkomst van de 
erectiele functie nar RARP vergeleken met LRP zien. Verder is de kwaliteit van het onderzoek 
naar RARP te beperkt om betrouwbare conclusies te kunnen trekken over klinisch relevante 
uitkomstmaten als overleving, ziektevrije overleving en kwaliteit van leven. De introductie van 
de robotchirurgie verloopt gezien de hoge kosten en de geringe wetenschappelijke evidentie 
onverantwoord snel. Er is beter wetenschappelijk onderzoek nodig voordat robotchirurgie 
breed kan worden ingezet in de klinische praktijk.
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De oorspronkelijke vraag naar een operatierobot waarmee artsen op een veilige afstand 
ingrepen op het slagveld konden verrichten, kwam vanuit het Amerikaanse leger in de jaren 
80 van de vorige eeuw. In 2000 bracht het Amerikaanse bedrijf Intuitive Surgical Inc. de da 
Vinci-operatierobot, vernoemd naar Leonardo da Vinci, de eerste ontwerper van een robot. Met 
wereldwijd circa 360.000 ingrepen per jaar domineert deze operatierobot momenteel de markt 
(1). Naar verwachting zullen er de komende jaren ook andere fabrikanten met operatierobots 
op de markt komen, omdat de patenten op de da Vinci-operatierobot binnenkort aflopen (2).
In dit artikel geven we een overzicht van het gebruik van de operatierobot in Nederland 
en bespreken we onze resultaten van een systematische review naar de effectiviteit en de 
veiligheid van de robotgeassisteerde radicale prostatectomie (RARP).
Robotchirurgie in Nederland
De eerste robot geassisteerde operatie in Nederland was een cholecystectomie en deze werd 
verricht in het Universitair Medisch Centrum Utrecht in 2000 (3). 2 jaar later werd in datzelfde 
ziekenhuis de eerste RARP in Nederland uitgevoerd, gevolgd door de eerste hysterectomie 
met robotassistentie in het Vrije Universiteit Medisch Centrum te Amsterdam in 2006.
Inmiddels is in 17 Nederlandse ziekenhuizen een da Vinci-operatierobot operationeel, maar 
er is weinig zicht op het beloop van de klinische implementatie van deze nieuwe technologie. 
Vanuit de Nederlandse Vereniging voor Urologie (NVU) wil men de nationale registratie van 
alle prostatectomieën, die tot nu toe op vrijwillige basis geschiedt, verplicht gaan stellen. 
De NVU liet ons echter weten dat de registratie tot nu toe nog onvoldoende betrouwbaar en 
onvolledig is. Ook de Dutch Gynecologic Robotics Society, die begin 2012 werd opgericht, 
streeft ernaar om alle robot geassisteerde gynaecologische ingrepen die in Nederland worden 
verricht te registreren en te evalueren. Ondanks deze ontwikkelingen is er tot op heden geen 
inzichtelijke nationale registratie. Intuïtive Surgical Inc. beschikt als enige over een database 
waarin alle ingrepen geregistreerd worden die met hun systemen worden uitgevoerd, maar 
het bedrijf geeft deze informatie niet vrij.
Om een overzicht te verkrijgen van de toepassing van robotchirurgie in de Nederlandse 
ziekenhuizen, namen wij contact op met de Nederlandse ziekenhuizen die met de da 
Vinci-operatierobot werken. Op www.ntvg.nl/A5145 is een tabel te raadplegen waarin voor 
verschillende ziekenhuizen in Nederland het jaar van aanschaf van de operatierobot, de 
specialismen die gebruik maken van de operatierobot en de ingrepen dat daarmee verricht 
worden zijn weergegeven.
Tot 2008 verliep de groei van het aantal centra met een operatierobot gestaag. Sindsdien 
is er een explosieve toename geweest: momenteel beschikken 5 academische en 12 niet-
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academische ziekenhuizen over een da Vinci-operatierobot. In het Maasstad Ziekenhuis 
zijn zelfs 2 robotsystemen operationeel. In 17 centra maken urologen gebruik van de da 
Vinci-operatierobot voor het verrichten van de RARP. In 11 centra gebruiken gynaecologen de 
operatierobot, met name voor het uitvoeren van hysterectomieën. De overige specialismen 
die een operatierobot tot hun beschikking hebben zijn de gastro-intestinale chirurgie (6 
centra), de cardio-thoracale chirurgie (4 centra) en de hoofd-halschirurgie (2 centra).
In Nederland is de meest uitgevoerde robot geassisteerde operatie de RARP. Naar schatting 
worden er jaarlijks circa 1200 RARP’s verricht, circa 70% van het totale aantal prostatectomieën 
per jaar (4). Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, het Jeroen 
Bosch Ziekenhuis, het Canisius-Wilhelmina Ziekenhuis en het Maasstad Ziekenhuis voeren 
jaarlijks ieder meer dan 200 RARP’s uit (La Chapelle, schriftelijke mededeling, 2013). De 
resterende 400 operaties komen op het conto van de overige 13 centra.
Systematische reviews
Wij vroegen ons af of de massale introductie van robotchirurgie wel gerechtvaardigd is in 
het licht van de kennis over de klinische effectiviteit en veiligheid van deze techniek. Om die 
vraag te beantwoorden zochten we naar artikelen over de effectiviteit en de veiligheid van de 
RARP. Recent werden in 4 systematische reviews de resultaten – oncologische uitkomsten, 
perioperatieve uitkomsten en complicaties, herstel van de urinecontinentie, en erectiele 
functie – van RARP vergeleken met die van de retropubische radicale prostatectomie (RRP) en 
de laparoscopische radicale prostatectomie (LRP) (5-8). In totaal werden er 44 vergelijkende 
en 136 niet-vergelijkende studies geëvalueerd; in elk van deze studies waren meer dan 100 
patiënten geïncludeerd. Op basis van het wetenschappelijke bewijs uit de 4 systematische 
reviews is het tot op heden niet duidelijk of RARP tot betere klinische resultaten leidt dan 
RRP en LRP. Hieronder bespreken wij de resultaten van de vergelijkende studies uit elk van 
de 4 reviews.
Oncologische uitkomsten
Er zijn nog te weinig data over de kankerspecifieke overleving na een robot geassisteerde 
radicale prostatectomie. In plaats daarvan werd in de eerste review het percentage tumor-
positieve snijranden als indirecte maat voor de overleving genomen (5). In 18 studies, 6 
prospectieve studies en 12 retrospectieve studies werden de percentages tumor-positieve 
snijranden na RRP en RARP met elkaar vergeleken; in 1 RCT, 1 prospectieve cohortstudie 
en 9 retrospectieve studies werd LRP vergeleken met RARP. De cumulatieve analyses lieten 
geen statistisch significante verschillen zien tussen RRP en RARP (respectievelijk 21 en 20% 
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tumor-positieve snijranden); bij de vergelijking tussen LRP en RARP waren deze percentages 
respectievelijk 18 en 18.
In 3 retrospectieve studies werden de aantallen biochemische recidieven na RRP en RARP met 
elkaar vergeleken; in 2 andere retrospectieve studies werden RRP, LRP én RARP met elkaar 
vergeleken. Er werden geen verschillen gevonden in de biochemisch bepaalde recidief-vrije 
overleving, met hazardratio’s van 0,9 (95%-BI: 0,7–1,2) voor RRP versus RARP en 0,5 (95%-BI: 
0,2–1,3) voor LRP versus RARP.
De auteurs van de review merken op dat er naast methodologische beperkingen van de 
individuele studies ook enkele bezwaren kleven aan de analyse van de studies. Zo was het niet 
mogelijk om de invloed van de chirurgische kundigheid te evalueren, terwijl verschillen hierin 
aanzienlijke gevolgen kunnen hebben voor de oncologische en functionele uitkomsten (9,10). 
Daarnaast is er niet gestratificeerd voor ziekte-specifieke karakteristieken als tumorstadium, 
Gleason-score en prostaatvolume, en is er geen rekening gehouden met verschillen in de 
pathologieprotocollen voor het beoordelen van de chirurgische preparaten. Deze aspecten 
kunnen een grote invloed hebben op de percentages tumor-positieve snijranden (5).
Perioperatieve uitkomsten en complicaties
In de tweede review werd de veiligheid van robotchirurgie onderzocht aan de hand van de 
volgende parameters: het aantal complicaties, de operatieduur, de hoeveelheid bloedverlies 
en het risico op een bloedtransfusie (6). Er werden 3 prospectieve en 9 retrospectieve 
cohortstudies gevonden waarin deze parameters vergeleken werden tussen RRP en RARP; in 
1 RCT en 6 retrospectieve studies werden deze parameters vergeleken tussen LRP en RARP.
De cumulatieve analyses toonden significant minder bloedverlies bij RARP dan bij RRP, met 
een gewogen gemiddeld verschil (‘weighted mean difference’, WMD) van 582,77 ml (95%-BI: 
435,25–730,29). Daarnaast was het risico op een bloedtransfusie significant lager bij RARP 
dan bij RRP (OR: 7,55; 95%-BI: 3,56–15,64). Tussen deze operaties werden geen significante 
verschillen gevonden in de duur van de operatie (WMD: -15,81; 95%-BI: -68,65–37,03) en in 
het aantal complicaties (OR: 1,25; 95%-BI: 0,53–2,93).
Tussen LRP en RARP werden geen significante verschillen gevonden in het aantal complicaties 
(OR: 1,4; 95%-BI: 0,73–2,69), in de hoeveelheid bloedverlies (WMD: 54,21; 95%-BI: -75,17–
183,59) en in de operatieduur (WMD: 34,78; 95%-BI: -1,36–70,93). Daarentegen was er bij 
LRP wel een hoger risico op een bloedtransfusie dan bij RARP (OR: 2,56; 95%-BI: 1,32–4,96).
Naast de methodologische beperkingen – vooral retrospectieve studies met onvoldoende 
statistische ‘power’ – zijn er nog een aantal zaken die de resultaten minder betrouwbaar 
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maken. In de meeste studies werden de complicaties niet accuraat geregistreerd. Verder zijn 
de analyses niet gecorrigeerd voor verschillen in patiëntkarakteristieken als BMI, eerdere 
abdominale chirurgie of prostaatchirurgie, prostaatvolume en de kundigheid van de chirurg.
Herstel van de urinecontinentie
In de derde review werden 4 prospectieve en 4 retrospectieve cohortstudies gevonden 
waarin het herstel van de urinecontinentie na RARP en na RRP met elkaar werden vergeleken 
(7). Een cumulatieve analyse van 5 van deze studies toonde een significant hoger aantal 
patiënten bij wie 12 maanden postoperatief sprake was van herstel van de urinecontinentie, 
in het voordeel van RARP (OR: 1,51; 95%-BI: 1,04–2,25). 1 RCT en 7 retrospectieve studies 
bestudeerden het herstel van de urinecontinentie na LRP en na RARP. De RCT toonde geen 
significant voordeel in het herstel na RARP ten opzichte van LRP (OR: 3,27; 95%-BI: 0,85–12,59). 
Een cumulatieve analyse van 5 van de 8 studies toonde een significant hoger aantal patiënten 
bij wie 12 maanden postoperatief sprake was van herstel van de urinecontinentie, opnieuw 
in het voordeel van RARP (OR: 2,39; 95%-BI: 1,29–4,45).
Erectiele functie
In de vierde review werden 4 prospectieve en 3 retrospectieve cohortstudies gevonden waarin 
de erectiele functie na RRP en na RARP met elkaar werden vergeleken (8). In 6 studies werd 
voor beide operaties 12 maanden na de ingreep het percentage patiënten met erectiele 
disfunctie gescoord: erectiele disfunctie werd vastgesteld bij 47,8% van de patiënten na RRP 
en bij 24,2% na RARP (OR: 2,84; 95%-BI: 1,48–5,43).
In 1 RCT en 3 retrospectieve studies werden de erectiele functie na LRP en na RARP met 
elkaar vergeleken (8). De RCT toonde significant betere uitkomsten na RARP dan na LRP: 77 
versus 32% van de patiënten had 12 maanden na de ingreep een goede erectiele functie 
(OR: 7,19; 95%-BI: 3,09–16,73). De cumulatieve analyse liet een niet-significant verschil zien 
in het voordeel van RARP (OR: 1,89; 95%-BI: 0,70–5,05).
Zowel de onderzoeken naar het herstel van de urinecontinentie als die naar de erectiele 
functie bij patiënten na prostaatchirurgie gaan gepaard met aanzienlijke methodologische 
beperkingen: het merendeel van de studies heeft een retrospectieve studieopzet en de 
definities en toegepaste methoden voor het beoordelen van urinecontinentie en erectiele 
functie verschillen tussen de studies. Informatie over de urinecontinentie en de erectiele 
functie voorafgaand aan de ingreep wordt in geen van de studies beschreven. Ook is er geen 
rekening gehouden met de kundigheid van de chirurg en met variaties in de chirurgische 
techniek.
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Kostenafwegingen
Bij de introductie van een nieuwe technologie spelen naast effectiviteit ook kosten een rol. 
De aanschafprijs van de da Vinci-operatierobot is ongeveer 1,7 miljoen euro en de jaarlijkse 
onderhoudskosten bedragen ongeveer 10% van de cataloguswaarde. Daarbovenop komen 
de kosten voor wegwerpmateriaal en voor specifieke instrumenten die na 10 ingrepen door 
nieuwe moeten worden vervangen. Een laparoscopische radicale prostatectomie kost 
8000–9000 euro, terwijl de RARP 2000–4500 euro per ingreep méér kost (11).
Een Nederlands ziekenhuis dat de aanschaf van een da Vinci-operatierobot overwoog, schatte 
dat de totale kosten ongeveer 1 miljoen euro per jaar zouden bedragen. Daarmee liggen de 
jaarlijkse kosten om in 17 ziekenhuizen in totaal 18 operatierobots operationeel te houden 
rond de 18 miljoen euro. Mogelijk dat de extra materiele kosten van een operatierobot 
gecompenseerd kunnen worden door een afname van het aantal postoperatieve 
bloedtransfusies, door de kortere opnameduur en door betere functionele uitkomsten 
bij robotchirurgie. Daarnaast kunnen de veel genoemde voordelen van robotchirurgie 
als de kortere leercurve en de betere ergonomie voor de chirurg, met name ten opzichte 
van conventionele laparoscopische chirurgie, een rol spelen bij de kosten-batenanalyse 
van een robotsysteem. Wij zijn echter van mening dat deze potentiele voordelen van 
robotchirurgie eerst moeten worden aangetoond voordat ze kunnen worden meegenomen 
in de beschouwingen over de kosten rond de robotchirurgie.
Beschouwing
In september 2011 werd tijdens een bijeenkomst van de European Association of Urology 
een internationaal consensusdocument opgesteld als aanvulling op de 4 eerder genoemde 
systematische reviews. Ondanks het gebrek aan RCT’s van hoge kwaliteit, waarin de 
effectiviteit en de veiligheid van RARP worden vergeleken met die van de open radicale 
prostatectomie, werd vastgesteld dat robotgeassisteerde prostaatchirurgie al op grote schaal 
is geïmplementeerd in de klinische praktijk (12).
Ook in Nederland is er sprake van een snelle groei van het aantal ziekenhuizen met een 
operatierobot, met een geschatte kostenpost van 18 miljoen euro per jaar. Dusdanig hoge 
kosten zijn naar onze mening alleen maatschappelijk verantwoord als de effectiviteit 
van de operatierobot evident superieur is aan de conventionele technieken. De geringe 
methodologische kwaliteit van de studies die wij vonden en het ontbreken van data over 
(ziektevrije) overleving genereren wat ons betreft twijfel over de juistheid van de massale 
introductie van de robotchirurgie in Nederland. 
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De academische ziekenhuizen die de robotsystemen introduceerden hebben weinig 
bijgedragen aan de evaluatie van de effectiviteit daarvan. In het Nederlands Trial Register 
vonden wij 1 onderzoek naar robotchirurgie (13). Als argument tegen het opzetten van een 
gerandomiseerde studie wordt gesteld dat het grootste deel van de patiënten desgevraagd 
voor de operatierobot zou kiezen, waardoor een gerandomiseerd onderzoek niet meer 
mogelijk is (14). Naar onze mening zijn dergelijke studies wel mogelijk als patiënten goed 
worden voorgelicht over de onzekere verschillen in klinische uitkomsten tussen de diverse 
operatietechnieken. Dit blijkt ook uit de meer dan 10 geregistreerde en lopende RCT’s naar 
robotchirurgie in het metaregister voor klinische trials (bron: www.controlled-trials.com/
mrct/).
Wij vinden dat zorgprofessionals en ziekenhuizen de verantwoordelijkheid hebben om 
ervoor te zorgen dat data over de effectiviteit en de veiligheid van robotchirurgie bekend zijn 
voordat er massale introductie plaatsvindt. De juiste volgorde waarin een klinisch vraagstuk 
om een technologische oplossing vraagt (‘clinical driven approach’) is hier omgekeerd 
toegepast. De technologie heeft gezocht naar een medische indicatie (‘technical driven 
approach’) en geresulteerd in een brede suboptimale inzet van een wellicht veelbelovende 
nieuwe technologie (15). Vanuit dat perspectief valt de door ons geïnventariseerde situatie 
te omschrijven als een bijna gemiste kans. De gedane investeringen kunnen immers niet 
meer teruggedraaid worden, maar onder het motto ‘beter ten halve gekeerd dan ten hele 
gedwaald’ hebben de ziekenhuizen met een operatierobot nu nog de gelegenheid de handen 
ineen te slaan voor een systematische evaluatie van de robotchirurgie.
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Abstract
Background: Minimally invasive surgery (MIS) is a medical technology that intends to 
minimize surgical trauma as opposed to the conventional surgical techniques. MIS has been 
assessed in randomized controlled trials (RCTs), that aim to evaluate the clinical advances of 
these new medical methods. The aim of this study is to critically appraise clinical relevance, 
clearness and objectivity in randomised controlled trials (RCTs) on gynaecological MIS. 
Methods: We searched the Cochrane Library for systematic reviews on minimally invasive 
procedures in gynaecology. We browsed the topic ‘gynaecology’ for RCTs wherein MIS 
procedures were evaluated: i.e. different approaches and different techniques within a 
minimally invasive procedure. Data on various methodological traits were extracted from 
the included studies within a pre-defined assessment tool, with a view to investigate the 
clinical relevance, clearness and objectivity of RCTs. 
Results: Out of the 566 systematic reviews found in the Cochrane database, we selected 47 
RCTs eligible for further assessment. Procedural and costs outcomes were set as primary 
outcome in 32%, patient comfort in 29%, effectiveness in 15% and safety in 12% of these 
RCTs. Sufficient sample size, adequate distribution of participants arms and sufficient follow 
up duration were reached in 24 RCTs (51%) RCTs. We found a complete match between the 
authors’ conclusion and the results in eight (17%) RCTs. None of the RCTs provided sufficient 
data supporting superiority of a new MIS method over the existing method.
Conclusions: This study shows that the clinical relevance, clearness and objectivity 
of RCTs on gynecological MIS is suboptimal. RCTs do have large difficulties to provide 
sufficient information for decisions on implementation of new MIS techniques. The validity 
of observational studies should be further explored to provide additional evidence. 
Furthermore, it is of clinical importance that authors, reviewers and editors criticize the 
consistency between results and conclusions of their forthcoming study publications.
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Introduction
Minimally invasive surgery (laparoscopy) is a medical technology that intends to minimize surgi-
cal trauma as opposed to the open abdominal surgical technique (laparotomy). With advanced 
laparoscopic operations for pelvic organ prolapse, urinary incontinence and gynaecological 
cancers, laparoscopy has become completely integrated into the field of gynaecologic surgery. 
Minimally invasive surgery is called a technology because it applies on scientific principles and 
keeps on advancing to make its appliances smarter and more efficient. The rapid evolution of 
this technology has led to the development of new technologies and techniques within the 
field of minimally invasive surgery such as Robot (-assisted) surgery, natural orifice transluminal 
endoscopic surgery (NOTES), laparo-endoscopic single-site surgery (LESS) and minilaparos-
copy. Robot surgery is a technological development where robotic systems are used to aid 
in surgical procedures. It was developed to overcome the limitations of pre-existing minimally-
invasive surgical procedures (1). NOTES refers to surgery via natural orifices, where procedures 
are performed with transluminally placed instruments to gain access to the abdominal cavity (2). 
LESS surgery is an advanced minimally invasive approach that allows laparoscopic operations 
to be undertaken through a single small incision, typically placed at the patient’s umbilicus (3). 
Minilaparoscopy involves the use of smaller incisions, smaller instruments and fewer ports to 
further reduce perioperative morbidity and enhance cosmesis (4). 
Physicians and patients often embrace new technologies before their clinical and economic 
implications are fully evaluated (5) There are numerous examples of recalled “new methods” 
that were already broadly applied in clinical practice but proved to be insufficiently safe or 
cost-effective (6). Medical technology is often driven by commerce, though its driving force 
should primarily be what clinical practice is demanding for (7). Firstly, commercial pressure 
can lead to new methods being implemented too quickly, for another thing clinical research 
is slow at adopting new clinical applications. Secondly, the conduct of clinical research for 
new methods is often of limited size and could be more targeted to relevant clinical questions. 
A third weakness can be found in the presentation of research results. It is questionable 
whether the conclusions drawn from clinical research match the actual reported data. As 
the minimally invasive procedures are usually evaluated by the same people who developed 
and introduced those techniques, the results are potentially interpreted with overoptimism. 
To determine what the main conclusions of trials are, studying the abstract of the paper is 
not enough, but can serve as a starting point. It is supposed that reading only the abstract 
or conclusions of a study is insufficient and may lead to an overstatement of study findings 
(8). We think that commercially driven medical technology, insufficient clinical research and 
overstatement of study findings could lead to incautious implementation of new methods 
in clinical practice.
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Randomised controlled trials (RCTs) represent the best method to evaluate the effectiveness 
of healthcare interventions (9). They are the most rigorous way of assessing the effectiveness 
of a treatment. RCTs aim to evaluate the (clinical) advances of new and existing medical 
technologies. The bundled outcomes of different RCTs should ultimately lead to a clear 
answer whether the new method should be used over the existing method. The Cochrane 
collaboration is a globally known as an independent network where the best evidence from 
research is gathered and summarised for the use of high quality information to make health 
decisions (10). 
In this study, we inquire if randomised controlled trials serve the clinical needs of minimally 
invasive surgery. We assessed the clinical importance of primary and secondary study 
outcomes, whether studies are set up sufficiently to answer their research question and if 
the conclusions of the articles corresponded to their actual results. The aim of this study is to 
critically appraise clinical relevance, clearness and objectivity in randomised controlled trials 
(RCTs) on gynaecological minimally invasive surgery. We aim to provide guidance towards 
more useful (less wasteful) future research in minimally invasive surgery.   
Methods
Search methods for the selection of studies 
We searched the Cochrane Library for systematic reviews on minimally invasive procedures 
in gynaecology. Two assessors (SV and CC) browsed the topic ‘gynaecology’ independently 
and screened titles and abstracts for reviews addressing minimally invasive gynaecologic 
surgery. We included RCTs comparing laparoscopic surgery with other surgical approaches 
(e.g., laparotomy or different minimally invasive techniques) and newer techniques within 
minimally invasive surgery (e.g., laser vs diathermy, different trocar design). In order to 
focus on current scientific literature, we excluded RCTs published before 2005. We also 
excluded trials that compared substantially different treatment techniques (e.g. excision 
versus ablation of cysts) or a minimally invasive surgical approach to a conservative or 
pharmacological approach. Furthermore, cohort studies were excluded. We only assessed 
full text manuscripts. Studies reported in abstracts-only were excluded.
Data collection and assessment
Two assessors (SV and CC) independently assessed the selected RCTs. Each article was read 
and examined for clinical relevance, clearness and objectivity. We focussed on the following 
aspects: 
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1. clinical relevance: what are the defined study outcomes and what is their clinical 
relevance? 
2. clearness: does the RCT comprise a sample size calculation for the defined outcome(s) of 
the trial? Is the study power and follow up sufficient to ensure distinctiveness to provide 
a clear answer to the study objective?
3. objectivity: represents the conclusion the actual results of the RCT?   
The assessors evaluated the RCTs independently with use of a pre-defined assessment tool 
(figure 1) To evaluate the clinical relevance of a RCT, the defined primary and secondary 
study outcomes were assessed. To do so, we categorized these study-outcomes into: 1) 
effectiveness, 2) safety, 3) patient-comfort, 4) procedural and costs, 5) surgeon comfort and 
6) other outcomes. For outcomes of effectiveness, a distinction was made between clinical 
effectiveness (e.g. reduction of the complaints of urinary incontinence) and technical 
effectiveness (technical success of the procedure, e.g. correction rate of the anatomical 
position of the bladder). This distinction is important for the clinical interpretation of effect 
measures. We denoted conversions as an outcome measure of technical effectiveness 
since a conversion indicates that the intended procedure has not been successful (11). 
Safety-outcomes were defined as complications and adverse events. For patient-comfort 
outcomes we included all outcomes directly relating to or affecting the comfort of the patient 
(i.a. quality of life, postoperative pain, duration of postoperative paralytic ileus). Procedural 
and cost outcomes concerned organizational aspects that are principally more important to 
healthcare institutions than to patients. For surgeon comfort, all aspects directly influencing 
the comfort of the surgeon were included. The remaining outcomes that we could not classify 
were assigned to other outcomes.  
The clearness of a RCT was investigated by determining whether the achieved sample size, 
follow up duration and completeness provided enough power to detect significant differences 
in the studied outcomes.
We studied the objectivity of the RCT by assessing the results per outcome. Preferably odds 
ratios, risk ratios, and mean differences were collected all including confidence intervals (CI) 
or p-values. We indicated whether the result for the new versus existing method is positive, 
indifferent, or negative. Based on the obtained overview of investigated and missing clinically 
important outcomes, we considered if the “newer method” would be sufficiently effective and 
safe to be implemented in daily surgical practice. In the context of objectivity we examined 
the abstract conclusion compared to the full-text conclusion. These were judged being 
concordant or discordant. Thereafter, we extracted the overall conclusion of the authors 
of the RCT and classified the style as “nuanced” or “outspoken”. “Nuanced” signified that 
the specific findings are subtly described in the conclusion. Conversely, an “outspoken” 
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Study: ……..
Effectiveness: 
How is the effect of the 
intervention on the disease 
or condition assessed? 
Make a clear distinction 
between technical 
effectiveness and clinical 
effectiveness:
Safety:
How is the safety of the 
intervention assessed 
(complication rate)?
Patient- comfort:
How are factors on patient-
comfort assessed (e.g. 
adverse effects, pain, 
fatigue, satisfaction)?
Procedural and costs: 
How are organizational 
or economical aspects                      
assessed (e.g. operative 
time, hospital stay)?
Surgeon-comfort: 
How are aspects that aim 
advantages for the surgeon 
assessed (ergonomics, 
technical difficulties) 
 Other: 
What other outcomes are 
assessed (e.g. secondary 
outcomes or indirect 
outcomes)?
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conclusion postulates the newer method either showed to be superior, comparative or 
inferior to the conventional method. We labelled “outspoken” conclusions as superior, 
indifferent or inferior. The authors’ conclusions were independently scored for consistency 
with the results. The possible scores to be assigned were: “no”- “partly”- “largely”- and 
“completely”, the motivation for judgement was included. Completed assessment forms 
were compared and any disagreements were solved by a third author (FWJ). We investigated 
whether the style of the conclusions was related to differences in consistency between 
conclusion and results. 
Statistical analysis
Data were initially analysed descriptively to estimate frequencies and percentages for the 
number of RCTs and categorical variables. Differences between groups were tested by using 
the Fisher’s exact test (Freeman-Halton extension) for categorical data. A p-value < 0.05 
(two-sided) was considered statistically significant. http://vassarstats.net/fisher2x4.html 
was used for statistical analysis.
Results
We identified a total of 566 items by browsing for topic gynaecology in the Cochrane database. 
We considered 23 items potentially relevant based on their title. We excluded five items with 
abstract screening: three were a review protocol and two reviews compared substantially 
different treatments. This resulted in 18 reviews including a total of 257 RCTs considered 
feasible for inclusion in this study. Of these 257 RCTs, 97 were published between 2005 – May 
2017. After further selection 47 RCTs remained eligible for assessment (figure 2).
Clinical relevance: study-outcomes
In 34 out of the 47 RCTs (72%) the primary outcome was indicated (figure 3a). In five RCTs 
the primary outcome was a measure for effectiveness (15%), in four RCTs for safety (12%), in 
10 RCTs for patient comfort (29%), 11 RCTs used procedural and cost outcomes (32%) and 
four defined primary outcomes were categorized as “other” outcomes (12%). None of the 
RCTs was carried out with a primary focus on surgeon-comfort outcomes. 
Two RCTs assessed clinical effectiveness as primary outcome, two other RCTs clinical and 
technical effectiveness and one RCT technical effectiveness. A total of 32 RCTs reported 
measures of effectiveness as a secondary outcome including nine times clinical and 
respectively 14 times technical measures. Seventeen trials reported conversions. 
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The distribution of secondary outcomes was as follows: 24% of the secondary outcomes 
were set at safety, 22% at procedural and costs, 19% at effectiveness 17% at ‘other’, 15% at 
patient comfort, and 3% at surgeon comfort (figure 3b). 
Based on the particular findings of each individual RCT we judged none of the RCTs providing 
sufficient evidence supporting the newer method should be implemented in daily surgical 
practice. From the results of 40 RCTs we found the newer method not (yet) acceptable since 
more important outcomes should be evaluated. From the results of seven RCTs we judged 
the newer method should not be implemented at all because the newer method showed 
more disadvantages and less advantages.
Figure 2 Flowchart of selection of studies. last searched may 22th 2017, Cochrane Library, Cochrane 
Reviews, Browse by topic, Gynaecology 566 HITS.
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Clearness
A total of 31 RCTs (66%) performed a sample size calculation for the primary study outcome 
(figure 4). The total calculated sample size was included in 25 RCTs. One RCT did not achieve 
the calculated sample at all, in four RCTs the distribution of the sample size across the groups 
was inadequate resulting and the distribution was unclear in one RCT. For all 25 RCTs with 
sufficient sample size the intended duration of follow-up was estimated to be appropriate 
for the analysis. 
Figure 3 a) Primary study outcomes, categorized. b) Secondary study outcomes, categorized.
Figure 3.  
a. Primary study outcomes, categorized 
b. Secondary study outcomes, categorized 
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Objectivity
We found 39 (83%) abstract conclusions concordant with the conclusions in the full text of 
the article. In eight RCTs (17%) we judged the abstract conclusion discordant with the full 
text conclusion. Six abstract conclusions were more positive compared to the conclusion 
in full text. One full-text conclusion described extra advantages compared to the abstract 
conclusion. And in one RCT word usage differed between the abstract and full text conclusion 
leading to confusion about what was actually meant.
In eight (17%) RCTs we found the conclusion completely matching with the results. From 10 
RCTs (21%) we criticized the conclusion “largely” matching the results, in 22 (47%) this was 
“partly” and in seven (15%) the conclusion did not match the results at all. The conclusion of 
24 (51%) RCTs was labelled having a “outspoken” style. In 16 of these the authors concluded 
the “newer” method being “superior” to the existing method. In six RCTs the methods were 
concluded to be “indifferent” and in two the newer method was judged “inferior”. In the 
conclusions of the remaining 23 (49%) RCTs a more nuanced judgement was postulated, 
where the pros and cons were more specifically described. The RCTs with “nuanced” 
conclusions showed statistically different scores for consistency of conclusion with results 
compared to RCTs with “outspoken” conclusions (p = 0.01).
Figure 4 Sample size and follow up flowchart.
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Discussion
Main results
Concerning the clinical relevance, in this cohort of 47 recent RCTs on gynecological minimally 
invasive surgery, over 60% focussed their primary study outcomes on patient comfort, 
procedural and cost aspects. Outcomes on effectiveness and safety remained underexposed. 
The results of individual RCTs showed insufficient evidence to support implementation of 
a new method into surgical practice. The ability to provide clarity was suboptimal: slightly 
more than 50% of the RCTs paid sufficient attention to an adequate sample size calculation 
followed by sufficient inclusion and distribution across the study groups. The objectivity of the 
studies is also debatable: we found discordance in the conclusions stated in the full articles 
compared with those in the accompanying abstracts in more than 15% or the RCTs. We also 
found that a substantial percentage of the conclusions in RCTs were not (15%) or just partly 
(47%) matching the actual results. The conclusions were formulated in different styles: we 
could distinguish a “nuanced” style and an “outspoken” style. The style of the conclusion 
and the degree of consistency between study-results and conclusion seems to be associated. 
Importance to clinicians and researchers
These findings inform the readers of medical scientific literature that the clinical relevance, 
clearness and objectivity of RCTs on gynecological MIS can be unsatisfactory. It appears 
that RCTs do not provide sufficient information for decisions on implementation of new 
MIS techniques. Furthermore, it is of clinical importance that authors, reviewers and 
editors criticize the consistency between results and conclusions of their forthcoming study 
publications.  
Additionally, these findings should alert researchers. The usefulness of RCTs on new tech-
niques in MIS could be improved. Study objectives should be considered clinically relevant. 
A proper RCT focusses on relevant outcome measures and applies a careful weighting to 
assess the importance of related clinical outcomes. Study outcomes should be chosen for 
their clinical relevance and study designs should fit the study objective. This study shows 
that RCTs are not necessarily the appropriate design to study effectiveness and safety in MIS: 
the reality shows it is challenging to recruit sufficient participants and to achieve long-term 
follow-up to provide clearness. Observational studies can provide evidence additional to 
that available from randomised trials about long term outcomes, rare events, adverse effects 
and populations that are typical of real world practice (12). 
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Other publications and concerns on this topic
This is not the first study that identifies the shortcomings in clinical relevance, clearness and 
objectivity of RCTs. From among 114 published RCTs of systemic therapy in lung cancer, 10% 
of the articles presented discordant conclusions in the abstract versus article (13). Another 
study compared the abstract conclusions and results sections of 144 RCTs in rheumatology 
and reported almost one quarter contained misleading conclusions (14). The issues even 
extend far beyond invalid research conclusions: concerns about poor clinical research design 
and the arbitrary choice of analyses and an overemphasis on random extremes affecting 
reported findings have been growing increasingly (15,16). Statements and networks have 
been designed to increase the value in research design, conduct and analysis (such as the 
Equator network, REWARD statement and CONSORT STATEMENT) (17,18,9). All with the 
purpose of making clinical research more useful.  
Alternative explanations for the observations
We already discussed one reason why the RCTs tended to refrain from studying the most 
clinically relevant outcomes of effectiveness and safety: - RCTs are not necessarily the 
appropriate design. This methodological challenge is also represented where half of the 
effectiveness-outcomes were set for technical effectiveness and the other half respectively 
for clinical effectiveness. In trials on surgical procedures, technical effectiveness is more often 
evaluated since it has less methodological barriers compared to clinical effectiveness. Another 
underlying reason might be that there already is sufficient knowledge of these outcomes (and 
these outcomes did not need to be studied anymore). Two other possible reasons we did 
not explore, could be publication bias and conflicts of interest. Ocana et al. also suggested 
the choice to investigate less relevant outcome measures might be the consequence of the 
quest for adequate statistical power (at the cost of generalizability) (18).   
The assessment objectivity: consistency between study results and conclusions, is a complex 
process that relies on subtle interpretations of language used to convey a bottom-line 
message from the study. To minimize the impact of subjectivity, two authors independently 
categorized the conclusions, with any disagreements being resolved by consensus. The 
inconsistencies we found between study results and conclusions could be subject to our 
self-designed assessment tool and personal interpretation. The validity of our assessment 
may be improved by expanding such an evaluation, with multiple reviewers and a more 
sensitive assessment scale (e.g. 7-point Likert scale).    
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Limitations of the study
As described, the assessment of objectivity should be viewed with caution, because 
interpretation is subject to differences in individual perception. Thereby, the assessors were 
not blinded for information that could lead to conscious or unconscious bias on their part. 
This was not feasible because blinding would hinder adequate evaluation of the relevance 
of outcome measures. Additional to the validity of our assessment of objectivity, there 
are some other limitations. We focused on RCTs in one medical field (minimally invasive 
surgery). We restricted our selection of articles because of our particular experience in this 
specialty. The results of this study may, accordingly, not be generizable to other medical areas. 
Furthermore, we selected RCTs that were included in Cochrane reviews. We assumed the 
Cochrane database as a helpful base for our study: the methodological quality of included 
trials is already systematically and critically assessed (e.g. risk of bias assessment and 
prioritizing outcome measures). However, this selection results in the risk for a selection 
bias: non-Cochrane RCTs may have different outcomes. To get more insight in the clinical 
relevance, clearness and objectivity of RCTs, studies are needed to see whether our results 
are confirmed in more randomly selected RCTs and within other medical areas. 
Finally, determining the clinical relevance of the outcome measures gives difficulties. Clinical 
relevance is subject to several factors, including the severity and consequences of the type 
of disease, patient’s context (e.g. age) and cultural values. To explain this: in the case of an 
oncological disease, long-term patient comfort may be more important than recurrence free 
survival (effectiveness). And: “should paralytic ileus time”, “febrile morbidity” or “blood loss” 
be categorized as a safety concern or patient comfort? This should of course depend on the 
impact on the patient’s quality of life. These difficulties can be resolved when outcomes for 
RCTs are carefully weighted for their clinical importance and thoroughly specified at the 
set-up of an RCT.         
Conclusion
The findings of our study show that the clinical relevance, clearness and objectivity of RCTs 
on gynecological MIS can be unsatisfactory. It appears that RCTs do have large difficulties to 
provide sufficient information for decisions on implementation of new MIS techniques. The 
validity of observational studies should be further explored to provide additional evidence. 
Furthermore, it is of clinical importance that authors, reviewers and editors criticize the 
consistency between results and conclusions of their forthcoming study publications. 
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Minimally invasive surgery (MIS) aims to achieve at least similar clinical effectiveness for a 
quicker recovery compared to the conventional surgical approaches. In the last decades, 
MIS has led to great clinical improvements in many fields of surgery; however the invasive 
and innovative character also entails additional risks. Starting something new is often 
more difficult and risky than doing things the old familiar way. Clinical research generates 
knowledge that allows assessment whether the aims of MIS are targeted. Gathering the 
best evidence from clinical research and subsequently integrating it into daily practice gives 
valuable input to evolve MIS.   
This thesis describes the multidisciplinary guideline for minimally invasive surgery, identifies 
the scientific evidence of four recent innovations within MIS, addresses the quest for evidence 
supporting surgical practice and appraises the clinical relevance, clearness and objectivity 
of recent randomized controlled trials in MIS.
The translation from evidence to practice: evidence-based guidelines
Evidence-based guidelines facilitate integration of the best evidence into surgical practice. 
Guidelines are developed by groups of experienced individuals who carefully weigh syntheses 
of evidence and the strength of the evidence before developing recommendations for 
interventions (1). In Chapter 2 we present the multidisciplinary evidence-based guideline 
for MIS. At the initiation of the development of this guideline, the problem analysis revealed 
the following main problem topics in laparoscopic surgical practice: entry-techniques, the 
pneumoperitoneum, port instruments, trocar site closure and electrosurgical techniques. 
Based on the available evidence we formulated general recommendations for minimally 
invasive surgery. However, the majority of recommendations in the guideline was based 
on the findings of descriptive studies and expert opinion. To date, high quality evidence is 
lacking to formulate clear answers to important clinical questions. The unanswered questions 
offer interesting opportunities for future research. This illustrates the dynamic and cyclic 
process of an evidence-based guideline: pragmatic clinical questions lead to a review of the 
evidence, the best evidence is extracted, balanced with other considerations to formulate 
recommendations for clinical practice and future research. In a later stage, new research will 
potentially provide answers to the outstanding questions resulting in new recommendations 
for clinical practice. Eventually leading to better surgical care.      
Gathering evidence of new techniques in minimally invasive surgery
The evolution of instrumentation leads to the development of new applications for minimally 
invasive surgery. As shown in the evidence-based guideline, questions about the safety of 
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different port instruments persisted (i.e. trocars). The aim to make the use of trocars more 
effective and safe results in continuing development of different trocar types. In Chapter 3, 
we present a systematic review that assesses the evidence of trocar types. We used GRADE 
(Grading of Recommendations Assessment, Development and Evaluation), as a tool that 
facilitates the translation from evidence to recommendations (2). This method optimizes 
the presentation of evidence per clinically important outcome. The review on trocar types 
showed a lack of data from randomized controlled trials (RCTs) on the incidence of major 
trocar-related complications. The incidence of these serious complications was extremely low 
and a RCT is therefore not the most appropriate design of choice. Adaptations in the design 
of trocars to prevent adverse events that occur only infrequently may be best assessed by 
good-quality observational studies such as cohort and case-control studies. Minor trocar-
related complications (trocar site bleeding, trocar site infection and trocar site herniation) 
were generally more common: low quality evidence suggested the use of radially expanding 
trocars compared to cutting trocars leads to reduced incidence of trocar site bleeding. Though 
this outcome is viewed with less clinical importance. The review particularly illustrates the 
importance of focussing on the outcome measures when selecting a study design. Studies 
on outcomes that can be expected shortly after the intervention and with high incidence 
rates, do fit in an experimental (RCT) design. Though, studies on outcomes that are extremely 
rare, need large well-conducted observational studies. The disadvantage of observational 
studies is however the risk of bias. This emphasizes the importance of proper methodology 
to reduce the risk of bias. It is finding the balance, on one hand, the most rigorous method 
(RCT) though with usually insufficient power to draw conclusions and, on the other hand, 
observational studies to gain more power to draw conclusions though with an increase in 
risk of bias. 
Returning to the trocar types, the systematic review of RCTs provided advantageous evidence 
for the radially expanding trocar concerning minor complications, however, the clinical 
importance of this finding is debatable. To get more clarity upon possible risk-differences 
between trocar types, a systematic review including (non-randomized) observational studies 
may provide more information. 
We explored the latter, investigating the possible advantages of laparoendoscopic single-site 
surgery (LESS) for hysterectomy over the conventional laparoscopic approach. 
LESS was designed to decrease abdominal wall trauma resulting in less postoperative pain 
and better cosmetic outcomes. In Chapter 4 we primarily investigated the safety, effectiveness 
(including conversion rate, postoperative pain and patient satisfaction) of LESS hysterectomy. 
A total of 23 comparative studies (RCTs plus comparative cohort studies) with approximately 
4000 participants did not reach sufficient power to measure differences for infrequent outcomes, 
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such as major complications and conversions. Where statistically significant advantages for 
the outcomes postoperative pain, operative time and hospital stay appeared, these results 
show significant statistical heterogeneity and should be interpreted with caution. The 
evidence regarding the advantages of LESS-hysterectomy is not a sufficient base for broad 
implementation of this surgical technique. It can be stated that this technique is still under 
evaluation. Future RCTs with adequate power are mandatory to identify the possible benefits 
in patient satisfaction and cosmetic satisfaction. Furthermore a better understanding of its 
effectiveness and costs is needed. Remarkably, more than 85% of the included studies on LESS 
originated from Asia. This remark also applies to the Natural Orfice Translumenal Endoscopic 
Surgery (NOTES)- hysterectomy. NOTES is another new approach for hysterectomy, where 
the transvaginal access route is used to perform intra-abdominal surgery. Also here, the 
effectiveness of NOTES could not be fully demonstrated. The scant available evidence for NOTES 
was found to be retrieved from Asian tertiary centres with a high proficiency for doing this kind 
of advanced surgery (3). Publication bias could be the underlying reason or reasons causing 
Asian surgeons to be more inclined to use such new approaches. Those motives could be 
technological advancement, commercial drives or maybe cultural motives regarding cosmetics. 
Another new minimally invasive technique that was enthusiastically introduced in the United 
States and Europe is hysteroscopic sterilization. Also within the purposes of MIS, hysteroscopic 
sterilization aims to avoid incisional surgery and further reduce morbidity compared to the 
conventional techniques (laparoscopic sterilization). An additional advantage of hysteroscopic 
sterilization is the reduced need of anesthesia, which facilitates the procedure in an ambulatory 
setting. To verify the effectiveness (i.e. reliability) and safety of the hysteroscopic sterilization 
we performed a systematic review, presented in Chapter 5. The review was performed in 
2015, all data from available observational studies that involved more than 20 participants 
were included. Three types of devices that have been available on the market were evaluated: 
Ovabloc, Essure and Adiana. At the time of performing the review, Ovabloc and Adiana were 
no longer available, Essure still was. From a total of 37 articles concerning Essure (counting 
over 14,000 women), the effectiveness (i.e. reliability), long term safety and risk factors for 
failure of sterilization could not be identified. 
From evaluation to introduction into practice
In 2002, the U.S. Food and Drug Administration (FDA) approved the Essure technique for clinical 
use. The approval was based on two short-term safety studies, 92% of the participants were 
followed up at one year, and 25% for two years (4,5). More than ten years after the approval 
an estimated 750,000 women that had received Essure, even though the effectiveness and 
long-term safety remained unclear. Indeed, the clinical research with regards to Essure has 
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not gone beyond demonstrating feasibility. Hence, since 2013 Essure has been the subject of 
controversy raised by large numbers of women with these devices who complained of adverse 
events (6). In 2015, the FDA reconvened its Obstetrics and Gynecology Devices Panel to evaluate 
its safety and effectiveness and to investigate the need for additional post marketing studies 
(7). In 2017, the manufacturer withdrew the product from the Dutch market. 
A similar situation concerning the clinical introduction of robotic- assisted surgery is described 
in Chapter 6. We questioned the progress of introducing robotic-assisted surgery, given the 
high costs and small scientific evidence. In the Netherlands, the robotic-assisted radical 
prostatectomy (RARP) is the most frequently performed robotic-assisted procedure. We 
found robotic-assisted surgery being increasingly applied into Dutch urological surgical 
practice, although the clinical superiority compared to the existing techniques (open and 
laparoscopic prostatectomy) had not been demonstrated. Robotic assistance for performing 
radical prostatectomy was introduced in the early 2000s with the aim to overcome significant 
challenges and learning curve for laparoscopic radical prostatectomy (LRP) (8). The surgical 
system currently used for RARP, is called the da Vinci® surgical system and offers additional 
technological innovations (3D visualisation, articulated instruments, tremor filtration) 
addressing some of the technical limitations of LRP. A recent systematic review showed 
the lack of high-quality evidence from RCTs for prostate cancer-specific survival and other 
oncological outcomes (9). Other systematic reviews of non-RCTs concluded that the quality 
of the evidence base in observational studies is low (10,11). RARP is still under evaluation: 
understanding of the impact of risk of LRP/RARP on oncological outcomes is needed. The 
robotic-assisted technology is likely to provide useful benefits. But still, it appears difficult to 
prove the effectiveness compared to the conventional laparoscopic techniques. For example 
in gynecologic oncology concerns were raised about the minimally invasive hysterectomies 
for endometrial cancer. In 2010, in the United States, around 60% were performed robotically, 
despite the limited available evidence (12). The highlighted examples illustrate a self- regulated 
process of surgical innovation: following FDA approval or a CE marking (Conformité Européene) 
products may be legally placed on the market. Thereafter, the extent of clinical implementation 
and evaluation depends on its users, manufacturers and local authorities. The extent of clinical 
implementation of a new technique is subject to different forces. Commercial drives of the 
industry, funders of research and development, characteristics of early users, perceptions and 
medical publishing industry are elements influencing the innovation environment. In general, 
sales of new devices and instruments are permitted in most jurisdictions on the basis of proof 
of safety (e.g. the FDA, CE marking), rather than of efficacy or effectiveness. Implementation of 
new appliances just after CE marking exposes health care to risks of unexpected patient harm, 
suboptimal treatments and higher costs. On the other hand, a vigorous ongoing process of 
innovation is central to continuing improvement of surgical care. Delaying the introduction of 
an ‘effective’ technique into surgical practice, may withhold benefits to patients. 
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Challenges for RCTs in minimally invasive surgery
In clinical research, RCTs are still considered the gold standard for establishing data about 
safety and effectiveness of an intervention. A proper RCT, focusses on relevant outcome 
measures and applies a careful weighting to assess the importance of related clinical 
outcomes. Secondly, it has the potential to provide a clear and distinctive answer to its 
research question. Thirdly, it is objective and based on facts. Therefore the ingredients for 
an appropriate trial are: 
1. clinical relevance: it includes a consideration of assessing effectiveness, safety, patient 
comfort, procedural aspects (i.e. costs) and surgeon comfort of a surgical procedure.
2. clearness: it considers an adequate power and follow up, calculated for the defined 
outcome(s) of the trial. Adequate study power and follow up to ensure sufficient 
distinctiveness and to provide a clear answer to the study objective.
3. objectivity: it includes a conclusion that represents the actual study results.   
In Chapter 7 we examined recent RCTs on gynecological MIS for clinical relevance, clearness 
and objectivity. We found more than 60% of RCTs had focussed their primary outcome 
on patient comfort, procedural and cost aspects. Clinically more relevant outcomes for 
effectiveness were underrepresented. Primary outcomes for effectiveness were set in only 
15% of the included RCTs. With regards to clearness, slightly 50% of the RCTs included 
sufficient participants in both study arms, meeting the calculated sample size. With these 
little study-powers, nearly half of the RCTs could not ensure sufficient distinctiveness to 
provide a clear answer to the study objective. A third weakness was identified in the objectivity 
in presenting results and conclusions of a RCT. In 15% of the RCTs the conclusion was 
inconsistent with the actual study results. As previously mentioned, and supported by these 
findings, RCTs are not necessarily the appropriate design to study effectiveness and safety 
in MIS. The reality shows it is challenging to recruit sufficient participants and to achieve 
long-term follow-up to provide clearness. Furthermore, to improve the clinical relevance of 
forthcoming study publications it is of clinical importance that authors, reviewers and editors 
criticize the consistency between results and conclusions of their manuscripts.  
Conclusions
MIS is introduced with the aim to achieve at least similar clinical effectiveness with a quicker 
recovery compared to the conventional surgical approaches. The last decades, MIS has led 
to great clinical improvements in many fields of surgery. The advent of evidence-based 
medicine has led to increasingly more clinical research (including RCTs) which has been 
carried out within the field of MIS. This brings great possibilities to acquire knowledge whether 
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the targets in MIS are achieved and how MIS should be applied to improve healthcare. The 
acquired knowledge can subsequently be reviewed and summarized to synthesize a practical 
guideline. In this way, the “multidisciplinary evidence-based guideline for minimally invasive 
surgery” facilitates the integration of the best evidence into MIS practice. The guideline 
additionally identifies a substantial lack of high quality evidence for important clinical 
questions. These unanswered questions offer interesting opportunities for future clinical 
research. Evidence-based guidelines would thus be a good addition to the innovation cycle: 
by reviewing the existing evidence and indicating which innovation and research are needed. 
We reviewed three innovations within MIS: trocar types, LESS and hysteroscopic sterilization. 
These reviews typically provide data on short term outcomes. For all three subjects, it showed 
lack of evidence for infrequent outcomes and long term outcomes. These concerned in 
particular outcomes as major complications and long-term effectiveness (contraceptive). 
The latter information should probably be searched in well-conducted observational studies. 
Although these three innovations and robotic -assisted surgery have promising advantages, 
their clinical superiority has not (yet) been demonstrated. Therefore, these techniques should 
be considered under evaluation. 
MIS continues to evolve through innovation, though appropriate frameworks for regulation 
and evaluation of innovation in MIS are needed. The usefulness of RCTs on new techniques 
in MIS could be improved. Eventually, we have seen that a RCT is not necessarily the most 
appropriate design to evaluate new techniques. Study designs should fit the study objective 
and thus focus on the primary outcome measure. 
There is a lot of activity in clinical research for MIS. MIS has brought clinical improvement 
through innovation and research. There still is substantial room to optimize the 
implementation of evidence-based MIS. There are many opportunities from different 
perspectives to pursue improvement, several are described in the future perspectives.  
Future perspectives
Extracting clinically driven research questions from evidence-based guidelines
Within the development and maintenance of guidelines, good opportunities are provided 
to identify knowledge gaps and formulate clinically driven questions for research. A useful 
distinction can be made for the type/direction of research questions: developmental, 
explanatory or pragmatic: developmental questions seek new methods or devices, 
explanatory questions seek whether a new method can work and pragmatic questions seek 
to inform clinical decisions. The advantages of this method for extracting research questions 
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are: focus on the needs of MIS practice and specification of important clinical outcomes to 
be addressed. Currently, robotic-assisted surgery and hysteroscopic sterilization are, with 
many others, interesting subjects for the development of evidence-based guidelines and 
subsequently extract research questions. 
(Re)organizing research for MIS
Incorporating different experts into research teams, representing the necessary disciplines 
(including clinicians, methodologists, statisticians, patients, research nurses) enables a better 
match between clinically-driven research questions and study-design and conduct. Much 
research has been done by individuals for whom it is not their main sphere of activity; notably, 
clinicians are expected to conduct some research early in their careers. Methodological 
experts name this as one of the factors related to poor quality research (13,14). The 
importance of involving methodologists and statisticians also applies to accomplishment 
of systematic reviews. Cochrane is a global independent network, concerned with the 
methodology of systematic review. Their aim is to summarize the best health evidence from 
research (15). Though Cochrane groups principally conducted systematic reviews only on 
RCTs, recently Cochrane members became more interested in considering nonrandomized 
studies for systematic reviews. Debate about the validity of observational studies versus 
randomized trials for estimating effectiveness and safety of interventions has continued 
for decades (16,17). This thesis contains two systematic reviews where it showed that the 
included RCTs were not large enough to accurately measure outcomes of interest that are 
infrequent and/or in distant future. Observational studies can provide evidence additional to 
that available from randomised trials about long term outcomes, rare events, adverse effects 
and populations that are typical of real world practice (18). Methodologists are continuously 
exploring the validity of observational studies (19).   
The above described developments apply to evidence-based medicine in general and should 
be passed through to MIS. Within MIS, additional emphasis should be placed on the need 
for (re)organizing surgical research. Formal assessment (RCTs) might even be less feasible 
in surgery than in other medical domains (20). Widespread use of prospective databases 
and registries for MIS have the potential to provide solutions.
Close involvement with innovating industry and technology
Various forces are involved with the introduction of surgical innovations into clinical practice. 
Commercial drives play a major role: it is in the interest of the manufacturer to increase the 
market share. Though clinicians primarily have pragmatic objectives: to improve health care 
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through innovation. The first drive is called a commercially driven approach, the second 
a clinically driven approach and a third drive is the technically driven approach, where 
indications are searched to use an existing technology (for example robotic surgery, laser 
surgery) (21). Enhancing the communication between these forces, potentially leads to better 
alignment of their efforts and would make the process of surgical innovation more efficient. 
Frameworks for evidence-based MIS 
The intricate relation between innovation and daily practice in MIS needs a formalised 
evaluative framework. The last decade, various attempts have been made to develop a 
framework for regulation and evaluation of surgical innovation: ‘IDEAL’, ‘NOSCAR’ (22), 
‘Leidraad nieuwe interventies in de klinische praktijk’. The IDEAL (Idea, Development, 
Exploration, Assessment, Long term study) recommendations called for modifications 
to systems for regulating surgical innovation and for a change to the standard against 
which these innovations should be measured before being approved for general use, from 
demonstration of safety, to evidence of efficacy (20,23,24). They proposed recommendations 
for the assessment of surgery based on a five-stage description of the surgical development 
process. In 2014, in the Netherlands, a framework for new techniques was developed (25). 
The Dutch framework describes the conditions for careful introduction and evaluation of 
new methods in clinical practice. Potential roles for medical specialists and other healthcare 
professionals in this process are suggested. The above perspectives fit into these frameworks. 
Paramount is proper communication and collaboration between stakeholders and the 
implementation of these or similar frameworks. 
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In the last decades, minimally invasive surgery (MIS) has led to great clinical improvements in 
many fields of surgery, achieving at least similar clinical effectiveness for a quicker recovery 
compared to the conventional surgical approaches. However, the invasive and innovative 
character also entails additional risks. Clinical research generates knowledge that allows 
assessment whether the aims of MIS are targeted. Gathering the best evidence from clinical 
research and subsequently integrating it into practice gives valuable input to evolve MIS. 
In 2007, the Dutch Health Care Inspectorate published the report “Risico’s minimaal 
invasieve chirurgie onderschat”. They had conducted a study of the risks presented by MIS 
procedures and observed many unsubstantiated pragmatic differences between general 
surgery, gynecology and urology. Though these specialisms practice relatively similar basic 
techniques, there was little cooperation to assure and improve the quality of minimally 
invasive surgery. The Dutch Health Care Inspectorate encouraged the specialties practising 
laparoscopic surgery to develop a multidisciplinary guideline for MIS, with the purpose to 
reduce large variations in surgical care.
In this thesis we presented the multidisciplinary guideline for minimally invasive surgery. 
With the development of this guideline, multidisciplinary recommendations were formulated, 
based on ‘evidence’ and balanced with ‘experience’. An evidence-based (EB) guideline is an 
instrument supporting integration of the best evidence into clinical practice. Eventually this 
guideline as well identified knowledge gaps for future research. Thereafter, we identified 
the scientific evidence for four recent innovations within MIS and addressed the quest for 
evidence supporting surgical practice. Finally we appraised the clinical relevance, clearness 
and objectivity of recent randomized controlled trials in MIS. 
In Chapter 2, the multidisciplinary evidence-based guideline is presented. The following 
main problem topics in laparoscopic surgical practice discussed were: entry-techniques, the 
pneumoperitoneum, port instruments (i.e. trocars), trocar site closure and electrosurgical 
techniques. Remarkably, the majority of recommendations in the guideline was based on 
the findings of descriptive studies and expert opinion. High quality evidence to formulate 
clear answers to important clinical questions was lacking. For example, questions about the 
safety of different trocar types remained unanswered. 
In Chapter 3, we assessed the evidence of trocar designs for laparoscopy. Trocar designs 
are continuously being innovated to improve the safety of trocar use. We analysed the 
rates of trocar-related complications and postoperative pain for different trocar types. 
The examined trocar types were: radially expanding, cutting, conical blunt-tipped, single-
bladed and pyramidal-bladed. Data were lacking on the incidence of major trocar-related 
complications, such as visceral or vascular injury, when comparing different trocar types 
with one another. However, caution is urged when interpreting these results because the 
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incidence of serious complications following the use of a trocar was extremely low. There 
was very low quality evidence for minor trocar-related complications suggesting that the 
use of radially expanding trocars compared to cutting trocars leads to reduced incidence of 
trocar site bleeding. These secondary outcomes are viewed to be of less clinical importance. 
Regarding postoperative pain, there was insufficient evidence to draw a conclusion. Here, 
we encountered the problem of a RCT design for assessing complications that occur 
infrequently. RCTs are rarely large enough to measure accurately infrequent outcomes. We 
advise to establish an international network for recording infrequent but clinically important 
complications following laparoscopic surgery.  
In Chapter 4 we systematically reviewed the evidence of a second innovation in MIS: 
laparoendoscopic single-site surgery (LESS) for hysterectomy. RCTs and observational 
studies comparing LESS versus conventional laparoscopy for hysterectomy were included 
for analysis. 
We found very low quality evidence suggesting LESS – hysterectomy to be equally safe 
compared to conventional laparoscopic hysterectomy. This results should be interpreted 
with caution: very low quality evidence means the estimated effect is very uncertain and the 
number of participants (n = 4,000) does not provide sufficient power to measure differences 
for infrequent outcomes. We found the outcomes of effectiveness discussable, since in 3.5% 
of the LESS procedures an additional port was needed. No clinically relevant advantages 
were identified regarding postoperative pain, patient satisfaction (including cosmetic 
satisfaction) and operative time. We concluded that there are no current valid arguments 
to broadly implement LESS for hysterectomy. 
A third innovation in MIS, hysteroscopic sterilization, was evaluated in Chapter 5. We 
performed a systematic review of the literature to assess the feasibility and effectiveness 
of hysteroscopic sterilization and to identify risk factors for failure of sterilization. No RCTs 
comparing hysteroscopic sterilization with laparoscopic sterilization (the conventional 
technique) were found. Very low quality evidence from observational studies (prospective 
as well retrospective) demonstrated that hysteroscopic sterilization is feasible. However, 
the effectiveness and risk factors for failure remained unclear. Studies on hysteroscopic 
sterilization are lacking sufficient power and complete long-term (> 10 years) follow-up on 
unintended pregnancies and complications. Chapter 3, 4, and 5 do all support that RCTs are 
not necessarily the appropriate design to study effectiveness and safety in MIS. Therefore, 
when choosing a study design it is important to focus on the primary outcome. Outcome 
measures to be expected shortly after the procedure and with high incidence rates could 
best be investigated in a RCT. Though, research questions on outcomes that are extremely 
rare need large well-conducted observational studies.  
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In Chapter 6 we evaluated a fourth innovation in MIS, robotic-assisted surgery. In the 
Netherlands, robotic-assisted radical prostatectomy (RARP) is the most frequently performed 
robotic-assisted procedure. At the same time, the clinical superiority of RARP compared to 
open (RRP) and laparoscopic prostatectomy (LRP) has not been demonstrated. Given the high 
costs and small scientific evidence, the introduction of robotic surgery has been irresponsibly 
quick. Better scientific research of robotic surgery is needed before this technology can be 
broadly applied in clinical practice.
Clinical research generates knowledge that allows assessment whether the objectives in MIS 
are targeted. RCTs are considered the gold standard in clinical research. In Chapter 7 we 
examined recent RCTs in MIS and appraised their value in generating useful knowledge for 
the implementation of MIS innovations into daily surgical practice. Concerning the clinical 
relevance of these RCTs we found primary outcomes for effectiveness were set in 15% and 
for safety in 12% of the included RCTs. Nearly 50% of the RCTs could not ensure sufficient 
distinctiveness, due to inadequate study-power to provide clear answers to their study 
objectives. At last, we observed substantial inconsistencies between conclusions drawn 
and the actual reported results. 
To conclude, 
MIS has led to great clinical improvements in many fields of surgery; however the invasive 
and innovative character also entails additional risks. Clinical research generates knowledge 
that allows assessment whether the aims of MIS are targeted. A guideline facilitates the 
integration of the best evidence into clinical practice. Thereby, with the development of a 
guideline, knowledge gaps can be identified for future research. This thesis provides insight in 
the evidence of MIS and its limitations. Therewith, we provide guidance to optimize research 
and evidence-based implementation of MIS towards better minimally invasive surgical care. 
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De introductie van de minimaal invasieve chirurgie (MIC) in het chirurgisch palet heeft de 
afgelopen decennia gezorgd voor een revolutie in het oplossen van chirurgische problemen. 
Zo heeft deze techniek ertoe geleid dat minimaal invasieve chirurgische ingrepen vergeleken 
met de bestaande conventionele ingrepen een kortere herstelperiode hebben bij tenminste 
gelijke effectiviteit. Het minimaal invasieve en innovatieve karakter brengt echter ook risico’s 
met zich mee. Klinisch onderzoek kan bewijzen of met deze techniek de beoogde doelen 
daadwerkelijk behaald worden. Door het beste beschikbare wetenschappelijke bewijs uit 
klinisch onderzoek te verzamelen en vervolgens te integreren in de praktijk, wordt waar-
devolle input gegeven aan de evolutie van deze chirurgische techniek om haar zo op haar 
merites te kunnen beoordelen. Ook voor de introductie van nieuwe technieken in deze, zal 
nader klinisch onderzoek noodzakelijk zijn.   
In 2007 bracht de Inspectie voor de Gezondheidszorg (IGZ) het rapport “Risico’s minimaal 
invasieve chirurgie onderschat” uit. Hierin rapporteerde de inspectie haar onderzoek naar 
de risico’s van minimaal invasieve chirurgie. Onder de verscheidene disciplines die MIC uit-
oefenen (chirurgie, gynaecologie en urologie), bleken er veel ongegronde verschillen in de 
uitoefening te bestaan. Hoewel de basistechnieken van MIC in grote mate overeenkomen, 
bestond er weinig multidisciplinaire samenwerking om de kwaliteit van de MIC te borgen en 
te verbeteren. De in het IGZ-rapport beschreven problematiek noodzaakte de beroepsver-
enigingen tot het opstellen van een multidisciplinaire richtlijn, met als doel het reduceren 
van de praktijkvariatie binnen de MIC.
In dit proefschrift presenteren we allereerst de multidisciplinaire richtlijn Minimaal Inva-
sieve Chirurgie. Deze richtlijn omvat multidisciplinaire aanbevelingen die gebaseerd zijn 
op evidence (wetenschappelijk bewijs) gecombineerd met de kennis, ervaring en mening 
van deskundigen. De evidence-based richtlijn MIC biedt ondersteuning bij het integreren 
van het beste beschikbare wetenschappelijke bewijs in de klinische praktijk. Daarnaast 
geeft de Richtlijn MIC inzicht in de kennishiaten die er bestaan en die interessant zijn voor 
toekomstig onderzoek. In het tweede deel van dit proefschrift spitsen we ons toe op drie 
recente innovaties binnen de MIC, te weten:
1. trocartypes voor laparoscopische chirurgie
2. single port chirurgie
3. hysteroscopische sterilisatie.
Van deze innovaties presenteren we een systematisch overzicht (systematic review) van het 
beschikbare wetenschappelijke bewijs en identificeren we de behoefte aan wetenschappelijk 
onderzoek met een goede methodologische kwaliteit. Vervolgens wordt in het derde deel 
de introductie van de robotchirurgie in Nederland beschreven in het licht van de kennis over 
de klinische effectiviteit en de veiligheid van deze techniek. Tot slot worden in het vierde 
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deel van dit proefschrift de klinische relevantie, duidelijkheid en objectiviteit van recente 
gerandomiseerde gecontroleerde studies over MIC beoordeeld. 
De multidisciplinaire richtlijn Minimaal Invasieve Chirurgie wordt in hoofdstuk 2 van dit proef-
schrift beschreven. Belangrijke knelpunten uit de klinische praktijk van de MIC worden in de 
richtlijn behandeld. Deze knelpunten betreffen de volgende onderwerpen: entreetechnieken, 
het pneumo-peritoneum, poort-instrumenten (trocars), het sluiten van insteekopeningen en 
elektrochirurgische technieken. Opvallend is dat de meerderheid van de aanbevelingen in 
de richtlijn gebaseerd is op de bevindingen uit beschrijvende studies en de meningen van 
deskundigen. Er ontbrak hoogwaardig wetenschappelijk bewijs voor het formuleren van 
duidelijke antwoorden op belangrijke klinische vraagstellingen. Zodoende bleven onder 
andere vragen over de veiligheid van verschillende typen trocars onbeantwoord.
Er vindt continue innovatie plaats om veiligere trocars te ontwerpen. In hoofdstuk 3 gaan 
we in op de vragen over de veiligheid van de verschillende typen trocars. We analyseerden 
de incidenties van trocar-gerelateerde complicaties en de mate van postoperatieve pijn in 
relatie tot het gebruik van verschillende trocartypes. De onderzochte trocartypes zijn: radiaal 
expanderend, snijdend, conisch met stompe tip, trocars met een mes (zgn. single-bladed) 
en trocars met een piramidaal mes. Er waren onvoldoende data over de incidenties van 
ernstig trocar-gerelateerde complicaties (zoals visceraal en vasculair letsel) bij het verge-
lijken van verschillende trocartypes. Deze bevindingen moeten echter met voorzichtigheid 
worden geïnterpreteerd, omdat de incidentie van ernstige trocar-gerelateerde complicaties 
überhaupt erg laag is (kleiner dan 1 op de 1000). Wetenschappelijk bewijs van ‘zeer lage 
kwaliteit’ suggereert dat het gebruik van radiaal expanderende trocars, vergeleken met 
snijdende trocars, tot minder poortbloedingen leidt. Vanwege de lage klinische relevantie 
worden poortbloedingen echter als een secundaire uitkomstmaat gezien. Er konden geen 
conclusies worden getrokken betreffende trocar-gerelateerde postoperatieve pijn, omdat 
ook daar onvoldoende wetenschappelijk bewijs over was. Dit hoofdstuk illustreert duidelijk 
het probleem van het gebruik van een gerandomiseerd gecontroleerd studie-ontwerp (RCT), 
wanneer bij het onderzoek de incidentie van complicaties zeer laag is, cq. zelden voorkomen. 
RCT’s zijn daarom zelden van voldoende omvang om incidentieverschillen in zeldzame 
uitkomsten accuraat te kunnen bepalen. Een oplossing voor een dergelijk probleem is om 
een internationaal onderzoeks netwerk of datacollectie op te zetten om niet-frequente doch 
klinisch relevante complicaties na MIC-ingrepen te registreren.
Een recente andere innovatie binnen de MIC is de Laparoendoscopic single-site surgery (LESS). 
In hoofdstuk 4 presenteren we een systematische review van de evidence voor de LESS be-
nadering bij de hysterectomie (LESS-hysterectomie). Voor de analyse hiervan werden RCT’s 
en observationele studies vergeleken met de conventionele laparoscopische hysterectomie. 
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Ook hier werd wetenschappelijk bewijs van zeer lage kwaliteit gevonden, wat suggereert dat 
de LESS-hysterectomie en de conventionele laparoscopische hysterectomie even veilig zijn. 
Er is echter voorzichtigheid geboden bij de interpretatie van deze bevindingen: dat het be-
wijs van lage kwaliteit is betekent dat het geschatte effect zeer onzeker is en tevens geeft het 
aantal deelneemsters (n = 4.000) onvoldoende studie power om de verschillen voor zeldzame 
uitkomsten te kunnen meten. Ook de uitkomsten betreffende de effectiviteit zijn discutabel, 
in 3,5% van de LESS procedures was er een extra toegangspoort nodig voor het uitvoeren 
van de ingreep. Ten slotte konden wij geen voordelen vinden ten aanzien van postoperatieve 
pijn, patiënttevredenheid (inclusief tevredenheid over de het cosmetische resultaat) en de 
operatieduur. We concludeerden dat er momenteel geen valide argumenten zijn om de LESS 
benadering bij de hysterectomie breed te implementeren in de dagelijkse chirurgische praktijk.
In hoofdstuk 5 evalueren we een derde innovatie in de MIC, de hysteroscopische sterilisatie. 
Aan de hand van een systematische review van de literatuur werd de haalbaarheid (feasibility) 
en effectiviteit van deze sterilisatiemethode beoordeeld. Tevens werden zo de risicofactoren 
voor het falen van een hysteroscopische sterilisatie geïdentificeerd. Er werden geen RCT’s 
gevonden waarin de hysteroscopische sterilisatie met de (conventionele) laparoscopische 
sterilisatie wordt vergeleken. Wetenschappelijk bewijs was van zeer lage kwaliteit (uit pro-
spectieve en retrospectieve studies) en laat zien dat hysteroscopisch steriliseren haalbaar is. 
Echter, de effectiviteit en risicofactoren voor het falen van deze vorm van steriliseren blijven 
echter vanuit de literatuur onduidelijk. In de studies over hysteroscopische sterilisatie ont-
breekt het tevens aan voldoende power en complete follow-up voor de lange termijn (> 10 
jaar) ten aanzien van zwangerschappen na de sterilisatie en complicaties ten gevolge van 
de ingreep. De hoofdstukken 3, 4 en 5 illustreren dat een RCT niet per se het meest geschikte 
design is om effectiviteit en veiligheid van de MIC te bestuderen. Bij het selecteren van een 
studiedesign is het daarom van belang de karakteristieken van de primaire uitkomsten 
in ogenschouw te nemen. Zo kunnen uitkomstmaten die kort na de interventie worden 
verwacht en een hoge incidentie hebben het best worden onderzocht in een RCT. Terwijl 
onderzoeksvragen over zeldzame uitkomsten het beste kunnen worden beantwoord middels 
(grote) goed uitgevoerde observationele studies.
De robot-geassisteerde chirurgie, een vierde recente innovatie binnen de MIC, wordt in 
hoofdstuk 6 geëvalueerd. In Nederland is de meest frequent uitgevoerde robot-geassisteerde 
operatie de robot-geassisteerde radicale prostatectomie (RARP). Tegelijkertijd is de klinische 
superioriteit van RARP vergeleken met de open radicale prostatectomie (RP) en de laparo-
scopische radicale prostatectomie (LRP) niet bewezen. Gezien de hoge kosten en de geringe 
wetenschappelijke evidentie verloopt de introductie van de robotchirurgie onverantwoord 
snel. Er is beter wetenschappelijk onderzoek nodig voordat robotchirurgie breed kan worden 
ingezet in de klinische praktijk.
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Klinisch onderzoek genereert kennis waarmee beoordeeld kan worden of de door de MIC 
beoogde doelen daadwerkelijk behaald worden. Binnen klinisch onderzoek wordt de RCT 
beschouwd als de goudstandaard van onderzoek. In hoofdstuk 7 onderzochten we recente 
RCT’s binnen de MIC en beoordeelden de waarde van deze RCT’s voor het genereren van 
bruikbare kennis voor de implementatie van innovaties in de dagelijkse chirurgische prak-
tijk. De klinische relevantie van deze RCT’s betreffende, zagen we dat in 15% van de RCT’s 
de primaire uitkomst een maat voor effectiviteit was en in 12% een maat voor veiligheid, 
hoewel wij deze twee uitkomsten als de meest belangrijke beschouwen. Bijna 50% van 
de RCT’s hadden onvoldoende studiepower en daarmee onvoldoende onderscheidend 
vermogen om een duidelijk antwoord te kunnen geven op de onderzoeksvraag. Tenslotte 
observeerden we substantiële inconsistenties tussen de beschreven conclusies en de gerap-
porteerde resultaten. 
Concluderend, 
De MIC heeft vele klinische voordelen voor de patiënt gebracht binnen verscheidene chirur-
gische vakgebieden. Het invasieve en innovatieve karakter van MIC brengt echter additionele 
risico’s met zich mee. Met het uitvoeren van klinisch onderzoek kan uitgezocht worden of met 
de MIC techniek daadwerkelijk de beoogde doelen behaald worden. Een evidence-based 
richtlijn biedt ondersteuning bij het integreren van het best beschikbare wetenschappelijke 
bewijs in de klinische praktijk. Daarnaast geeft het ontwikkelen van een richtlijn inzicht 
in de kennishiaten die er bestaan en die voortgang geven aan toekomstig onderzoek. Dit 
proefschrift geeft inzicht in het wetenschappelijke bewijs waarmee de MIC techniek werd 
geïmplementeerd en geeft tevens de beperkingen weer van het klinisch onderzoek doen 
naar de MIC techniek. Hiermee bieden we mogelijkheden voor het optimaliseren van klinisch 
onderzoek en het evidence-based implementeren van MIC, met als hoger doel de beste 
minimaal invasieve chirurgische zorg naar de patiënt uit te kunnen rollen.
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